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Abstract 
 
Chronic consumption of, and acute intoxication from, alcohol can have profound effects on the 
functional integrity of the central nervous system (CNS). The resident immunomodulatory cells of 
the CNS, microglia, provide signaling factors with both pro- and anti-inflammatory effects for 
protection. Microglial activation ranges through a multiplex of phases, of which have yet to be 
defined when induced by exposure to alcohol, and how the activation impacts surrounding cells. 
Exposure of alcohol has been revealed to induce an immune response in microglia, which can 
exhibit characteristics unique to a pro-inflammatory response depending on dose and time of 
alcohol exposure. To define the activation state produced by microglia in response to alcohol, 
ethanol-induced microglial protein and microRNA (miRNA) global profile expression changes were 
obtained in vitro, using the BV2 murine microglial cells, using mass spectrometry (MS)-based 
proteomics and microarray-based transcriptomic approaches, respectively, revealing potential 
regulatory miRNAs for inflammation mediation. The 2,277 protein groups identified through mass 
spectrometry and 3,195 miRNA genes identified using microarray analysis provided a strong 
foundation to determine miRNA-mRNA regulators and the pathways in which they are involved, 
that potentially play a role in microglial activation. The comparison of the miRNA expressed in 
microglia after lipopolysaccharide (LPS) and ethanol (EtOH) exposure, indicate that EtOH 
influenced miRNA does not signify having a pro-inflammatory activation phenotype, but the 
miRNA expressed under the influence of LPS does support this phenotype. The global pathway 
regulation evidence and defined proteins and miRNA-mRNA interactions upon microglial activation 
have the possibility to unite the pathways described in previous studies and further our 
 xii 
 
understanding of EtOH-induced microglial activation, and their role in neuroinflammation and 
neurodegeneration. Further research to determine and validate the extent of gene regulation by 
miRNAs and subsequent impact on specific protein levels should be employed to define the miRNA 
transcriptome influence on pathways relevant to microglial function. 
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Chapter 1 
Introduction/Background 
 
Chronic Ethanol Consumption: Alcoholism 
Alcohol Use Disorder (AUD) is a significant health concern that affects millions of people 
worldwide. Harmful use of alcohol remains one of the leading causes of preventable death globally 
[1]. Chronic alcohol consumption has an impact on multiple organ systems and, in the context of 
the central nervous system, can lead to neurological dysfunction causing cognitive, memory and 
motor disturbance. Alcohol-Associated Dementia (AAD) is a long-term neurotoxic effect of heavy 
alcohol consumption [1]. Diagnosis of AAD can be done through behavioral evaluation and 
Computed Tomography (CT) brain imaging [1]. A cardinal feature of an alcoholic that may become 
one of the 10% that develop AAD is a history of heavy drinking, which; for men, is drinking more 
than 35 drinks/week, and for women it is drinking more than 28 drinks/week, over the course of 5 
years [1]. Alcohol content can be measured through urine, saliva, breath, and blood tests. The 
amount of alcohol is standardized, and based off of the total grams of pure ethanol (EtOH) in a 
drink being 14 g of EtOH [2, 3]. Binge drinking is defined as the continued consumption of an 
alcoholic beverage over the course of 2 hours, which is approximately 5 drinks for men, and 4 drinks 
for women, or when the blood alcohol concentration (BAC) has reached 80 mg/dl, which is 0.08 % 
(w/v) and is accepted as the standard amount for evidence of intoxication, in the United States [2, 
3]. Actual BAC reached depends on age, gender, height, and weight among other factors [2]. The 
rate of alcohol elimination in an average individual is estimated to be 0.015 to 0.020 grams per 
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deciliter per hour (g/dl/h) [4]. In this study, the focal EtOH concentration is 50 mM EtOH 
(EtOH), which corresponds to a BAC of 230 mg/dL, a value typically observed in chronic 
alcoholics. 
Ethanol Metabolism 
The body can metabolize a limited amount of alcohol each hour. The amount varies widely 
among individuals, and depends on a range of factors other than the amount of alcohol consumed 
and the individual’s size and nutritional status [5]. The genetic variation associated with alcohol 
metabolism also has a significant influence on the differences between individuals at greater risk 
than others for developing alcoholism, liver disease, pancreatitis, or various cancers associated with 
chronic alcohol consumption [5, 6]. After alcohol (ethanol a.k.a EtOH) consumption, EtOH is 
absorbed though the gastrointestinal tract lining and passed through the hepatic portal vein, which 
connects the gastrointestinal tract, gallbladder, spleen and pancreas to the liver [7], as seen in Figure 
1.  
 
Figure 1. Organs at Forefront of Alcohol Ingestion adapted from [8, 9]. 
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Ethanol (CH3CH2OH) is metabolized through several processes within the liver, however 
the most common catalysis is carried out by two enzymes, alcohol dehydrogenase (ADH) and 
aldehyde dehydrogenase (ALDH), the chemical breakdown of which results in the formation of 
acetate (CH3COO-) and nicotinamide adenine dinucleotide (NADH) [5, 7, 10, 11], as shown in 
Figure 2.  
 
Figure 2. Ethanol Metabolism adapted from [5, 7, 10, 11]. 
  Acetate can further be converted to acetyl-CoA or redistributed systemically after release to 
the blood circulation. In the process of EtOH metabolism, EtOH is transformed into a toxic 
intermediate compound called acetaldehyde (CH3CHO) that can react with various biomolecule in 
the cell [5, 11]. Although acetaldehyde is rapidly broken down into the less toxic compound, acetate, 
acetaldehyde is believed to be a contributor to the pathological effects post-alcohol consumption, 
such as incoordination, memory impairment, and sleepiness [7, 12, 13]. Previous research reports 
that the acetaldehyde concentration within the brain is not enough to produce those effects; 
however, it is also produced when alcohol is broken down by the enzymes catalase and cytochrome 
P450 2E1 (CYP2E1) [5, 11, 12, 14-16]. Catalase metabolizes a miniscule fraction of alcohol and 
small amounts of alcohol can also be non-oxidatively metabolized to fatty acid ethyl ester (FAEE) 
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compounds, which contribute to organ damage of the liver and pancreas [11, 17]. CYP2E1 becomes 
activated only after large amounts of alcohol have been consumed [5]. Long-term heavy drinking 
damages the liver and other organs at the forefront of EtOH metabolism, because the EtOH 
saturates enzymes altering the ability to break it down into nontoxic byproducts and remove it from 
the blood stream [5]. Prolonged binge drinking can lead to liver dysfunction, liver cirrhosis, and 
pancreatitis. Alcohol-damaged liver cells allow excess amounts of the harmful EtOH breakdown 
byproducts, such as ammonia, manganese, magnesium and chemicals called mercaptans, to continue 
through the blood stream, to the brain and heart [18, 19]. Alcoholic liver disease (ALD) can result in 
severe portal-systemic encephalopathy (PSE) (a.k.a. hepatic encephalopathy (HE)) and cerebral 
dysfunction [18-20]. PSE is the predominant neuropsychiatric irregularity resulting from the 
accumulation of ammonia (NH3) and manganese (Mn), two toxic substances in their variety of ionic 
forms within the brain when not released as urea and in bile respectively, post detoxification in the 
liver [18, 21]. In patients with ALD, NH3, and Mn have been identified as having a role in harming 
brain cells in the development of PSE, the potentially fatal brain disorder [19]. The accumulation of 
NH3 and Mn in the liver damaged condition has a marked effect on brain glutamine levels compared 
to the accumulation of only one factor under the same conditions [21, 22]. Amounts of glutamine 
(Gln) within the brain have been correlated with the severity of HE in patients, indicating that the 
brain is exposed to increasing levels of ammonia as the disease progresses [23, 24]. Ammonia 
detoxification is catalyzed by glutamine synthetase (GS), an enzyme that requires Mn or Mg as 
cofactor for the reaction of glutamate and NH3 into glutamine [20, 22]. Figure 3 (NH3, Mn, and 
Acetate Inputs to Brain Cells), shows the NH3, Mn, and acetate as inputs to the brain cells and 
muscle cells in HE [20, 25]. 
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Ethanol Influence on Neurotransmitters in the Central Nervous System: Neurotoxicity  
Glutamate (Glu) has numerous roles within the CNS, of which EtOH can have influence over. Glu 
is one of the most abundant amino acids in the brain, an intermediate component for metabolism, a 
protein building block, an energy substrate, an excitatory neurotransmitter, and the immediate 
precursor of an inhibitory neurotransmitter γ-aminobutyric acid (GABA), which contributes to its 
ability to be considered a potent neurotoxin in imbalanced conditions [25, 26]. 
 
Figure 3. NH3, Mn, and Acetate Inputs to Brain Cells, shows NH3, Mn, and acetate as inputs to 
the brain cells and muscle cells in HE, adapted from [20, 25]. 
Glutamate receptors are responsible for glutamate-mediated post-synaptic excitation of 
neural cells and are important for neuronal function, synaptic communication, cognition, memory 
formation, and motor function. Overstimulation through glutamate receptors can cause 
neurodegeneration and neuronal damage by inducing excitotoxicity, which can then be an 
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inflammatory trigger for microglia. Microglia are an attractive therapeutic target for the prevention 
of neuronal injury progression within the CNS due to microglia activation being associated with 
neuroinflammation and neurodegenerative diseases [27].  
CT imaging revealed that alcoholics have reduced brain volume, where there is white matter 
loss that includes both myelin and neuron axonal circuitry degeneration, causing severe brain 
damage with clear morphological changes evident [1]. Other studies found brain damage in over 
75% of autopsied chronic alcoholics, and more than 50% of recovered alcoholics displayed some 
degree of learning and memory impairment [1]. Additional symptoms with cognitive disturbances as 
mentioned in Vetreno et al, include: aphasia (inability to use or understand language), apraxia (failure 
to make purposeful movements), agnosia (difficulty in identify objects), or disturbance in executive 
functioning (deficits in planning, organizing, attention, and/or changing cognitive strategies) [1]. 
Women that drink while pregnant develop the risk of fetal alcohol spectrum disorders (FASD): 
alcohol-related neurodevelopmental disorder (ARND), alcohol-related birth defects (ARBD), and 
fetal alcohol syndrome (FAS), which is the most severe [28].  
Central Nervous System: Neurons and Glia 
The central nervous system (CNS) consists of the brain and spinal cord, which are made up 
of neurons and glial cells. Neurons are specialized cells capable of synaptic conduction of electrical 
stimuli, called neuronal synapses, and are responsible for integrating sensory information and 
dictating responses accordingly through their electrical relay [29]. The CNS organizes sensory 
information and synthesizes cognitive and motor function instructions through neuronal synaptic 
integration and output, that control the organism and define its interactions with its environment. 
The spinal cord serves as a passage for signals between the brain and the rest of the body, as well as 
for simple muscle-skeletal reflexes without input from the brain [30]. The brain is the center for 
assimilating most sensory information and generating the coordination of the body function and 
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reaction, both consciously and unconsciously. Complex functions like cognition (thinking and 
feeling) and the direction of motor function as well as regulation of homeostasis are dictated by 
specific cellular interactions derived from different parts of the brain, inhabited by different 
neuronal and supporting cell types [29, 30]. The cells within the brain that maintain the highly 
advanced higher organism functions are not directly protected by the lymphatic system like in the 
rest of the body, and are also not accessible by pathogenic factors circulating within the body 
because of a series of endothelial cells that make up the blood brain barrier (BBB) [31]. The BBB’s 
series of endothelial cells filter the capillaries delivering the blood to the brain from the spinal cord, 
preventing infectious material from reaching vital vulnerable synaptic cells [31]. Although the BBB 
elicits a form of protection for brain cells, it doesn’t eliminate the risk of invading pathogens and the 
necessity of immune function along with the homeostasis that the lymphatic system provides the 
rest of the body [31]. Instead, neurons are protected by glia cells, such as astroglia (astrocytes), 
oligoglia (oligodendrocytes) and microglia, to maintain the neuronal environment. Microglia, in 
particular, are the macrophage-like immune cell in the brain. Unlike the other glial cells of the brain, 
microglia act as antigen-presenting, phagocytic, and cytotoxic cells; all hallmark abilities of specific 
immune cells of the peripheral immune system [31-33]. Microglia are the immunocompetent cells of 
the brain and the first defense of protection within the central nervous system [31-34]. 
Microglial Activation  
Microglia comprise 10-15% of the cells within the CNS and assume various morphology 
depending on their functional state [33, 35, 36]. The microglial standard resting state is a ‘ramified’ 
morphological phenotype (as seen in 1. in Figure 4). Microglia progress through a multistage 
process from stimulated to a reactive ‘activated’ (a.k.a. primed, in step 2., Figure 4) microglial 
phenotype, before fully transforming in to a macrophage-like phagocytic microglia [33, 34]. 
Microglia rapidly mobilize to contact and engulf late-stage apoptotic neurons, and play an intricate 
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role in maintaining homeostasis in the CNS [37]. In severe cases of EtOH toxicity, the 
neurodegeneration rate exceeds the clearance capacity of endogenous microglia and apoptotic 
bodies accumulate in the brain. Research regarding microglia has implicated this glial cell type as a 
proinflammatory mediator that, when exposed to high concentrations of alcohol, have been shown 
to inhibit proliferation and promote cellular damage in the CNS [38]. Previous research shows that 
alcohol can induced various stages of microglial activation, which can affect the role it has in 
maintaining the homeostasis of proper neuronal functioning within the CNS [38-42]. Ethanol-
treated microglia have demonstrated expression changes involved in activation (4. in Figure 4), but 
the identification of individual factors and pathway information (in 5. & 6, Figure 4) on the effects 
of EtOH on CNS immune cells has yet to be defined [37].  
 
Figure 4. The Microglia Priming Hypothesis consists of 6 stages: 1) an initial immune 
strike that sensitizes microglia, 2) microglia becoming primed, 3) an event that triggers primed 
microglia into an activation state, 4) microglia’s transition to a pro-inflammatory activation state, 5) 
activated microglia’s release of signal factors and the subsequent 6) interaction of those signal factors 
with neurons. Adapted from [43, 44]. 
Microglia are sensitive to brain physiology and detect dysfunction within the CNS. There are 
many hypotheses about the altered expressions and phenotypes of each functional state of microglia 
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during the complex conversion into the activated state, and microglial influence upon events 
associated with CNS dysfunction onset, and progression within various ailments [33, 34]. 
Originating in the mesenchymal region, microglia migrate throughout the CNS, scanning the domain 
and expressing specific receptors for neuronal, glial and immune cell-specific factors before 
becoming stimulated [34]. In aged CNS, microglia are believed to be in a ‘hypersensitive’ state in 
which they are more easily activated [33]. Neurons are capable of triggering microglia activation not 
only for neuroprotection, but for remodeling of synapses and neurotrophic factors, for the removal 
of dysfunctional or apoptotic neurons. It is hypothesized that the microglia-neuron signals are 
facilitated when the cells are within close proximity, ensuring the intended highly specific response. 
The differential generation between survival-promoting and death-signaling factors may be narrow 
and more interconnected than previously examined [33].  
Immunocompetent Microglia Activation: Lipopolysaccharide 
Microglia are activated by pro-inflammatory cytokines, toll-like receptor (TLR) ligands, as 
well as anti-inflammatory cytokines. A well-known microglial immune stimulator, lipopolysaccharide 
(LPS), is an example of an inducer of the microglial endotoxic response. Lipopolysaccharides are 
large molecules found on the outer membrane of gram-negative bacteria that consists of a lipid and 
a polysaccharide that is composed of O-antigen [45, 46]. During a pathological insult by LPS, 
microglia up-regulate and release chemokines (type of cytokine) recruiting surrounding microglia in a 
‘ramified’ state and activating the immune cells. Fractalkine is an example of a cytokine that has the 
ability to be soluble or membrane-bound and is largely expressed in neurons, microglia and to a 
lesser extent on astroglia. Fractalkine is involved in adhesion and migration properties of leukocytes 
[47] and has an emerging role in regulating microglial function.  
The response of microglia to pro-inflammatory stimuli includes release of inflammatory 
factors such as tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β), fatty acid metabolites such 
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as eicosanoids, quinolinic acid, glutamate, as well as reactive oxygen/nitrogen species (ROS/RNS) 
such as nitric oxide (NO) and superoxide [47-50]. Fractalkine, for example, has shown to support 
microglia activation for developing synaptic plasticity as well as for neuroprotection functions, 
whereas in other settings contributes to the initiation of neuronal damage [47]. Fractalkine 
sequestration and activation of microglia is mediated through the chemokine receptor, CX3CR1 
(and other C-X-C motif chemokine receptors), and its ligand protein levels [47, 49, 50]. Previous 
findings have indicated that the downregulation of CX3CR1 decreases the activation state influence 
of microglia and that there are age-related impairments in C-X-C motif receptors that are directly 
correlated to microglial overstimulation, as well as the debilitated recovery from endotoxic influence, 
such as that of LPS [47]. The fractalkine CX3CR1 ligand/receptor pair are not dissimilar to other 
mechanisms of communication between neurons and microglia, of which have interactions that 
have not been defined in the balance between anti-inflammatory and pro-inflammation, but have 
been implicated in the process of microgliosis and neurodegeneration [47, 49, 50]. In this study, we 
propose to identify how EtOH, a known activator of microglia, induces activation in contrast to 
LPS, a known potent pro-inflammatory activator of microglia [51], through differential expression 
of miRNAs. The microglial activation can be differentiated based on conventional phenotypic 
markers [38] as well as changes in the proteomic landscape.  
Microglial Activation and Neuroinflammation  
Understanding the multi-phase activation of microglia through the various phenotypes, is 
critical to understanding their role in homeostasis/neuroprotection, versus neurodegeneration, and 
in alcoholic neuropathology; predicting the balance between these states is critical for 
neuroinflammatory therapies for the prevention of neuronal degradation and loss [38-42]. Previous 
studies indicate that alcohol-induced microglia activation can be more complicated than exhibiting a 
pro-inflammatory phenotype and that partial activation of microglia through alcohol needs to be 
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further defined in a dose- and time-dependent fashion [41]. Characterization of the activation state 
of microglia can reveal potential therapeutic targets to mitigate the negative effects of microgliosis 
(as seen in Figure 5), which is implicated in progression of numerous neurodegenerative diseases. 
 
Figure 5. Reactive Microgliosis Cycle of a microglia and neuron following a direct 
inflammatory trigger and/or neurotoxic insult. Inflammatory trigger, LPS, and the neurotoxic insult 
of a chronic EtOH dosage leads to microglial activation, increasing the neuroprotective /neurotoxic 
factors that affect neurons, which signal for the activation of microglia, in a perpetual cycle. The 
continued pro-inflammatory activation of microglia can induce further neuronal death/damage 
along with the damage of the direct insult. Adapted from [52]. 
Neurodegeneration and microglia activation have not only been evident in association with 
AUD, but have also been evident in Alzheimer’s disease (AD) and Parkinson's disease (PD) through 
the postmortem analysis of the patient’s brains. Results from in vivo and in vitro studies have also 
established microglial activation associated with the pathogenesis of amyotrophic lateral sclerosis 
(ALS), multiple sclerosis, prion-related diseases, human immunodeficiency virus (HIV), and acquired 
immunodeficiency syndrome (AIDS) dementia complex [48]. A common microglial mechanism of 
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self-defense upon viral infection, observed in herpes simplex infections, is the upregulation of 
glutamate transporter EAAT1 (excitatory amino acid transporter 1, also known as GLT-1) receptors, 
which is also induced through TNF-α signaling. The addition of GLT-1 receptors contributes to 
increased glutamate cellular uptake, resulting in production of the antioxidant glutathione, which has 
antiviral properties [53, 54]. In comparison to neurons and astroglia, microglia contain the highest 
concentration of glutathione, effectively aiding in the resistance to viral infection [53, 55]. With 
previously obtained neuronal and microglial expression profiles, signaling factors specific for 
inducing microglial activation of each of these diseases can be derived and compared to analyze with 
the findings of this study. For example, in the pathology of PD, reactive microglia were found to 
become activated by the release of neuron-expressed α-synuclein, inducing microglial expression of 
large numbers of human leukocyte antigen (HLA-DR), positive reactive microglia receptors, and 
activation of NADPH oxidase with production of ROS, which oxidize glutathione. The 
neurotoxicity found as a result of this interaction was dependent upon the microglial phagocytosis of 
α-synuclein and self-preservation from the ROS [48, 55]. Although each disease’s activation of 
microglia varies, if microglia can be limited to only partial (or an alternative activation state), they 
may be beneficial to preventing toxic insult-induced neurodegeneration, and enhance endogenous 
repair systems following CNS damage. Due to reported evidence of microglia being activated by 
EtOH exposure, we can use the proposed cell model to display the global phenotypic changes 
specific for microglia, that can potentially be translated to how microglia influence CNS function in 
regard to AUD [28, 40]. 
MicroRNA Expression in the CNS after Ethanol Exposure 
MicroRNAs (miRNAs), are a large family of short non-coding RNAs (17–25 nucleotides) 
that are capable of regulating messenger RNAs (mRNAs) by repress expression of their target genes 
through sequence complementation, through the binding the 3’ untranslated region of the target 
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mRNA [56-59]. This reduces the abundance of the target mRNAs inhibiting their translation [57-
59]. MicroRNA genes are initially transcribed by RNA polymerase II into miRNA primary 
transcripts, and are then processed into miRNA precursors by the Drosha/DGCR8 complex, before 
being transported to the nucleus[60]. Dicer and maternal miRNAs are essential for early 
development, in previous studies of mouse development the loss of function of Dicer and maternal 
miRNAs was shown to be embryonically lethal at day 7.5 [57, 61].  
To gain mechanistic insights into alcohol-related disorders, numerous animal models have 
been developed to study the consequences of EtOH-induced neurotoxicity, as well as on subsequent 
learning and memory function. These models have honed in on defining acute verse chronic EtOH 
exposure and the resulting neurotoxic effects [1]. In this study, we will employ an in vitro model that 
will isolate the effects of EtOH exposure as a first step in a systematic approach to understand the in 
vivo activation of microglia [28]. The four-day mouse binge ethanol exposure induced an acute event 
compared to the more chronic, 10-day ethanol exposure models. This procedure produces fully 
activated phenotypes of microglia, closely associated with their roles in homeostasis and 
neuroprotection during chronic ethanol exposure. Greater levels of activation have been shown with 
intermittent exposure models, which initiate severe priming/stimulation of microglia, inducing a 
hyperactive response to subsequent exposures as seen in other neurodegenerative disease models [1, 
28, 40, 62].  
In terms of miRNA differential expression after EtOH exposure, most studies have been 
limited to neuronal expression profiles. In a 30-day continuous, two-bottle choice test, in which 
mice consumed 20% EtOH, miRNA–mRNA synaptic interactions within neurons were studied for 
altered expression and synaptic regulation [63]. The bidirectional prediction analysis for identifying 
miRNA-mRNA interactions previously conducted by Most et al. (2016) in neurons, shows that a 
subset of alcohol-responsive miRNAs target many alcohol responsive mRNAs with overlapping 
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patterns of expression, and that a significant number of interactions are predicted to target each 
other, particularly within glutamate neurons [63]. The research of Most et al, (2016) has shown that 
chronic alcohol consumption altered the miRNA-mRNA coordination, enriching miRNAs more 
significantly in membrane vesicles of pre-and post-synaptic compartments of neurons, called 
synaptoneurosomes (SN), than that in the total cell population homogenate (TH) samples, obtained 
from the amygdala of C57BL/6 mice [63]. Both the qualitative and quantitative results shown little 
overlap between the miRNAs found in SNs and TH, except for the singular enrichment of miRNA, 
miR-411. This result suggests that alcohol influences the changes in trafficking of miRNAs within 
the cells prior to reaching the neuronal synapse; however, the details of how EtOH effects synaptic 
pathways remains unclear. Neurons, astrocytes and microglia contain SNs, and with the influence of 
EtOH are proposed to be altering the localized expression of miRNA-mRNA coordination within 
each cell type [63].  
The goal of this project is to define the molecular responses of microglia through miRNA 
expression and the subsequent impact on the proteomic landscape [64]. We will compare the well-
characterized pro-inflammatory response induced by LPS to the response of microglia to EtOH 
exposure. Specifically, through the quantitation of microglial protein expression and miRNA 
expression, in conjunction with bioinformatics-based approaches utilized to determine the 
regulatory miRNAs associated with microglial activation phenotype.  
The details of excessive alcohol consumption on the CNS and neuroimmune signaling are 
still unclear, but developing evidence suggests that through its diverse range of phenotypes and 
subsequent impact upon neuroinflammation, that microglia may play a role in AUD-induced CNS 
dysfunction. We hypothesize that the EtOH exposure activates microglia inducing an altered 
phenotype as a result of specific proteome profile changes. We also hypothesize that 
miRNA expression changes reflect the EtOH-induced proteome profile changes and related 
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activation phenotype as an associated regulatory mechanism. Identifying the changes in 
microglia protein abundances, on a global scale, allows for the interpretation of biological pathways 
affected, the potential impact of alcohol on the activation of microglia, and the subsequent factors 
that could lead to neuronal injury. We anticipate that the results of the proposed studies will 
contribute to further research projects with the ultimate goal of development of novel therapeutic 
strategies for treatment of alcohol-induced CNS dysfunction related to the microglial activation 
phenotypic changes that occur during chronic EtOH exposure.  
Summary of Approaches and Project Aims  
Microgliosis is the continued activation of microglia within the CNS and is proposed to be 
the core of microglia’s neurotoxic influence during neuroinflammation leading to subsequent 
neurodegeneration [32, 33]. This neurotoxic effect elicited by microglia activation is in addition to its 
neuroprotective roles in the brain [33, 64]. Microglia’s neurotoxic effects are implicated in numerous 
incurable ailments of the CNS such as in Huntington’s disease, PD, AD, and ALS, which result in 
detrimental defects in motor and cognitive signaling functions from neurodegeneration; yet the 
microglial influence has not been fully defined. Research on fetal alcohol exposure by Ahlers et al. 
(2015) found activated microglia near apoptotic neurons in the neocortex after the induction of 
alcohol [39]. Although, microglia were activated and mobilized rapidly to phagocytose late-stage 
apoptotic neurons, neurodegeneration exceeded the clearance capacity of microglia under conditions 
of severe alcohol toxicity. Ahlers et al. (2015) noted that the timing and molecular pattern of 
microglial activation varied with the level of cell death, implicating the sustained recruitment and 
activation of microglia as a primary contributor to the continued neurodegeneration [39]. 
Understanding alcohol’s effect on microglia allows for the expansion of our knowledge base on the 
effects of alcohol within the CNS. 
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To improve our understanding of the microglia response to the chronic exposure to alcohol 
to EtOH, we propose to determine the molecular responses of microglia using both proteomic and 
transcriptomic approaches. We will quantify both microglial protein expression and miRNA 
expression changes using the murine microglia-like BV2 cell line. We hypothesize that the alcohol 
exposure activates microglia into an alternative activation phenotype as a result of specific 
proteome profile changes, which will continue to be altered over the time of exposure. We 
also hypothesize that miRNA expression profiling reflects the EtOH-induced proteome 
profile changes and related activation phenotype and serve as a possible global-scale 
regulatory mechanism. Pathway changes identified will be compared to previous studies of EtOH 
induced proteome quantification performed, by Bell-Temin et al. (2013), in our laboratory on rat 
microglia-like, highly aggressively proliferating immortalized (HAPI), cell line to provide a 
multispecies in vitro contrast of expression [37]. The classical activation response of BV2 microglia 
will be further differentiated upon comparison of the LPS-treated and EtOH-treated microglial 
transcriptomic and proteomic datasets. Also, the functions associated with the differentially 
expressed proteins identified by microglia activation phenotype changes, and those from Bell-Temin 
et al. (2013) along with other studies will be determined by bioinformatics [37, 65]. The long-term 
potential of this project is that it will provide insight into the role of microglia in EtOH-induced 
neurotoxicity and neurodegeneration, and allows for the specific identification of potential 
therapeutic targets for the prevention of EtOH-induced CNS dysfunction mediated through 
microglia. 
Specific Aims  
The Specific Aims of this project are to perform a quantitative transcriptomic and 
proteomic analysis of the molecular responses of microglia to alcohol, in the form of EtOH, 
in vitro using the murine BV2, microglia-like cell culture systems.  
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Aim 1) Characterize the microglial miRNA expression profile after exposure to EtOH and 
LPS over time through transcriptomic approaches, using miRNA sequencing and miRNA 
microchip analysis and predict the quantity of miRNA–mRNA interactions through 
Decision Tree and Ingenuity Pathway analysis methods of bioinformatics to assess mRNA 
regulatory mechanisms associated with EtOH-induced microglial proteome profile changes. 
Aim 2) Identify and quantify the EtOH-induced microglial protein expression using mass 
spectrometry (MS)-based proteomics after exposure to EtOH. Predict the upstream miRNA 
influence through Ingenuity Pathway analysis method of bioinformatics, to assess miRNA 
regulatory mechanisms associated with EtOH-induced microglial proteome profile changes.  
The details of excessive alcohol consumption on the CNS and neuronal functioning are 
unclear, but developing evidence suggests that the subsequent impact of neuroinflammation and/or 
neurodegeneration is mediated by microglia. The influence of EtOH on microglia is multifaceted; 
one of a detrimental nature and one of a potentially beneficial alternative role [66]. The influence of 
alcohol on the brain, much like microglial activation to the phagocytic phenotype, is suspected to 
have multi components; one of a detrimental permanent nature and one of a beneficial transient 
nature, resembling activities of microglia such as inducing neuronal death through inflammation and 
modulating synaptic plasticity, respectively [66].  
Identifying the changes in microglia protein abundances, on a global scale, allows for the 
interpretation of biological pathways affected, and the impact of alcohol on the activation of 
microglia and possible mechanisms that lead to neuronal injury. This study proposes to alleviate 
some of the ambiguity related to the debated activation of microglia with the focus of alcohol 
stimulation by EtOH exposure. We anticipate that the results of these proposed studies will 
contribute to further research projects aimed to understand regulatory mechanisms associated with 
EtOH-induced microglial activation phenotype with the ultimate goal to identify novel therapeutic 
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strategies for the treatment of glial cell-mediated CNS dysfunction in AUD. 
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Chapter 2 
Experimental Methods 
 
Overview 
The research project is to determine the molecular responses of microglia to EtOH, using 
proteomic and transcriptomic approaches in vitro, using murine microglia (BV2) cell culture systems. 
The goal of this project is to define the phenotypic changes that occur in microglia induced by 
EtOH exposure through quantitation of microglial protein expression on a global scale, with the 
addition of the global miRNA expression profile, that was performed in parallel in order to identify 
possible regulatory mechanisms associated with EtOH-induced proteome profile changes and 
related activation phenotype. The in vitro results are then also compared to results obtained from 
previous in vitro and in vivo studies obtained from work of other researchers worldwide. 
Cell Culture and Treatment 
Murine BV2 microglial cells were grown in parallel cultures of control, EtOH and LPS 
treated media at 37°C and 5% CO2 (see Table 1. for Experimental Sample Breakdown for BV2 
Microglia Time Course Treatments) [37, 67, 68]. The cell culture media consisted of DMEM, 
supplemented with 10% dialyzed fetal bovine serum, 100 U/mL penicillin, and 100 µg/mL 
streptomycin [67, 68]. BV2 cell cultures were then treated with media alone to establish a control for 
12 and 24 hours each. Cell cultures for EtOH or LPS groups had the inclusion of either 50 mM 
EtOH or 30 ng/mL LPS, a potent stimulator of microglia (as an immune activation positive 
control), respectively for 12 and 24 hrs each [69-71]. At the end of the treatment, cells were washed 
 20 
 
three times, in HBSS, pelleted by centrifugation for 5 min at 2000×g and the supernatant was 
collected for further analysis [67]. Cell pellets were snap frozen and stored at -80°C until miRNA 
extraction [67].  
Table 1. Experimental Sample Breakdown for BV2 Microglia Time Course 
Treatments. A control (BV2 cells), 30 ng/mL LPS and 50 mM EtOH treated cells were collected 
separately at zero hours of treatment exposure as well as after 12 and 24 hrs of treatment. Each cell 
culture sample was maintained in 75cm2 media flask, with a total of 7 flasks producing 3 samples of 
each treatment at 12 and 24 hrs, and 3 samples collected at time of treatment for the time zero 
control (a total of 21 samples in all). 
 
In Appendix A, Figure A1-A3 contains the Microscopic BV2 Cell Images Under Each 
Condition Examined. 
RNA Extraction  
 
Figure 6: MicroRNA Extraction Experimental Procedure beginning with cell culture 
and treatment of microglia under each condition individually, miRNA extraction, and labeling for 
microarray analysis. The results of the microarray were then analyzed within Transcriptome Analysis 
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Console. Additional analysis using Ingenuity Pathway Analysis (IPA), allowed for miRNA and 
protein pathway identification to identify novel targets within the miRNA data set. Images adapted 
from Affymetrix, IPA.  
Total miRNA was extracted from 3 samples of approximately 106 cells from each treatment 
group; control, EtOH and LPS, using the miRNeasy RNA extraction kit (QIAGEN, CA) which 
combines phenol/guanidine-based lysis (QIAzol Lysis Reagent and Buffer) of samples and silica-
membrane–based purification of total and miRNA according to the manufacturer’s instructions [72]. 
The RNA was quantified using a Nano-Drop1000 (Thermo Fisher Scientific Inc., IL) and assayed 
for quality using an Agilent 2100 Bioanalyzer (Agilent Technologies, CA) [63, 73]. The criteria for 
RNA quantity and quality were as follows: total amount of RNA 125ng, 280/260 between 1.9–2.1, 
and RIN 9. We measured RIN of all of the samples using the Bioanalyzer miRNA kit (Agilent, CA) 
to ensure that samples with high RINs also included high quality and quantity of miRNAs [63]. All 
samples had a RNA integrity score (RIN, perfect RIN=10) somewhere between 8.9 and 9.8, with 
the majority between 9.2 and 9.5. Microarray Hybridization, Data Quality Assessment, and Analysis 
and RNA Integrity (RIN) and Quantification Post Microarray for Each Sample can be found in 
Appendix B and Appendix C, respectively. 
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Microarray Hybridization, Data Quality Assessment, and Analysis  
The 3 samples of approximately 106 cells from each experimental group, control, EtOH and 
LPS, at 12 hrs and 24 h each, were hybridized to 4 miRNA microarrays. The RNA transcripts 
targeted for miRNA analysis were labeled with flash-tag biotin HSR RNA Labeling Kit (Affymetrix, 
CA) and hybridized to GeneChip miRNA 4.1 Arrays (Affymetrix, CA) at the USF CMMB Core 
facility, in Tampa [63, 72]. Affymetrix microarrays show a high correlation with results obtained 
from other platforms such as qPCR [63, 72-75]. This microarray platform uses annotations from 
miRBase version 20 and contains 30,434 probe sets for mature miRNAs from all organisms [76-78]. 
For this study, we focused on the 1,908 mature and pre-miRNA of the murine species miRNA set 
detected on the array. The miRNA data discussed in this thesis have been annotated, normalized and 
deposited to be accessible on the University of South Florida’s Department of Cell Biology, 
Microbiology, and Molecular Biology, Stanley Stevens Laboratory Microarray Results 
(http://biology.usf.edu/cmmb/research/Stevens.aspx).  
The array targets specific miRNA sequences that will be matched to a battery of synthetic 
miRNAs that range in known and unknown pathways [76-78]. The total number of transcripts 
identified, 3195, were analyzed using Affymetrix’ Transcriptome Analysis Console (TAC) software in 
which intensity values were bi-weighted log2 and normalized [79, 80]. TAC software explores the 
interaction between coding and non-coding RNA relationships with mRNA as well as simplifying 
the interpretation of complex alternative splicing events and can reveal genes or pathways of interest 
[79, 80]. The content in TAC is derived from the Sanger miRBase (miRNA database v11) with target 
identification for human, murine and rat, mRNAs and miRNAs derived from the snoRNABase 
(small nuclear RNA data base) and the Ensembl Archive (www.ensembl.org/biomart/martview) [74, 
79, 80].  
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Statistical Analysis 
In TAC the raw data intensities are bi-weighted log2, and differential expression analysis 
between paired EtOH or LPS samples with the control (paired/dependent t-test) were performed. 
MicroRNAs of interest that are differentially expressed when comparing EtOH or LPS treated with 
the control are considered significant with P<0.05 and a fold difference cutoff of 2. Descriptive 
statistics, such as the mean and standard errors were calculated along with inferential statistics, 
specifically independent t-tests, to compare EtOH and LPS treatment groups. ANOVA tests were 
performed in two separate analyses, one for each preparation and one per condition, p-values 
expressed in at least one condition and its gene expressed in both conditions were then FDR 
adjusted based on Benjamini-Hochberg Step-Up FDR-controlling procedure [81]. For comparison 
of EtOH and LPS expression levels, fold changes were calculated as the ratio of EtOH (n=3) or 
LPS (n=3) to the control (n=3). Fold changes greater than 2 are referred to as ‘up-regulated’ and 
fold changes less than -2 are referred to as ‘down-regulated’. Summary of LPS and EtOH 
microRNA Quantification can be found in Appendix D. 
Classification of microRNA–mRNA Interactions: Bioinformatics Approach  
Mouse target predictions for microRNAs and mRNAs were obtained from TAC fold change 
data. The Decision Tree (DT) Bioinformatics Approach was utilized to predict miRNA-mRNA 
interactions (see Figure 7. for A Detailed Flowchart of the Extensive Battery of Decision Tree 
Bioinformatic Analyses).  
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 Figure 7. A Detailed Flowchart of the Extensive Battery of Decision Tree 
Bioinformatic Analyses. DT is an algorithm that integrates multiple online resources such as; 
miRanda, miRDB, PITA, and TargetScan, used to predict miRNA-mRNA interactions [82, 83]. The 
miRNA identifications and fold change data from TAC were input into the four individual miRNA-
mRNA predictors and the scores from each individual predictors were combined as an input file for 
the DT two-step based predictor. In the first step, the program will obtain the positive predicted 
miRNA-mRNA pair by comparing first threshold value with each individual predictor [82, 83]. In 
the second step, the first step negative miRNA-mRNA pairs with individual predicted scores will go 
into the secondary process. The program compares the individual predicted scores with the 
secondary threshold values, if any two of individual predicted results are decided to be positive, this 
miRNA-mRNA are to be treated as positive pairs [82, 83]. Combining the first step positive result 
and secondary step positive result, the DT based predictor can decide whether the miRNA-mRNA 
pair can interact with each other or not [82, 83]. If the miRNA-mRNA pair is predicted to be 
positive, the distance between predicted score of individual predictors to their default thresholds will 
be calculated and transformed into Z-score [82, 83]. The larger absolute value of Z-score indicates 
the more possible this miRNA-mRNA pair can interaction [82, 83].  
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 The mRNA obtained from DT were run through the Database for Annotation, Visualization 
and Integrated Discovery (DAVID), a bioinformatics resource that provides functional annotation 
tools to understand biological meaning behind large gene lists to produce a predicted protein target 
list, and through Kyoto Encyclopedia of Genes and Genomes (KEGG). KEGG is a database 
resource for high-level cell and molecular functions of the biological system for large-scale molecular 
datasets generated by genome sequencing. As KEGG defines the individual proteins the 
information is returned back into DAVID which provides a list of pathways that, that protein is 
involved in. This process was done for each treatment (control, LPS, and EtOH) under each time (0, 
12 and 24 hours) to provide a list of predicted pathways effected. Each target protein ID was 
classified into different pathways, and the number of proteins within a pathway were summed to 
identify the top 20 predicted pathways effected. The open source software, Cytoscape, was used to 
display the miRNA-mRNA networks that have a 1 fold change probability of interaction obtained 
from the DT results. This process was also done for the predicted downstream target list that were 
generated in TAC. Tables of the Downstream Target Interaction Predictions by Decision Tree 
Analysis for the 24 hour Lipopolysaccharide and Ethanol Exposures Regulated microRNAs, can be 
found in Appendix E and F, respectively. 
Protein Extraction, Digestion, and Desalting  
Protein was extracted from 3 samples of approximately 106 cells from each experimental 
group; control, EtOH and LPS, using lysis buffer of 100 mM Tris, 4% SDS, and 100 mM 
dithiothreitol, followed by sonication. Protein concentrations were determined using the 660 nm 
Protein Assay supplemented with Ionic Detergent Compatibility Reagent supplementation (Pierce). 
Protein Assay Results, Including; Standard Curve (Stdcurve) and Calculated Concentrations of Each 
24 hour Sample can be found in Appendix G. To isolate, reduce, and alkylate proteins, an in-gel 
digest was performed using sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-
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PAGE), followed by reducing reagent of 200 mM dithiothreitol (DTT), and alkylating reagent of 200 
mM iodoacetamide (IAA), respectively. Complex protein samples separated by SDS-PAGE were 
fractionated by molecular weight region and digested with trypsin and Lys-C (Promega). For 
increased proteome coverage, peptide samples were extracted and then concentrated in a vacuum 
concentrator and resuspended in 0.1% formic acid prior to LC−MS/MS analysis.  
 
Figure 8: Proteome Extraction Experimental Procedure I beginning with cell culture and 
treatment of microglia under each condition (individually), protein extraction, and mass 
spectrometry (MS) analysis. The results of the MS/MS will then be analyzed for quantity within 
MaxQuant and Perseus programs, followed by Ingenuity pathway analysis and protein pathway 
identification to identify novel targets within miRNA upstream data sets. Images adapted from 
Affymetrix, IPA.  
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LC−MS/MS and Statistical Analysis  
 Fractions were separated on a 10 cm × 75 µm I.D. reversed-phase (RP) column packed with 
5 µm C18 material with 300 Å pore size (New Objective) using 125 min gradients of 2−40% ACN 
in 0.1% formic acid. Inline mass spectrometric analysis was performed prior on a linear trap 
quadrupole (LTQ) Orbitrap XL (Thermo) and then the full MS survey scans used a resolving power 
of 60000 was performed selecting the top ten most abundant ions for MS/MS fragmentation and 
analysis. Peptides were secondarily identified on a Q-Exactive Plus hybrind quadrupole-Orbitrap 
mass spectrometer (Thermo Fisher Scientific) following separation on a 75µm x 50cm RP ultra-
performance liquid chromatography (UPLC) column (Dionex) packed with 5µm 300Å C18 material 
using a 120-minute gradient on an EASY-nLC 1000 system (Thermo Fisher Scientific).  
 
Figure 9: Proteomic Extraction Experimental Procedure II beginning with cell culture 
and treatment of microglia under each condition (individually), protein extraction, and mass 
spectrometry (MS) analysis. The results of the MS/MS will then be analyzed within MaxQuant and 
Perseus, followed by Ingenuity pathway analysis and protein pathway identification to identify novel 
targets within RNA upstream data sets. Images adapted from Affymetrix, IPA.  
Raw files were processed in MaxQuant 1.6.0.13 employing the Andromeda search algorithm 
and Perseus version 1.2.0.13 against the UniprotKB reference database for Mus musculus, 
concatenated with randomized protein sequences [84]. A second database of known contaminants 
 28 
 
provided with the MaxQuant suite was also employed. All fractions for each biological sample were 
combined for analysis. A false discovery rate of 1% was used for peptides and proteins. A minimum 
peptide length of 6 amino acids was used. Normalized ratios from MaxQuant for each biological 
sample were input into the Perseus processing suite. Statistical significance of quantitation values 
were determined using a Welch’s t-test with a significance value of p < 0.05 respective and 
irrespective to intensity. Protein expression changes were considered statistically significant if the 
intensity weighted ratio mean of all biological samples were significant, in addition to significance in 
two or more biological samples. Additionally, z-score values were calculated for each protein and 
considered significant if the absolute value was greater than 1. This combined filtering approach 
allows for FDR control while maximizing sensitivity.  
Pathway Analysis  
Ingenuity Pathway Analysis (IPA) is a scientific research access website that is significantly 
accurate for determining each proteins location within their most commonly found respective 
pathways within the cell, as well as the RNA modulation of those pathways [41, 42]. IPA was 
utilized to determine over-represented pathways associated with the activation of microglia induced 
by EtOH, including upstream regulator prediction and miRNA-gene target prediction [41, 42], as 
modeled in Figure 10 (Ingenuity Pathway Analysis Representation). IPA’s Knowledge Base contains 
collective results from previously published in vitro and in vivo data provided by previously published 
research. IPA provided the tools necessary to identify several models of protein expression regulated 
by miRNAs in the context of EtOH-induced microglia activation.  
For total protein expression ratios across biological samples, geometric means of intensity 
were calculated. Intensity means (converted to fold-change in IPA) and Uniprot Protein 
identification numbers were uploaded to IPA to determine localization, molecular function, and 
protein interactions [37]. Upstream regulator analysis was also performed within IPA, where activity 
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of potential upstream regulators are predicted based on the expression profile of known down-
stream targets in relation to known upstream regulator-mediated expression changes reported in the 
literature.  
 
Figure 10. Ingenuity Pathway Analysis Representation of pathways, indicating the flow 
of data analysis after predicted pathways have been identified within the program prediction of 
novel targets and the candidate mRNA can be retrieved (Qiagen, IPA).  
Downstream analysis was also performed utilizing miRNA target filter within IPA, using the 
miRNA identifications from TAC to determine localization, molecular function, and protein 
interactions of the transcripts [37, 85]. Table I1 &I2 (Lipopolysaccharide and Ethanol 24 hour 
Treatment Expressed Proteins Identified in IPA from LC-MS/MS Analysis) in the Appendix. The 
IPA miRNA Target Filter is based on experimentally validated interactions from TarBase and 
miRecords and the predicted miRNA-mRNA interactions are from TargetScan. IPA includes 
molecular activity predictions (MAP) of the up- or downregulation of an upstream molecule and the 
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inferred downstream predictions of activity within the networks and canonical pathways identified, 
providing insight into the biological effects of miRNA. This form of analysis determines the 
statistical significance of overlap of the detected upstream regulator with the targets through a 
Fisher’s exact test in addition to implementation of a z-score algorithm to make predictions of the 
direction of upstream regulator activity change [37]. Description of the z-score algorithm is available 
on the IPA Web site (www.ingenuity.com) [37]. MAP includes the prediction of interactive network 
and canonical pathway interrogation. 
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Chapter 3 
Results 
Specific Aim 1: MicroRNA Approach, Quantification, and Uniquely Expressed Transcripts 
Quantity of BV2 microRNA Expression Changes 
Across the 3 experimental groups (control, LPS and EtOH), a total of 3195 miRNA 
transcripts were identified and analyzed using the TAC (Affymetrix) software in which intensity 
values were bi-weighted log2 and normalized. Between the compared test groups (control, LPS, and 
EtOH), combining the 12 hour and 24 hour data, 16 transcripts were differentially expressed with a 
fold change cut-off of 2 at p<0.05 (ANOVA), as displayed in Figure 11 (Venn Diagram of 
MicroRNAs Identified).  
 
Figure 11. Venn Diagram of MicroRNAs Identified. 
The LPS-treated cells had 12 transcripts differentially expressed (6 transcripts with increased 
and 6 with decreased expression) when compared to the control group. The EtOH condition 
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contained 3 transcripts differentially expressed (1 transcript with increased expression and 2 
transcripts with decreased expression) when compared to the control, as shown in Figure 12. Venn 
Diagram of MicroRNAs Differentially Expressed in LPS and Ethanol Between 12 and 24 hours. 
 
Figure 12. Venn Diagram of microRNAs Differentially Expressed in LPS and Ethanol 
Between 12 and 24 hours. 
When comparing the EtOH-treated group to the LPS-treated group, 9 transcripts were differentially 
expressed where 1 transcript had increased expression and 8 transcripts were decreased from EtOH 
treatment (not shown). Between the EtOH and LPS groups, one miRNA transcript, mmu-301b-5p, 
had decreased expression similarly, when compared to the control. 
After statistical analysis and comparison of the experimental groups, corresponding to 
changes of miRNA transcript expression over time at 12 and 24 hrs, data were separated revealing 
390 transcripts differential expressed across the 6 conditions, as displayed in the center circle of 
Figure 11, indicated 47 transcripts with increased expression and 8 transcripts down-regulated. 
Upon comparison of the 12 and 24 hrs time points of the LPS group, 58 transcripts had increased 
expression and 3 transcripts were down-regulated. Upon comparison of the 12 and 24 hrs time 
points of the EtOH group, we identified 119 transcripts with increased expression and 9 transcripts 
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down-regulated. Figure 13, (Bar Graph of MicroRNAs Differentially Expressed Over Time) shows 
the EtOH-treated microglia miRNA transcripts that were differentially expressed where a significant 
number of up-regulated transcripts between 12 and 24 hrs, in comparison to the control and LPS 
conditions, were observed. The number of microglia miRNA transcripts with decreased expression 
within the control and EtOH conditions were more compatible than that of the LPS condition, and 
the number of transcripts up-regulated were more similar between the control and LPS conditions 
than that of the EtOH treatment group. Separating each condition by time point (12 and 24 hrs), the 
miRNA changes over time indicate a trend of up-regulation for each condition with the control 
condition expression changes being the least of the three conditions observed. The control group 
difference in differentially expressed miRNA transcripts upon comparison of time points indicate 
natural variation of miRNA expression in control cells over time and/or other sources of 
experimental variability. 
 
Figure 13. Bar Graph of MicroRNAs Differentially Expressed Over Time. 
Post 12 hours of Lipopolysaccharide or Ethanol Treatment 
At 12 hours of exposure, the LPS group contained 26 transcripts that were differentially 
expressed, which were comprised of 10 transcripts with increased expression and 16 transcripts with 
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decreased expression when compared to the control group. The EtOH treatment group contained 
73 transcripts differentially expressed, which were comprised of 17 transcripts with increased 
expression and 56 transcripts with decreased expression when compared to the control. When 
comparing the EtOH and LPS treatment groups, 45 transcripts were differentially expressed where 7 
transcripts and 38 transcripts were up and down-regulated in the EtOH group (not shown). Between 
the EtOH and LPS treatment groups, 6 miRNA transcripts had similar expression changes when 
comparted to the control (2 transcripts with increased expression and 4 transcripts with decreased 
expression) as displayed in Figure 14 (Venn Diagram of MicroRNAs After 12 hours of Exposure). 
 
Figure 14. Venn Diagram of MicroRNAs After 12 hours of Exposure. 
As seen previously in other research on alcohol effects on cellular expression the transcript mmu-
miR-155-5p revealed opposing regulation between the LPS and EtOH conditions in which, it is up-
regulated in LPS and down-regulated in the EtOH treated cells, after 12 hours of exposure[86-96].  
Post 24 hours of Lipopolysaccharide or Ethanol Treatment 
At 24 hours of treatment, the LPS group contained 21 transcripts that were differentially 
expressed with 12 and 9 transcripts showing increased and decreased expression, respectively, when 
compared to the control. The EtOH treatment group contained 31 transcripts differentially 
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expressed with 22 transcripts showing increased expression and 9 transcripts showing decreased 
expression when compared to the control. Upon comparison of the EtOH and LPS groups, 47 
transcripts were differentially expressed, comprised of 40 transcripts with increased expression and 7 
transcripts with decreased expression in the EtOH group (not shown). Comparing the EtOH to 
LPS group, at 12 and 24 hrs there is an opposing trend in which the number of transcripts down-
regulated within the EtOH condition at 12 hrs is greater than the number of up-regulated 
transcripts. Additionally, the number of transcripts up-regulated within the EtOH condition at 24 
hrs is greater than the number of down-regulated transcripts. Between the EtOH and LPS groups, 2 
miRNA transcripts, mmu-miR-186-5p and mmu-miR-21a-5p, had similar expression changes when 
comparted to the control, both with increased expression, as displayed in Figure 15 (Venn Diagram 
of MicroRNAs After 24 hours of Exposure). Transcript mmu-miR-21a-5p was up-regulated in the 
LPS 12 hrs treatment group and increased after 24 hrs of exposure. Interestingly, the transcript 
mmu-miR-155-5p was shown to be significantly up-regulated in the LPS group after 24 hrs 
treatment in microglia but was not differentially expressed at greater or less than a two-fold change 
in EtOH-treated microglia at 24 hrs.  
 
Figure 15. Venn Diagram of MicroRNAs After 24 hours of Exposure. 
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Quantity of Predicted microRNA–mRNA Interactions 
Post 24 hours of Lipopolysaccharide Treatment Group 
Utilizing the Decision Tree (DT) bioinformatics approach for the 24 hrs LPS dataset, 1000 
mRNAs were identified to interact with the miRNA identified within this group and time point. Of 
the 12 miRNAs up-regulated, 5 miRNA transcripts had known mRNA interaction networks, with 
325 mRNA targets, of which 4 miRNA transcripts had influence upon an mRNA in another 
transcript network, as shown in Figure 16 (Up-Regulated microRNA-mRNA Network After 24 
hours of LPS Exposure). The Table E1 (Lipopolysaccharide Exposures Up-Regulated microRNAs 
Downstream Target Interaction Predictions by Decision Tree Analysis), in the Appendix E, 
contains the interaction probability z-scores of each miRNA-mRNA pairing that is represented in 
Figure 16, with the hue of the red transcript nodes being a brighter tone when the predicted 
miRNA-mRNA interaction is greater. 
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The top 20 mRNA transcripts predicted to be down-regulated by the miRNAs that have 
increased expression after 24 hours of LPS exposure in DT analysis were: HMG20A, LPP, 
TMEM183A, ECE1, ERBB2IP (regulated by miR-155), ZXDB (regulated by miR-146b), SLC11A2, 
STRN4, FREM1, CCDC93, FRMD6, LPHN3, BRWD1, NOB1, ESM1, RHOV, USP2, EMP1, 
TIA1, and PGM2L1 (regulated by miR-146a) and are displayed in the bar graph of Figure 17 (Top 
20 Predicted Down-Regulated mRNA Transcripts from LPS 24 hour Up-Regulated microRNA). Of 
the top 20 mRNA transcripts predicted to be inhibited from the up-regulated miRNA in the LPS 
treatment group, SLC11A, STRN4 and HMG20A were the transcripts with the highest miRNA-
mRNA probability of interaction calculated from the z-scores of known interactions. 
 
Figure 17. Top 20 Predicted Down-Regulated mRNA Transcripts from LPS 24 hour Up-
Regulated microRNA. 
Of the 9 miRNAs down-regulated in the LPS group, 7 transcripts had known mRNA 
interactions with 675 mRNA targets and all seven transcripts having influence upon an mRNA in 
another miRNA network, as demonstrated in Figure 18 (Down-Regulated microRNA-mRNA 
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Network After 24 hours of LPS Exposure). In Appendix E, Table E2 (24 hour Lipopolysaccharide 
Exposures Down-Regulated microRNAs Downstream Target Interaction Predictions by Decision 
Tree Analysis) contains the interaction probability z-scores of each miRNA-mRNA pairing, which is 
represented in Figure 18. The hue of the green nodes indicates greater predicted miRNA-mRNA 
interaction when the color is brighter. 
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Figure 18. Down-Regulated microRNA-mRNA Network After 24 hours of LPS Exposure 
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The top 20 mRNA transcripts predicted to be less inhibited by the miRNAs that have 
decreased expression after 24 hours of LPS exposure through DT analysis were: C1QTNF7, SCLT 
1, FXYD3 (regulated by miR-34a), GABRP, DMWD, LRIG2 MTMR2, IFT80 (regulated by miR-
212), TWSG1 (regulated by miR-210), ADAMTS9, KCNJ6, TMEM109, CRY1, NRCAM, ITGA3, 
TIMM17A (regulated by miR-181A), IYD, SOCS6, NEK8, and TMC5 (regulated by miR-132) 
displayed in bar graph Figure 19 (Top 20 Predicted Up-Regulated mRNA Transcripts from LPS 24 
hour Down-Regulated miRNA). Of the top 20 mRNA transcripts predicted to have less inhibition 
by miRNA that were down-regulated after 24 hours of LPS exposure; C1QTNF7, ADAMTS9, and 
IYD were the transcripts with the greatest probability of miRNA-mRNA interaction change, 
calculated from the z-score of known interactions.  
 
Figure 19. Top 20 Predicted Up-Regulated mRNA Transcripts from LPS 24 hour Down-
Regulated miRNA. 
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IPA results for Microglia microRNA exposed to LPS for 24 hours 
For a parallel target prediction approach to the DT method of identifying miRNA-mRNA 
interactions, Ingenuity Pathway Analysis (IPA), which also includes TargetScan, was employed. 
Within IPA, activity of downstream targets and potential upstream regulators are predicted based on 
the expression profile of known reports in literature [37]. 
In IPA, of the 12 miRNAs identified in the LPS condition, 5 transcripts increased and 7 decreased, 
and altogether 7,754 mRNA targets were recognized with 10,555 miRNA-mRNA interactions, as 
seen separated by miRNA transcript in Table 2 (miRNA-mRNA of BV2 after Lipopolysaccharide 
24hrs Treatment).  
Table 2. miRNA-mRNA of BV2 after Lipopolysaccharide 24hrs Treatment. DT identified 
miRNA are highlighted and transcript expression shown as decreased (green) or increased (red). 
  
Increasing the probability of interaction filter to only the highly predicted and experimentally 
observed for 24 hrs post-LPS treatment, there were 956 mRNA identified with 1,051 miRNA-
mRNA connections. Locations of the transcripts in networks identified under the 24 hr LPS group 
were cytoplasm (38.3%), plasma membrane (25.8%), nucleus (20.9%), extracellular space (12.7%), 
and (2.4%) localized to unknown or multiple compartments, as shown in Figure 20 (miRNA-
mRNA Transcript Location for 24 hour Lipopolysaccharide Treatment).  
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Figure 20. miRNA-mRNA Transcript Location for 24 hour Lipopolysaccharide. 
The most abundant molecular function assignment was enzyme, followed by transcription 
regulator, transporter, and transmembrane receptor, as found in Figure A8 (miRNA-mRNA 
Transcript Type for 24 hour Lipopolysaccharide Treatment) of the Appendix. 
Post 24 hours of Ethanol Treatment Group 
The 24 hr EtOH treatment dataset resulted in 885 mRNA transcripts identified as having 
interactions with the miRNA using DT analysis. Twelve miRNA transcripts of the 22 miRNAs were 
up-regulated in the EtOH condition have known mRNA interaction networks, with 882 mRNA 
targets, of which 12 miRNA transcripts had influence upon a mRNA in another transcripts network, 
as shown in Figure 21a and 21b (Up-Regulated miRNA-mRNA Network after 24 hours of Ethanol 
Exposure). In Appendix F, Table F1 (24 hour Ethanol Exposures Up-Regulated miRNAs 
Downstream Target Interaction Predictions by Decision Tree Analysis) contains the interaction 
probability z-scores of each miRNA-mRNA pairing, represented in Figure 21. The greater predicted 
miRNA-mRNA interactions are indicated by the brighter red hue of the node.  
 44 
 
 
NRSN1
PTPN4
ABHD5
mmu-miR-21a
ATAD2B
FAIM
HOXA5
BAZ2B
LDOC1
ZFP462
ARHGAP17
TBC1D23
GABRA1
HMGA1
mmu-miR-26b
STYX
2810474O19RIK
ESCO1
ACBD5
PAPPA
NAB1
GSPT1
USP25
RPS6KA6
SLC7A11
RPS6KA1
TRAPPC6B
SRA1
INO80
NEU1SUV39H1
SUMO3 SIRT6
SERPINB9B
SLMAP
SLC25A16
GATA5
EIF2S1
ACTR6
GRPEL1
HSPA4L
BHLHE40
SGCB
DOCK4
RCBTB1
BCL7B
GMDS
CREBZF
TNRC6B
HSBP1FBXL19
XKRX
PCDH9
ELAVL2
PLP1
HOXC4
DEPDC1B
ERC2
ULK2
MIER3
CCR9
RAB11FIP2 CTCFHOXB2
KCNE4
CDK14
SLC5A12
MET
OAT
ATG5TMEM55A
KCND3
TGIF2
CDC73
GOLGA7 SLC31A2
AI467606
ASF1B
TDO2
CWC25
mmu-miR-340
DCUN1D1
CLIC6
C1QTNF7
DPP8
GRM5
SLC25A37
SLITRK1
USP33
SSX2IPNDRG2
RBBP6
EVI2B
CXCL5
ARG1
MAGI2
IL1A
ANKRD44
PDGFC
CROT
OAS2
CEP97
TMEM151BLIMCH1
ATRNL1
ADAM11
MDH1B
THEM5
ME2
PTH2R DCUN1D3
KCNS3
LHFPL3
GATAD1
APBB3
TBKBP1
GNG5
DDI2
ZFP617
FRMD4A
NTSR1
MMP1A
DDX19A
TGDS
FNIP1
TARBP2
COL5A2
SLC10A7
ANKRD49
SMARCAD1
CD200R1
LIMD2 B3GAT3
CBX2
mmu- le t -7e
BZW1
PLEKHG6DF6WNT9AIGF2BP2
CCNJOSMRPCGF3GATM
ADAMTS8CRT
ERCC6
NSMCE2
12-Sep
EEA1
GAS7
CCDC135
KLK10
HDLBP
E2F5
LIN28B
ADHFE1
NR6A1
RNF5
TGFBR3
ARID3C
ADAMTS15KIF2B
RNASE10
IL21
MEGF11
ANO1
CCDC122
LZTFL1
SUPT16H
FGL2
ARIH1
TRAF4
TPR
BICD1
PCDHAC2
ATP6V1E1
BCL2L13
SLC14A1
TMF1
FHL4
FNDC3B
FBXO30
XRCC4
ACTG1
ADD1 KCNB2
HIC2CRYBG3
ZBTB41
ADRB3
ADRB2TAF9B
GLRXNRAS
DMD
GPATCH3ABCB9DLL3
STAG2
GOLT1B
CUL4B
PCNT
WIPF1
SERINC3
LRRN1
STK17B
WDR44
KCNK2
RIOK3
PPM1B9330159F19RIK
CDC42
mmu-miR-186
NSD1
MDM4
SPAG17PGAM5
BCAR1
LMO3 USP7
PLXNC1
ABI1
BMX CADM2
EVI5
FMNL3
PPP4R2
ALDH6A1
PDHX
PPP1R3A
SLC7A14
DLK2
BMP8A
SS18
EPX
FOXC1
ATP13A5
TWF1 CTDSP2
TAOK1
CALN1
CUTC
MYB
DDX26B
GPR61
STC1
FBXO32
MPP1
STEAP2
GABRB2
PAWR
FOXP2
SLC12A8
COMMD8IGSF10
MBL2WSB2HECTD1
TRIM59
TSKU
YES1
PAQR9
INPP4B
SLC6A3
ZDHHC3
RNF19A
SPRY1NPM1
mmu-miR-33
MAPK6
ZCCHC3
MITF
ART3CPEB3
CD53
COL11A1AMOT
DNAJC3
PPP2R1B
SPIN1 PRKAA1
LACE1IPPK
CLPB
PLEKHA6
PLAA
PRKACB
SALL3
GLS
mmu- le t -7 fSLC37A3
PLEKHJ1
MORC3
BRD8
YIPF2
PAMBCL6B
MSI2
CBX4
LARP4GPC5
EIF5B
TCERG1
WNK1
MBTPS2
RUFY3
ISCA1
IDH1
ZFP820 TTPA MTPN
CARD11
RSAD1 6-Mar
PPP1R2 ITGA2
PKNOX2
ANO5
CD2AP
FBXO11
TRIM71
MAGOHB
CALCA
ADAM12TGFBI
LONRF2
ACSL1
TRPD52L3
IFI44
LYRM4
CRK
ARL4D
QARS
ST5
ZFYVE16
JMJD4
NUSAP1
XKR8
GALNT1
SLC20A1
LIN28A
NAP1L5
MYSM1
RAP2C
YOD1
RDH10
mmu-miR-98AMMECR1LSNX16CASP3USP32
TYK2
CLDN12
SERF2
TMEM41A
ZFYVE26SOCS1
TSPAN13
SLC5A9CERCAM
ZMIZ1
TMPRSS2
CLP1
ROCK1
ZFP248
ARHGAP20
ZMAT4
KLF15
PWP1
FNDC3A
DDIT4L
LPCAT2
GSE1
SLC7A13
INSM2
SPIRE1
PCGF6
TNFAIP1
SCN4B
TBC1D1
ANKRD27
TBCEL ARRB2
MANEA
RNMT
CYP2C39
KIFC3
AQP3
SSR1
DAGLA
MED8
mmu-miR-181d
ANP32E
RNF20
AGFG2
PRTG
SNTG1
PNRC2
ZFP286
SOS1
CPD
CNR1
SIN3B
ISOC1DDX3X
RFX6
PROX1
TMEM144
STRNITGA7
CPA3
DCUN1D4
BRIP1
VPS37C
NSG2
DIS3L2
GRIN2D
IL6ST
ABHD3
RHOQ
CENPL
FTL2
STK38L
SLC16A1
ODF2
EIF6
LHFPL2
9830107B12RIK
CPSF6
USP45
TIMM8A1
FTO
CALU
ATP1B4 NPL
ENO1
TSPAN11GRB14
EPHA4
MYO9AFOXO1
mmu-miR-125a
GHRL
STX6
CNTN4
YY1
CCKAR
ITGA4
PPP1CB
POLDIP2
GPR55
HMG20A
SERTAD3
AP1G2
LMOD1
ABHD6
OSBPL9
CEACAM2
NDFIP1
ZSWIM6
NAA25
EMCN
GKN1
SLC39A8
ARFIP1
OSGEPBET1
DHX33
AR MCL1
IRF4
LEPRCSD1
SLC24A3
BMF
SLC18A1 PFPLRSPRY1
TNS4
MR1 BSNMYT1
FMOD
DHCR7
KLF6
ABCB11
CDH2
NT5DC1
ODC1
CSDE1
LARP7
TRIM2
RNF170
SPOPL
AP4E1
TIGD2DCLRE1C
HMX3ST6GAL1
GUF1
ACN9 GTPBP1
ARL4C
GPR37
DUSP21
UQCRFS1
GNG2
CTSC
GALNTL5
SNX2DYNC1I2
SPIN4
FIGNHRASLS
PITPNC1
ZIC4PANK3
KLHL15
PJA2AHRR
CSE1L
GNAI3CYBRD1
WDR12
FGD1
SNX33
LRAT CLCC1
TMEFF1TBC1D12
NUDT4
EDNRB
IL33
BRCC3
ANKRD1SERBP1
TRHDE
PHF20L1
NOS2
IL6
NFAT5
CHD9
WDR82
MINA
ARVCF
NIPAL3
TBC1D14
STC2
TANK
B3GNT5
TRIP12
OMP
ASPH
OCLN
SLA2
PPP1R1AFOXJ3
ATP2B4
POLA2 TIPARPCTSH
MATN2
CLDN18CDV3
MBIP
LONRF3
FMNL2
INPP5F
ACVR2A
FUT9
SLITRK4
DGKB
MYCN
ZNRF3
EEFSEC
PDK1
mmu-miR-223
DAAM1
AXIN2TRIM35
LPAR1
NEK2
GIT1
TMEM87B
ZKSCAN2 KCTD12
GNA11
CDK17
ANGPTL2BCAP29
KCNK13ZRANB3
CYBB
HECTD2
SMCR8
STAT3
PSMA6TBC1D16
NTRK3
PCDHAC1
NRP1
SPEN
TM4SF1 NHLH2
CYP24A1
BIVM
LRRC19
LUZP1
ABCA13TM4SF20
SDC2MMGT1
IGF2BP3ETS1
KPNA1
SV2BMLC1SOX9 PIWIL1
TPPP ACTR1A
SLC16A6 CASP9TIFAB
S1PR1
ROBO2
NTRK2
G6PC2
SMAD1
MEF2C
IRS1
LPHN3
VPS41
DOCK8 AGK
ALDH1L2
MTAP ZCCHC14
ST8SIA3
ALCAM
NDNF ANKRD13C
IL23A
SLC2A2
SLC2A5 GUCY2C
POLE4 LGALS12
8-Sep
YIPF6RCN2
PRMT8
PIK3R3
CMTM3
CTSA
SBDS
YWHAZ
NXPH2 DOCK3
GEMIN5
6-Sep
WWTR1
ZC3H13
BAALC
ATP2B1
USP49SNAI2
FAM83D
PIK3CA
RIMBP3
MT2
OBFC1
PARP9
RGS2
TTC9
HOOK1
MPP5
SYN1
CACHD1
XPNPEP2
YWHAH
HPS1
SNX10
CRHBP
ELK4
LNX2VSTM2A
SPOPCIDEB
RNF4
TMEFF2
SLC16A9
IL2RA
RFWD3
TMEM123
ZBTB2
CHRND
RAB18
RBMX
GABPB1
USP6NL
CTSB
PARP1 STXBP2
PLEC
DNAJC10
ZFAND1
RBM18
NAV2
RFX7
LARP4B
PEBP1CACNB4
MED17
CCNG2
GUCY1B3 VCAN
CYFIP1
ZFPM2
SLC30A7
VPS54
NDE1
GPR12
ATG2B
AQP4 IRF6
BLCAP
TMCO4
SMAD4
KLF4
GTF3C4
NEK6
SAMD10
HSPA4
PIK3CD
SLC4A4
NCOR1
LENG1
FOXJ2
TMEM26
STX3
ASB8
EYA4
STON2ATP1B2
LPL
ZFAND5
CD247 PRKCI
CDC14A SNX3 CORO1C TMEM86B
PCNXL2ATXN7HTR2C
SLC8A1
RABGAP1L
PID1
NBEAL1
ONECUT2
HECW1
MKNK2
SLC46A2
BOP1SHE
TMOD2
GSK3A
ACSL4
EPHA5
GHITM
ARCN1
STAG1
SLC25A42
ATP10D
B3GNT6
DCLRE1BACSS2
TCF12
IL1RL1
MLH3
TMEM30B
PTBP1
CREB1
SLC3A2RASEF
TLE1
SLC7A4
MAP3K2
BMPR1B
PIGK
STXBP6
CTNND1
CDH5
GCA
TM9SF3
RASA2
EDAR
COL2A1
CBFA2T2 PPP1R1C
PRAF2
TRAF5
LGR4
ZSWIM3
USP48
BARD1
SPEF2
HPCAL4
SOX13
PRDM1
ARHGEF12
ZCCHC2
ACTR3B
ITGB2
KIF3AG3BP2
RBM25
APBB2
SEMA3E
mmu-miR-7a
SLC12A5
LAMC2
CPLX1
HOMEZ
DPYSL2
CAMK2A
TRIM33
COL4A1
KRT33A
CALD1
CCDC23
CDC40
KLHL14
CCBL2
RNF14
PLXND1
IQGAP1
PML
SLC26A2
ACADMSFRP2
LCP1 GGTA1RNF185
PAX1PGGT1B
EFCAB4A
ZYG11B
MACROD2
GJA1
ARF4
RELA
FRMPD3
TMEM33
WDR47
SNAP29
CAB39LFAM189A1
CDR2L
SGIP1
TRIM58
MYLK2
NAPA
USP40
APLP2
CHRNA6
PIM1
PSME3
ZFP30 U2AF2
RTTN
CALR
WASF3
ATP2B2
TMEM79
CD180
APON
SLC6A6
NIPAL4
WHSC1
PLAU
ELAVL1
PRKCB
TOMM40L
CNOT8
STAT1
SEC14L2
SLAMF8
ERO1LB
MAPK10
BOC
PLOD3
Figure 21a. Up-Regulated microRNA-mRNA Network after 24 hours of Ethanol Exposure 
 45 
 
NRSN1
PTPN4
ABHD5
mmu-miR-21a
ATAD2B
FAIM
HOXA5
BAZ2B
LDOC1
ZFP462
ARHGAP17
TBC1D23
GABRA1
HMGA1
mmu-miR-26b
STYX
2810474O19RIK
ESCO1
ACBD5
PAPPA
NAB1
GSPT1
USP25
RPS6KA6
SLC7A11
RPS6KA1
TRAPPC6B
SRA1
INO80
NEU1SUV39H1
SUMO3 SIRT6
SERPINB9B
SLMAP
SLC25A16
GATA5
EIF2S1
ACTR6
GRPEL1
HSPA4L
BHLHE40
SGCB
DOCK4
RCBTB1
BCL7B
GMDS
CREBZF
TNRC6B
HSBP1FBXL19
XKRX
PCDH9
ELAVL2
PLP1
HOXC4
DEPDC1B
ERC2
ULK2
MIER3
CCR9
RAB11FIP2 CTCFHOXB2
KCNE4
CDK14
SLC5A12
MET
OAT
ATG5TMEM55A
KCND3
TGIF2
CDC73
GOLGA7 SLC31A2
AI467606
ASF1B
TDO2
CWC25
mmu-miR-340
DCUN1D1
CLIC6
C1QTNF7
DPP8
GRM5
SLC25A37
SLITRK1
USP33
SSX2IPNDRG2
RBBP6
EVI2B
CXCL5
ARG1
MAGI2
IL1A
ANKRD44
PDGFC
CROT
OAS2
CEP97
TMEM151BLIMCH1
ATRNL1
ADAM11
MDH1B
THEM5
ME2
PTH2R DCUN1D3
KCNS3
LHFPL3
GATAD1
APBB3
TBKBP1
GNG5
DDI2
ZFP617
FRMD4A
NTSR1
MMP1A
DDX19A
TGDS
FNIP1
TARBP2
COL5A2
SLC10A7
ANKRD49
SMARCAD1
CD200R1
LIMD2 B3GAT3
CBX2
mmu- le t -7e
BZW1
PLEKHG6DF6WNT9AIGF2BP2
CCNJOSMRPCGF3GATM
ADAMTS8CRT
ERCC6
NSMCE2
12-Sep
EEA1
GAS7
CCDC135
KLK10
HDLBP
E2F5
LIN28B
ADHFE1
NR6A1
RNF5
TGFBR3
ARID3C
ADAMTS15KIF2B
RNASE10
IL21
MEGF11
ANO1
CCDC122
LZTFL1
SUPT16H
FGL2
ARIH1
TRAF4
TPR
BICD1
PCDHAC2
ATP6V1E1
BCL2L13
SLC14A1
TMF1
FHL4
FNDC3B
FBXO30
XRCC4
ACTG1
ADD1 KCNB2
HIC2CRYBG3
ZBTB41
ADRB3
ADRB2TAF9B
GLRXNRAS
DMD
GPATCH3ABCB9DLL3
STAG2
GOLT1B
CUL4B
PCNT
WIPF1
SERINC3
LRRN1
STK17B
WDR44
KCNK2
RIOK3
PPM1B9330159F19RIK
CDC42
mmu-miR-186
NSD1
MDM4
SPAG17PGAM5
BCAR1
LMO3 USP7
PLXNC1
ABI1
BMX CADM2
EVI5
FMNL3
PPP4R2
ALDH6A1
PDHX
PPP1R3A
SLC7A14
DLK2
BMP8A
SS18
EPX
FOXC1
ATP13A5
TWF1 CTDSP2
TAOK1
CALN1
CUTC
MYB
DDX26B
GPR61
STC1
FBXO32
MPP1
STEAP2
GABRB2
PAWR
FOXP2
SLC12A8
COMMD8IGSF10
MBL2WSB2HECTD1
TRIM59
TSKU
YES1
PAQR9
INPP4B
SLC6A3
ZDHHC3
RNF19A
SPRY1NPM1
mmu-miR-33
MAPK6
ZCCHC3
MITF
ART3CPEB3
CD53
COL11A1AMOT
DNAJC3
PPP2R1B
SPIN1 PRKAA1
LACE1IPPK
CLPB
PLEKHA6
PLAA
PRKACB
SALL3
GLS
mmu- le t -7 fSLC37A3
PLEKHJ1
MORC3
BRD8
YIPF2
PAMBCL6B
MSI2
CBX4
LARP4GPC5
EIF5B
TCERG1
WNK1
MBTPS2
RUFY3
ISCA1
IDH1
ZFP820 TTPA MTPN
CARD11
RSAD1 6-Mar
PPP1R2 ITGA2
PKNOX2
ANO5
CD2AP
FBXO11
TRIM71
MAGOHB
CALCA
ADAM12TGFBI
LONRF2
ACSL1
TRPD52L3
IFI44
LYRM4
CRK
ARL4D
QARS
ST5
ZFYVE16
JMJD4
NUSAP1
XKR8
GALNT1
SLC20A1
LIN28A
NAP1L5
MYSM1
RAP2C
YOD1
RDH10
mmu-miR-98AMMECR1LSNX16CASP3USP32
TYK2
CLDN12
SERF2
TMEM41A
ZFYVE26SOCS1
TSPAN13
SLC5A9CERCAM
ZMIZ1
TMPRSS2
CLP1
ROCK1
ZFP248
ARHGAP20
ZMAT4
KLF15
PWP1
FNDC3A
DDIT4L
LPCAT2
GSE1
SLC7A13
INSM2
SPIRE1
PCGF6
TNFAIP1
SCN4B
TBC1D1
ANKRD27
TBCEL ARRB2
MANEA
RNMT
CYP2C39
KIFC3
AQP3
SSR1
DAGLA
MED8
mmu-miR-181d
ANP32E
RNF20
AGFG2
PRTG
SNTG1
PNRC2
ZFP286
SOS1
CPD
CNR1
SIN3B
ISOC1DDX3X
RFX6
PROX1
TMEM144
STRNITGA7
CPA3
DCUN1D4
BRIP1
VPS37C
NSG2
DIS3L2
GRIN2D
IL6ST
ABHD3
RHOQ
CENPL
FTL2
STK38L
SLC16A1
ODF2
EIF6
LHFPL2
9830107B12RIK
CPSF6
USP45
TIMM8A1
FTO
CALU
ATP1B4 NPL
ENO1
TSPAN11GRB14
EPHA4
MYO9AFOXO1
mmu-miR-125a
GHRL
STX6
CNTN4
YY1
CCKAR
ITGA4
PPP1CB
POLDIP2
GPR55
HMG20A
SERTAD3
AP1G2
LMOD1
ABHD6
OSBPL9
CEACAM2
NDFIP1
ZSWIM6
NAA25
EMCN
GKN1
SLC39A8
ARFIP1
OSGEPBET1
DHX33
AR MCL1
IRF4
LEPRCSD1
SLC24A3
BMF
SLC18A1 PFPLRSPRY1
TNS4
MR1 BSNMYT1
FMOD
DHCR7
KLF6
ABCB11
CDH2
NT5DC1
ODC1
CSDE1
LARP7
TRIM2
RNF170
SPOPL
AP4E1
TIGD2DCLRE1C
HMX3ST6GAL1
GUF1
ACN9 GTPBP1
ARL4C
GPR37
DUSP21
UQCRFS1
GNG2
CTSC
GALNTL5
SNX2DYNC1I2
SPIN4
FIGNHRASLS
PITPNC1
ZIC4PANK3
KLHL15
PJA2AHRR
CSE1L
GNAI3CYBRD1
WDR12
FGD1
SNX33
LRAT CLCC1
TMEFF1TBC1D12
NUDT4
EDNRB
IL33
BRCC3
ANKRD1SERBP1
TRHDE
PHF20L1
NOS2
IL6
NFAT5
CHD9
WDR82
MINA
ARVCF
NIPAL3
TBC1D14
STC2
TANK
B3GNT5
TRIP12
OMP
ASPH
OCLN
SLA2
PPP1R1AFOXJ3
ATP2B4
POLA2 TIPARPCTSH
MATN2
CLDN18CDV3
MBIP
LONRF3
FMNL2
INPP5F
ACVR2A
FUT9
SLITRK4
DGKB
MYCN
ZNRF3
EEFSEC
PDK1
mmu-miR-223
DAAM1
AXIN2TRIM35
LPAR1
NEK2
GIT1
TMEM87B
ZKSCAN2 KCTD12
GNA11
CDK17
ANGPTL2BCAP29
KCNK13ZRANB3
CYBB
HECTD2
SMCR8
STAT3
PSMA6TBC1D16
NTRK3
PCDHAC1
NRP1
SPEN
TM4SF1 NHLH2
CYP24A1
BIVM
LRRC19
LUZP1
ABCA13TM4SF20
SDC2MMGT1
IGF2BP3ETS1
KPNA1
SV2BMLC1SOX9 PIWIL1
TPPP ACTR1A
SLC16A6 CASP9TIFAB
S1PR1
ROBO2
NTRK2
G6PC2
SMAD1
MEF2C
IRS1
LPHN3
VPS41
DOCK8 AGK
ALDH1L2
MTAP ZCCHC14
ST8SIA3
ALCAM
NDNF ANKRD13C
IL23A
SLC2A2
SLC2A5 GUCY2C
POLE4 LGALS12
8-Sep
YIPF6RCN2
PRMT8
PIK3R3
CMTM3
CTSA
SBDS
YWHAZ
NXPH2 DOCK3
GEMIN5
6-Sep
WWTR1
ZC3H13
BAALC
ATP2B1
USP49SNAI2
FAM83D
PIK3CA
RIMBP3
MT2
OBFC1
PARP9
RGS2
TTC9
HOOK1
MPP5
SYN1
CACHD1
XPNPEP2
YWHAH
HPS1
SNX10
CRHBP
ELK4
LNX2VSTM2A
SPOPCIDEB
RNF4
TMEFF2
SLC16A9
IL2RA
RFWD3
TMEM123
ZBTB2
CHRND
RAB18
RBMX
GABPB1
USP6NL
CTSB
PARP1 STXBP2
PLEC
DNAJC10
ZFAND1
RBM18
NAV2
RFX7
LARP4B
PEBP1CACNB4
MED17
CCNG2
GUCY1B3 VCAN
CYFIP1
ZFPM2
SLC30A7
VPS54
NDE1
GPR12
ATG2B
AQP4 IRF6
BLCAP
TMCO4
SMAD4
KLF4
GTF3C4
NEK6
SAMD10
HSPA4
PIK3CD
SLC4A4
NCOR1
LENG1
FOXJ2
TMEM26
STX3
ASB8
EYA4
STON2ATP1B2
LPL
ZFAND5
CD247 PRKCI
CDC14A SNX3 CORO1C TMEM86B
PCNXL2ATXN7HTR2C
SLC8A1
RABGAP1L
PID1
NBEAL1
ONECUT2
HECW1
MKNK2
SLC46A2
BOP1SHE
TMOD2
GSK3A
ACSL4
EPHA5
GHITM
ARCN1
STAG1
SLC25A42
ATP10D
B3GNT6
DCLRE1BACSS2
TCF12
IL1RL1
MLH3
TMEM30B
PTBP1
CREB1
SLC3A2RASEF
TLE1
SLC7A4
MAP3K2
BMPR1B
PIGK
STXBP6
CTNND1
CDH5
GCA
TM9SF3
RASA2
EDAR
COL2A1
CBFA2T2 PPP1R1C
PRAF2
TRAF5
LGR4
ZSWIM3
USP48
BARD1
SPEF2
HPCAL4
SOX13
PRDM1
ARHGEF12
ZCCHC2
ACTR3B
ITGB2
KIF3AG3BP2
RBM25
APBB2
SEMA3E
mmu-miR-7a
SLC12A5
LAMC2
CPLX1
HOMEZ
DPYSL2
CAMK2A
TRIM33
COL4A1
KRT33A
CALD1
CCDC23
CDC40
KLHL14
CCBL2
RNF14
PLXND1
IQGAP1
PML
SLC26A2
ACADMSFRP2
LCP1 GGTA1RNF185
PAX1PGGT1B
EFCAB4A
ZYG11B
MACROD2
GJA1
ARF4
RELA
FRMPD3
TMEM33
WDR47
SNAP29
CAB39LFAM189A1
CDR2L
SGIP1
TRIM58
MYLK2
NAPA
USP40
APLP2
CHRNA6
PIM1
PSME3
ZFP30 U2AF2
RTTN
CALR
WASF3
ATP2B2
TMEM79
CD180
APON
SLC6A6
NIPAL4
WHSC1
PLAU
ELAVL1
PRKCB
TOMM40L
CNOT8
STAT1
SEC14L2
SLAMF8
ERO1LB
MAPK10
BOC
PLOD3
Figure 21b. Up-Regulated microRNA-mRNA Network after 24 hours of Ethanol Exposure 
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The top 20 mRNA transcripts predicted to be inhibited by the miRNAs that have increased 
expression after 24 hours of EtOH exposure by DT analysis were: POLDIP2 (regulated by miR-
125a), ANP32E (regulated by miR-181d), HPS1, KPNA1, HECTD2, TIFAB (regulated by miR-
223), GPR61, LPHN3, G6PC2, MINA (regulated by miR-33), PML, SLC7A4, PLOD3, ACTR3B, 
STX3, ZCCHC2, RBMX, RTTN, STAT1, STAG1(regulated by miR-7a) and displayed in the bar 
graph shown in Figure 22 (Top 20 Predicted Down-Regulated mRNA Transcripts from Ethanol 24 
hour Up-Regulated miRNA). Of the top 20 mRNA transcripts predicted to be inhibited from the 
up-regulated miRNA in the EtOH treatment group (24 hrs), SLC7A4, and PLOD3 were the 
transcripts with the highest miRNA-mRNA probability of interaction calculated from the z-scores 
of known interactions. 
 
Figure 22. Top 20 Predicted Down-Regulated mRNA Transcripts from Ethanol 24 hour Up-
Regulated miRNA. 
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 Of the 9 miRNAs down-regulated in the EtOH condition, one miRNA transcript had 
known mRNA interactions with a total of 3 mRNA targets identified, as seen in Figure 23 (Down-
Regulated miRNA-mRNA Network After 24 hours of Ethanol Exposure), in which the hue of the 
green nodes indicates greater predicted miRNA-mRNA interaction with the brighter node color. 
The top 3 mRNA transcripts with the greatest probability of decreased regulation by miR-126a, 
calculated from the z-score of known miRNA-mRNA interactions, were CADM1, FBXO33, and 
TTC39B, as seen in Figure 24 (Top 3 Predicted Up-Regulated mRNA Transcripts from Ethanol 24 
hour Down-Regulated miRNA). In Appendix F, Table F2 the 24 hour Ethanol Exposures Down-
Regulated miRNAs Downstream Target Interaction Predictions by Decision Tree Analysis can be 
found.  
                      
 
 
 
 
 
IPA results for Microglial miRNA differential expression from Ethanol (24 hrs ) 
In IPA, of the 14 miRNAs identified in the EtOH condition, 12 transcripts increased and 2 
decreased, and altogether 6,139 mRNA targets were recognized with 7,951 miRNA-mRNA 
interactions. Increasing the probability of interaction filter to only the highly predicted and 
experimentally observed, at 24 hrs post-EtOH treatment there were 568 mRNA identified with 620 
Figure 23. Down-Regulated microRNA-mRNA 
Network After 24 hours of Ethanol Exposure 
Figure 24. Top 3 Predicted Up-Regulated 
mRNA Transcripts from Ethanol 24 hour 
Down-Regulated microRNA 
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miRNA-mRNA connections, separated by miRNA transcript and shown in Table 3 (miRNA-
mRNA of BV2 After Ethanol 24hrs Treatment). Locations of the transcripts in networks identified, 
in the 24 hrs EtOH treatment group, were cytoplasm (40.8%), nucleus (25.8%), plasma membrane 
(20.2%), extracellular space (11.8%), and (1.5%) localized to unknown or multiple compartments, as 
shown in Figure 25 (miRNA-mRNA Transcript Location for 24 hour Ethanol Treatment). The 
most abundant molecular function assignment, as seen in Figure H2 (miRNA-mRNA Transcript 
Type for 24 hour Ethanol Treatment in Appendix H2) was enzyme, followed by transcription 
regulator, kinase, and cytokines.  
Table 3. miRNA-mRNA of BV2 After Ethanol 24hrs Treatment. DT identified miRNA are 
highlighted and transcript expression shown as decreased (green) or increased (red). 
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Figure 25. miRNA-mRNA Transcript Location for 24 hour Ethanol Treatment 
Aim 2: Proteomic Approach, Quantification, and Uniquely Expressed Proteins  
LTQ Orbitrap XL Mass Spectrometer Results for LPS and Ethanol Treatments 
Proceeding with only 24 hrs data, a total of 2,277 protein groups were identified across the 3 groups 
(each containing 3 replicates) when initially screened on the LTQ Orbitrap XL MS after analysis by 
MaxQuant and Perseus. The resulting data were log 2-transformed and, using a two-tailed Welch’s t 
test, intensity ratios were considered significant at p < 0.05. Between the compared test groups 
(control, LPS, and EtOH), 170 protein groups were differentially expressed as displayed in Figure 
26 (Venn Diagram of All Proteins identified though the LTQ Orbitrap XL Mass Spectrometer). 
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Figure 26. Venn Diagram of All Proteins Identified Though the LTQ Orbitrap XL 
Mass Spectrometer. Of those 170 proteins identified, 26 proteins were identified in the LPS and 
the EtOH groups. The LPS condition contained 94 differentially expressed proteins, 62 proteins 
with increased expression and 32 proteins with decreased expression when compared to the control. 
The EtOH treatment group contained 76 differentially expressed proteins, with 52 having increased 
expression and 24 with decreased expression, when compared to the control, Figure 27 (Proteins 
Identified Though MS Differentially Expressed in LPS and Ethanol After 24 hours of Treatment 
Exposure). 
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Figure 27. Proteins Identified Though MS Differentially Expressed in LPS and 
Ethanol After 24 hours of Treatment Exposure. Of those protein groups, 26 were differentially 
expressed in both LPS and EtOH, with 20 of those proteins being similarly increased and 2 proteins, 
ADH5 and GANAB, down-regulated similarly. The EtOH condition had 3 proteins, ARPC5L, 
FERMT3, and MARS also identified in the LPS condition with increased expression opposing their 
expression within the LPS condition. Protein PABPC1, also found in each condition indicated up-
regulation within the LPS condition but decreased expression with EtOH treatment. 
Q-Exactive Plus Mass Spectrometer Results for LPS and Ethanol Treatments 
Protein groups secondarily identified through the Q-Exactive Plus mass spectrometer (LC-
MS/MS) after the same statistical analysis through MaxQuant and Perseus, with the resulting data 
normalized, using a two-tailed Welch’s t-test, intensity ratios with a significance value of p < 0.05 
were considered statistically significant. Of the 2,147 protein groups identified, the test groups 
compared (control, LPS, and EtOH) at 24 hrs treatment exposure showed 166 protein groups that 
were differentially expressed, as displayed in Figure 28 (Venn diagram of All Proteins Identified Q-
Exactive Plus Mass Spectrometer). Of those 166 proteins identified, 7 proteins were identified in 
both the LPS and EtOH conditions as significantly differentially expressed. 
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Figure 28. Venn Diagram of All Proteins Identified by Q-Exactive Plus Mass 
Spectrometer. 
In Appendix I (Proteins Identified in IPA from LC-MS/MS for Each Condition After 24 hours) 
can be found in Tables I1-I2. The LPS condition contained 102 differentially expressed proteins, 
with 76 proteins up-regulated and 22 proteins decreased in expression, when compared to the 
control. The EtOH condition contained 65 differentially expressed proteins, with 30 having 
increased expression and 35 proteins with decreased expression, when compared to the control. 
These results are shown in Figure 29 (Proteins Identified Through LC-MS/MS Differentially 
Expressed in LPS and Ethanol After 24 hours of Treatment Exposure).  
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Figure 29. Proteins Identified Through LC-MS/MS Differentially Expressed in LPS and 
Ethanol After 24 hours of Treatment Exposure. 
Of the 7 protein groups identified as differentially expressed in both LPS and EtOH, 5 
proteins (PTK2B, PTPMT1, TMEM109, CERS2, and MRPL49) were similarly increased and 1 
protein, ADD1, had been down-regulated similarly. The EtOH condition had 1 protein, TMEM11, 
with decreased expression opposing the regulation found within the LPS condition. 
Quantity of Protein and Predicted microRNA Upstream Regulation 
The LC-MS/MS top quantities measured, the peptides can be matched to their upstream 
regulators within IPA, using the proteomic approach of prediction for narrowing the investigation 
of specific transcript influence in a bottom-up trend interpretation, in which downstream proteins 
predict their upstream modulators. 
Post 24 hours of Lipopolysaccharide Treatment  
In IPA, of the 102 protein identified in the LPS condition, 76 transcripts increased and 22 
decreased, altogether having 606 predicted up stream regulators with 10 specifically being identified 
as miRNA families. MicroRNA Up Stream Regulators Predicted in IPA from Differentially 
Expressed Proteins after 24hrs of Lipopolysaccharide Treatment are displayed in Table 4, which 
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includes the calculated p-value overlap. Locations of the proteins identified under the 24 hours LPS 
condition were cytoplasm (60.8%), nucleus (18.6%), plasma membrane (7.8%), extracellular space 
(3.9%), and (7.8%) were localized to unknown or multiple compartments, as shown in Figure J1. 
Proteomic Location After 24 hours of Lipopolysaccharide Treatment found in the Appendix. The 
most abundant molecular function assignment was enzyme, followed by transporter, kinase, 
transcription regulator, translation regulator and transmembrane receptor, as found in Figure 30. 
Proteomic Transcript Type for 24 hours of Lipopolysaccharide Treatment. 
Table 4. MicroRNA Up Stream Regulators Predicted in IPA from Differentially Expressed 
Proteins after 24hrs of Lipopolysaccharide Treatment 
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Figure 30. Proteomic Transcript Type After 24 hour Lipopolysaccharide 
Post 24 hours of Ethanol Treatment  
In IPA, of the 65 proteins identified in the EtOH condition, 30 transcripts increased and 35 
decreased, altogether having 123 predicted upstream regulators with 10 specifically being identified 
as miRNA families. MicroRNA Up Stream Regulators Predicted in IPA from Differentially 
Expressed Proteins After 24hrs of Ethanol Treatment are displayed in Table 5, which includes the 
calculated p-value of overlap. Locations of the proteins identified under the 24 hrs EtOH treatment 
were cytoplasm (55.4%), nucleus (24.6%), plasma membrane (10.8%), extracellular space (3.1%), and 
(4.6%) were localized to unknown or multiple compartments, as shown in Figure J2, (Proteomic 
Location After 24 hours of Ethanol Treatment) found in Appendix. The most abundant molecular 
function assignment was enzyme, followed by transporter, kinase, Phosphatase and transcription 
regulator, as found in Figure 31 (Protein Type from 24 hours of Ethanol Treatment). 
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Table 5. MicroRNA Up Stream Regulators Predicted in IPA from Differentially Expressed 
Peptides after 24hrs of Ethanol Treatment 
 
 
Figure 31. Protein Type for 24 hour Ethanol Treatment 
IPA Upstream Regulatory miRNA Match to miRNA Analysis Data 
The predicted the upstream miRNA influence through IPA method of bioinformatics, was 
used to assess miRNA regulatory mechanisms associated with EtOH and LPS-induced microglial 
proteome profile changes, with influences upon the same proteins affected, revealing miRNAs 
expressed in different species (of which we can use to identify the gene/chromosome origins) 
inclined to be affected. Molecules predicted to be targets of miRNAs from the proteome expressed 
by microglia upon 24 hours of LPS were: DHFR, CERS2, TBL1X, BAX, TLR2, LARP4, MTHFD2, 
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POLR2K, PPIB, SRXN1, ISG15, OAS1, ADD1, BET1, PPIB, ARF6, CKS2, UBE2L6, VRK1. 
Target molecules of miRNAs from the proteome expressed by microglia upon 24 hours of EtOH 
were: ATL3, CERS2, TMEM109, PPIF, UBE2S, SRSF2, MIF, FTL, RAP1B, RAC1, SLC39A7. 
Both lists of molecules to be targeted containing CERS2, ceramide synthase a transcription 
regulator. 
The predicted upstream regulators within the EtOH condition consist of 6 miRNAs that are 
comparable to the miRNAs identified through the microarray results: miR-124-3p, miR-183-5p, 
miR-451a (mir-451), miR-133a-3p miR-193a-3p, miR-149-5p, and mir-194. The upstream regulators 
predicted within the LPS condition consist of 7 miRNAs that are comparable to the miRNAs 
identified through the microarray results: miR-192-5p, miR-133a-3p, miR-125b-2-3p, miR-24-3p, 
miR-1-3p, mir-15, mir-1, and mir-21. Both lists of upstream regulatory miRNAs contain miR-133a-
3p, a regulator of CERS2. The miRNA transcripts that were predicted upstream were done so 
without a species filter between human, mice, and rat when matching the miRNAs influence upon 
the expressed proteome. These transcripts correlate to the expressed proteome and the functions of 
some transcripts that are not well known can be revealed.  
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Chapter 4 
Discussion 
Summary of LPS and EtOH microRNA Transcripts 
The differences in the number of transcripts identified and the amount of interactions able 
to be predicted utilizing the miRNA pathway analysis (DT and IPA) reveal the gaps of information 
within knowledge bases, for both of the conditions examined, specifically in regard to the miRNA 
down-regulated network under the EtOH treated microglia, as well as each of the up-regulated 
miRNA networks for the treatment groups only having about half of the miRNA with significant 
changes expressed within networks being identified, as seen in Table 6. The networks of up-
regulated miRNAs under the EtOH treatment and the down-regulated miRNAs under LPS 
treatment had extensive known interconnections (see Figure 18 for LPS and Figure 21 a & b for 
Ethanol). Further work is needed to include the understanding within the research knowledge bases 
of the functions associated with miRNAs that were identified, but had indeterminate activity. In 
Table 6 (Decision Tree Analysis miRNA-mRNA Identification in Comparison to Ingenuity 
Pathway Analysis), the number of transcripts differentially expressed can be compared.  
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Table 6. Decision Tree Analysis miRNA-mRNA Identification in Comparison to Ingenuity 
Pathway Analysis. The number of transcripts differentially expressed, compared to the number of 
miRNA-mRNA networks identified by DT and IPA databases, including the total mRNA identified 
in TAC, as well as the amount of the IPA miRNA-mRNA predicted interactions that are highly 
predicted or experimentally observed. 
 
An extended Summary of LPS and EtOH Quantification can be found in Table D1, of 
the appendices, which include quantity of those transcripts in specific locations and the type of 
protein the transcript is translated into. As predicted, a small population of miRNA were shown to 
have influence over multiple mRNAs, similar to that found in the miRNA-mRNA synaptic 
coordination study within neurons reported by Most et al, (2016) [63]. 
Regulatory Influence Upon Important Cellular Networks 
Within each condition, the influence of different miRNA families identified were predicted 
to affect the same cellular networks differently, such as that of apoptosis and cell proliferation of 
tumor cells, as shown in Figure 32, from the miRNA data results. The LPS influence upon BV2 
microglia miRNA expression is predicted to decrease apoptosis and increase cell proliferation of 
tumor cell lines, through the upregulation of miR-155, and miR-21 and the downregulation of miR-
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132, miR-34a, and miR-26a, as shown in Figure 32 A. Comparatively, the influence of EtOH 
increases apoptosis and decreases cell proliferation of tumor cell lines, primarily through the 
predicted influence of miR-181a, let-7a, miR7a, and miR26a upregulation as shown in Figure 32 B. 
The upregulation of transcripts let-7a, miR7a, and miR26a, were also identified as inhibiting cell 
proliferation of tumor cell lines along with miRNA-223, miR-181a, and miR-125b, as a response to 
EtOH exposure, seen in Figure 32. D. The up regulation of miR-155 and miR-21, and the down 
regulation of transcripts miR-34a and miR-26a, support LPS influence upon microglia regulation for 
cell proliferation of tumor cell lines, as shown in Figure 32 C.  
 
Figure 32. LPS and Ethanol miRNA Influence Comparison Upon Apoptosis and Cell 
Proliferation Pathways. MicroRNA families’ regulation upon pathways and proteins interactions 
predicted through IPA QIAGEN Bioinformatics, for A. LPS and B. Ethanol exposure, on 
apoptosis and cell proliferation of tumor cell lines, and the networks of C. LPS and D. Ethanol with 
the greatest molecular interactions predicted. Image color prediction legend can be found in Figure 
33 below (Qiagen, IPA). 
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BV2 Microglial Cell Immune Response to LPS and Ethanol 
Post 24 hours of Lipopolysaccharide Treatment: Predicted MicroRNA Regulation  
The miRNA upstream regulators predicted in IPA from differentially expressed protein 
groups after LPS exposure for 24hrs contained one match for the miRNA highly expressed (2-fold 
change) from the miRNA microarray profile, miR-21, which was also found in the miRNA 
microarray profile of the EtOH treatment group, however opposite regulation being expressed. All 
of the miRNAs of the upstream predicted miRNA regulators exhibit highly similar regulation in 
terms of predicted gene targets, supporting cell functions of endotoxic activation of microglia. 
After 24 hours of LPS exposure, 8 of the miRNAs identified as differentially expressed are 
involved in the inflammatory response network, as displayed in Figure 33. The decreased 
expression of miR-26a, miR-342 and miR-125 supports the increased immune response mediated 
through the proteins NFKB, LGALS9B, MIF and BID. The increased expression of miR-146a and 
miR-6825 are predicted to inhibit inflammatory response proteins ABDH and PTK2B. The 
predicted influence of TLR2 is that of activating miRNAs: miR-155, mir-132, miR-132, miR-212 and 
miR125b. 
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Figure 33. Post 24 hours of Lipopolysaccharide Treatment: Predicted microRNA 
Upstream Regulation. Image color prediction legend included (Qiagen, IPA). 
Proteome: Predicted microRNA Upstream Regulation  
 
Figure 34. Post 24 hours of Lipopolysaccharide Treatment: Predicted miRNA 
Upstream Regulation from Peptide Quantification, with image color prediction legend (Qiagen, 
IPA). 
Comparing the miRNA downstream predictions to the proteomics-based upstream regulator 
predictions, the insight regarding regulation of pathways can be more defined (as shown in Figure 
34). For example, significantly increased levels of transcript miR-155 that was experimentally 
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measured shows that TLR2 activation will likely activate/increase levels of miR-155. TLR2 
activation is predicted from the protein quantification data where increased expression was 
observed. TLR2 activation that is expected with LPS exposure also indicates predicted 
activation/increased levels of miR-132, miR-212 and miR125b, which is inconsistent with our 
miRNA expression data. Influence predicted from the protein quantification of TLR2 is shown to 
equally distribute activation between miRNAs that it has known influence upon, although the 
quantified values of miRNA transcript data indicate the greater increase in miR-155, in comparison 
to that of mir-132, miR-132, miR-212 and miR125b, from the protein quantifications predicted 
influence. Further mechanistic work is needed to understand the probability of influence of the 
protein regulators upon the transcript expression associated with these miRNAs. 
The predicted decreased miRNA expression of miR-26a and miR-342 from the protein 
quantification correlate with the quantified values obtained by the miRNA analysis, in which the 
decreased expression of these miRNAs could potentially be inhibiting levels of proteins that are 
involved in the inflammatory response. The miR-125b transcript also indicating decreased 
expression from the miRNA quantification and functioning as an inhibitor of the inflammatory 
response, which supports the result of an inconsistent prediction of mir-125b in the predicted 
miRNA upstream regulation from peptide quantification. Although miR-146a is highly expressed 
within the miRNA results, its increased activation was not predicted based on proteomics data 
related to PTK2B levels, and corresponding influence on the inflammatory response. This 
comparative analysis of miRNA and protein profiles allude to miR-146a inhibition predicted to be 
acting upon an alternative gene target or multiple gene targets not displayed. The inhibition of the 
inflammatory response inhibitor protein ABHD12, by miR-6825, was not predicted as an upstream 
influence based on the overall network, but protein quantification of ABHD12 supports inhibition 
by the highly increased miRNA found in our miRNA expression profiling results. Altogether, 
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miRNA and protein expression obtained for LPS treatment of microglia highly support activation of 
the inflammatory response, in both quantitative profiles.  
The Up-regulated Proteins of LPS-Activated Microglia, as shown in Figure 35, support the 
known inflammatory response of microglia to a pathogen through increased activation of EIF4E, 
TNF, IL1B, STAT1 and Interferon alpha.  
 
Figure 35. Up-Regulated Proteins of LPS-Activated Microglia: Known Pathogen Activation 
Response. Image color prediction legend found in Appendix K (Qiagen, IPA). 
This response of microglia is expected with the inflammatory LPS stimulus, which is 
detected by Toll-like receptors (TLRs) on the cell surface, inducing an activation cascade of events 
leading to the cellular release of TNF-α into the surrounding environment, further activating TLR2s. 
These actions of cellular defense are corroborated by previous work in highly aggressively 
proliferating immortalized (HAPI) rat microglial cells performed by our lab, and published by Bell-
Temin et al [97]. 
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Post 24 hours of Ethanol Treatment: Predicted MicroRNA Regulation 
When comparing the miRNA transcripts of EtOH to that of LPS in the inflammatory 
processes related to activated microglia, it was found that the increased miRNA in the EtOH group 
following 24 hour treatment are inhibiting the inflammatory processes, and the increase in miRNA 
in LPS group following 24 hour treatment are inducing an adaptive immune response, as shown in 
Figure 36. Specifically, transcript mmu-miR-155-5p that has shown opposing regulation between 
the LPS and EtOH conditions after 12 hours of exposure, in which it is up-regulated in LPS and 
down-regulated in the EtOH treated cells. At 24 hours of LPS and EtOH exposure, miR-155 had 
shown to be significantly up-regulated in the LPS-treated microglia, with transcript miR-155 having 
the predicted influence upon 656 mRNAs, not indicating a greater or less than a two-fold change 
within EtOH 24 hour treated microglia. In Figure 36 and Figure 37, miRNA regulation in relation 
to the inflammatory processes such as inflammation of anatomical region, adaptive immune 
response, M1 polarization of M2 macrophages and experimental autoimmune encephalomyelitis can 
be compared between the EtOH microglia activation and the LPS-induced cell activation. 
 
Figure 36. MicroRNAs Post 24 hours of EtOH and Potential Regulation of 
Inflammatory Processes of Activated Microglia, with image color prediction legend (Qiagen, 
IPA). 
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Figure 37. MicroRNAs Post 24 hours of LPS and Potential Regulation of 
Inflammatory Processes of Activated Microglia. Image color prediction legend found in 
Appendix K (Qiagen, IPA). 
After 24 hours of EtOH exposure, 8 of the miRNA identified are involved in the immune 
response, as displayed in Figure 38. Charting the inflammatory response within the EtOH 
condition, as seen in Figure 38, shows significantly increased miR-26a inhibiting BID which 
influences the response, along with the inflammatory response being inhibited by miR-125b. The 
miRNAs that are activated by the influence of TLR2, are indicated to have been increased in 
expression, but the predicted influence of TLR2 is inconsistent in regards to the inhibition of the 
inflammatory response directly. 
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Figure 38. Post 24 hours of Ethanol Treatment: Predicted microRNA Upstream 
Regulation, upon Inflammatory Response protein network. Image color prediction legend included 
(Qiagen, IPA). 
Although both methods of quantification (miRNA and protein) have indicated the predicted 
inhibition of the immune response, they each have done so through potentially different supporting 
routes. As shown in Figure 39, the predicted activation of miRNAs based on the proteomic data 
show possible inhibition of the inflammatory response that is unique compared to predicted 
activation based on miRNA expression data for the same pathway. 
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Proteome: Predicted microRNA Upstream Regulation  
 
Figure 39. Post 24 hours of Ethanol Treatment: Predicted miRNA Upstream Regulation 
from Peptide Quantification, with image color prediction legend included (Qiagen, IPA). 
When the protein groups quantified are used to predict the inflammatory response, post 24 
hours of EtOH exposure, it is predicted to be decreased by the influence of miR-6825 transcripts 
decreased expression, and the increased expression of miRNA family miR-342, by the protein group 
upstream prediction. Also, recall that miRNA family miR-6825 was increased within the LPS 
condition which could activate the inflammatory response through inhibition of the protein 
ABHD12, and has an effect on inflammatory response protein PTK2B (Protein tyrosine kinase 2 
beta), which has an effect in the inflammatory response that had not yet been predicted in the 
networks shown in this report. However, after EtOH treatment in microglia, increased expression of 
miR-342 was observed, which could result in decreased expression of the supportive immune 
response regulators, NFKB, LGALS9B, and MIF. These results support the predicted decrease of 
activation or inhibition of inflammatory responses in microglia activated by EtOH exposure, that are 
activate upon LPS exposure. 
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Direct Comparison of Lipopolysaccharide and Ethanol Results on selected miRNAs and 
Proteins 
Utilizing the miRNA expression profiling results as a method of prediction for protein 
levels/activity, as well as matching them to the proteins found from the LC-MS/MS analysis, a 
detailed bioinformatic analysis allowed for identification of enriched pathways and miRNA 
regulatory networks, in a top-down interpretation. Using the proteomic approach of narrowing 
investigation of specific transcript influences the downstream proteins quantification was used to 
predict their upstream modulators in the trend of a bottom-up interpretation (shown in Figure 40.A 
and C), indicating how influential a transcript expressed within the transcriptome profile produced 
is, and the preference of the transcripts gene targets can be interpreted. The upstream transcript 
predictions, top-down (shown in Figure 40.B and D), indicate that there is greater miRNA 
influence than the quantity predicted from the bottom-up predictions of upstream protein factors 
alone.  
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Figure 40B. LPS Top Down Analysis of Differentially 
Expressed   Protein  Groups 
 
 
Figure 40A. LPS Bottom Up Analysis of Differentially 
Expressed Protein Groups 
 
 
 
Figure 40C. EtOH Bottom Up Analysis of Differentially 
Expressed Protein Groups 
 
Figure 40D. EtOH Top Down Analysis of Differentially 
Expressed Protein Groups 
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Figure 40. Lipopolysaccharide Immune Activation Verses Ethanol Induced 
Microglia Activation Based on Select miRNAs and Peptides are displayed through 2 distinct 
vantage points each designated Bottom Up (A and C), indicating that the molecular path activity is 
being predicted from the protein MS values quantified, and Top Down (B and D) indicating that the 
molecular path activity is being predicted from the miRNA microarray values quantified, with image 
color prediction legend included (Qiagen, IPA). 
 Comparing the selected miRNA profiles of the inflammatory response, the highly different 
transcripts between conditions are miR-125b and miR-26a between LPS and EtOH (displayed in 
Figure 40. B and C, respectively), in the top-down analysis. MiR-26a and miR-7a show decreased 
expression in LPS, when predicted by downstream targets in the bottom-up analysis (shown in 
Figure40. A), with miR-7a having the most difference between the two profiles. Transcripts miR-
21, miR-181a and miR-125b in the bottom-up analysis are predicted to be similar for both LPS and 
EtOH conditions, influencing activation of the inflammatory response. Although their bottom-up 
predictions are of opposing the regulation of the inflammatory response, the transcripts miRNA 
quantifications (top-down analysis) indicate that the transcripts maybe specific for other molecules 
not shown or that the transcripts have been down-regulated/degraded by other molecules not 
included. 
 Comparing the different expressions of each transcript for LPS, miR-7a is the most dissimilar 
to that predicted and miR-21, miR-18a, miR-125b and miR-26a are the most different for the EtOH 
condition than predicted from the miRNA quantification. For both of the bottom-up networks of 
the inflammatory response, the inflammatory response is predicted to be activated more so in LPS 
than in EtOH condition. Within the LPS condition, there are no inhibitions from the miRNAs upon 
the proteins predicted. Comparatively, there are numerous predicted inhibitions within the EtOH 
bottom-up analysis. In the EtOH condition for the bottom-up network of the inflammatory 
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response, shown in Figure 40C, there is a decrease in the inflammatory response with the influence 
of the miRNAs, also sown in Figure 40D, the top-down analysis. Within the EtOH bottom-up 
analysis, many of the predicted inhibitions are coming from the transcripts miR-7a and miR-125b. In 
the EtOH condition the inhibited proteins are MYDGIF, MIF, CISD2, POLE3, RNF181, PPIF, 
TRAPPC6B, MRPL30, PPIA, SNAP, and CMC2. 
In Figure 40 A and C, the influence of TLR on miR-125b, is inconsistent to miR-125b 
activation and the expression of miRNA determined from the miRNA analysis. miR-125b 
quantification shows to be more predictive to the downstream molecule expression. Specifically, it 
indicates TLR2 is not influencing miR-125b to become more expressed/active, but instead, the 
miRNA quantity may indicate an inhibitory preference for specific molecules as a determinant factor 
mechanism of an alternative proteomic expression between the conditions.  
The miRNA quantity and its specific mRNA inhibition probability are potentially adequate 
metrics for inferring the detailed differences of expression of the resulting proteins; moreover, the 
probability of interaction (or miRNA-mRNA preference) is necessary for the accurate inferences to 
be made regarding the miRNA-protein networks and how their profile expressions clearly coincide. 
Following the increase of TLR2 inflammatory response (displayed in Figure 38), TLR2 regulates the 
effective inhibition of miRNAs: miR-155, miR-125b, miR-132, mir132 and miR-212, as well as being 
regulated by miRNA transcripts, miR-105 and mir-21 (shown in Table 4). Within this study, TLR2 
predicted quantities were not cohesive with the miRNA transcript expressions measured, but shows 
significant increase expression measured within the LPS-treated group and not within the proteome 
of the EtOH-treated microglia. TLR2 was predicted within each condition to be associated with the 
miRNA dataset and related to the inflammatory response as an upstream regulator but was only 
truly validated by the LPS proteomic dataset. These results may be due to the amount of 
experimental support for the transcripts provided (containing only known miRNAs) within the 
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pathway prediction analysis and knowledge base of IPA. The inflammatory response of TLR is more 
highly defined within the intracellular pathway networks previously shown. 
Other molecules, MAP3K5, MRPL49, SRI, and CD69, also became more highly expressed, 
predicting the decreased activity of their inhibitory miRNAs: miR181a, and miR-21, as shown in 
Figure 40 A, that highlight the proteomics-based bottom-up analysis. Although those miRNA 
transcript quantities were more significant within each condition, through the miRNA 
quantification, greater inhibition of inflammation was predicted with the top-down approach. 
Highly expressed miRNAs are not predicted to be inhibiting the gene transcript(s) they are 
shown to regulate when following the miRNA influences from B to A (shown in Figure 40) for 
LPS. Although a miRNA is up-regulated when quantified within the condition, it could have limited 
to no influence upon the expression of the selected gene transcripts, which may indicate regulation 
upon the miRNA transcript or the transcript having greater influence upon specific molecules not 
shown. The results are supporting the miRNA specificity of molecular inhibition for specific gene 
transcripts, which were predicted in the DT analysis, but not through IPA in this study. Examples 
within both EtOH and LPS treatment groups are miR-125b and mir-7a within each condition, 
respectively, where the miRNA expression is increased but the upstream prediction of the molecules 
predicted to have an inhibitory influence upon have increased expression, and a greater influence 
upon the inflammatory activation states of each condition disparate from the other.  
The miRNA impact of some significantly down-regulated proteins (CMC2, MAP1S, and 
MIF) is shown to be significantly inhibited within the proteomic profile as well as predicted to be 
highly inhibited by the upregulation of transcripts within the miRNA dataset of EtOH-treated 
microglia (shown below in Figure 41).  
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Figure 41. Ethanol Exposure Shows Inhibition of Proteins Associated with the Immune 
Response of Macrophages, A. miRNA and B. protein influence as measured from the microarray 
and MS analysis, respectively. Image color prediction legend found in Appendix K (Qiagen, IPA). 
The selected proteins all have highly altering activity within the cell and are potentially down-
regulated by miRNAs expressed after EtOH exposure, which cause them to no longer support the 
macrophage-like activities. Also shown in Figure 41 B is the influence of TLR2 on the immune 
response of macrophages. The miRNAs displayed are from the top-regulated within the EtOH 
condition as predicted with miRNA-mRNA interaction in IPA. Six of the miRNA families that are 
highly expressed are capable of inhibiting CMC2 (C-X9-C Motif Containing 2), a protein located in 
the mitochondrial intermembrane space, that is involved in the assembly and maintenance of the 
respiratory chain complex. MAP1S (microtubule associated protein 1S) is a protein involved in 
microtubule assembly, shown in Figure 41 A to be inhibited by miR-3937. Microtubule assembly is 
an essential step of morphology, migration and cellular genesis [98-100]. MAP1S is found to be 
similar to neuron specific cytoskeletal proteins in dendrites for cellular stability during neuron 
development within mice and rats [98-100]. Transcript miR-451a is potentially an inhibitor of 
macrophage migration inhibitory factor (MIF), a pro-inflammatory cytokine that induces the 
macrophage activation for host defense, which is also predicted to be significantly decreased by 
A. B. 
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miR-342 inhibition in EtOH-activated microglia in comparison to that of the LPS-induced 
microglial activation, in which MIF is highly active. Summarizing these activities, the possible 
influence of the up-regulated miRNAs would induce a potentially quiescent state for microglia, into 
a less sensitized more ramified morphology, reducing pressure upon making ATP, migrating and 
responding to host defense.  
Although the inclination of these proteins to be reduced upon inhibition, reducing the 
immune response of macrophages within microglia, the influence of TLR2 on microglia along with 
activating transcript miR-125b can potentially induce the immune response of microglia, while 
CMC2, MAP1S, and MIF remain inhibited, as well as be inhibited through other molecules such as 
RPS19.  
Direct Comparison Through Multiple Data Sets of Ethanol Influence Upon Microglia: 
RICTOR and Endocytosis Implications within the Inflammatory Response 
It was found that a subset of differentially expressed proteins are highly associated with 
RICTOR inhibition after EtOH exposure in BV2 microglia, as shown in Figure 42.  
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Figure 42. Upstream Regulation of Proteins Supported by the Down Regulation of RICTOR 
Activity Under the Influence of Ethanol Exposure in BV2 microglia. Image color prediction 
legend found in Appendix K (Qiagen, IPA). 
There was a notable increase in proteins up-regulated by the inhibition of RICTOR activity. 
RICTOR (RPTOR independent companion of MTOR complex 2) is a component of a protein 
complex that is essential for embryonic growth due to the ability to integrate signals for nutrients 
and growth factors that regulate growth.  
RICTOR in BV2 microglia at 24 hrs of exposure to LPS condition is up-regulated, but not 
significantly, by the down regulation of miRNA 212 (Fold Change -2) and miRNA 132 (Fold 
Change -2.32) with a less than 0.03 and a less than -1 probability of interaction, respectively. 
RICTOR after 12 hrs under LPS condition is predicted to be up-regulated, by the down regulation 
of miRNA 301b (Fold Change -6.13), with a less than -0.2 probability of interaction (data not 
represented within this report). Interestingly, BV2 microglia after 12 hrs of exposure to EtOH show 
the predicted upregulation of RICTOR, due to the decreased possibility of inhibition by the down 
regulation of miRNA 212 (Fold Change -2.45), miRNA 301b (Fold Change -4.22), and miRNA 491-
5p (Fold Change -3.28). The probability of interaction of miRNA 212 and miRNA 301b being less 
than 0.03 and -0.2, respectively. MicroRNA 491-5p was not identified in the data set for probability 
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analysis. When the comparison of the BV2 microglia transcripts of the EtOH and LPS conditions 
were compared over time (12 and 24 hours), the single transcript, mmu-miR-301b-5p, had decreased 
expression similarly (which would increase RICTOR expression for lack of miRNA inhibition), 
when compared to the control, but increased in EtOH over time and decreased in LPS over time to 
which there were no results for RICTOR at EtOH 24 hours. 
To identify what upstream regulation is occurring to decrease RICTOR, the BV2 protein 
groups and miRNA global profiles were combined, predicting the highly increased transcript let-7a 
to be an effective inhibitor of RICTOR, displayed in the center of Figures 43 and 44. The transcript 
let-7a was also effective in the influence of inhibiting cell proliferation of tumor cell lines as well as 
an activator of apoptosis.  
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Figure 43. A Proteomic and microRNA Network of Molecules Expressed by Microglia After 24 hours of Ethanol Exposure
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Figure 44. MicroRNA Inhibition Upon RICTOR Protein Network Post 24 hour Ethanol 
Exposure. Images color prediction legend included (Qiagen, IPA). 
Let-7a is predicted to be an inhibitor of RICTOR, which could be a regulatory mechanism of 
RICTOR inhibition associated with our datasets. MRPL13, a downstream target of RICTOR, can be 
inhibited by miR-181 and miR-126a. These are also transcripts that are expressed in microglia within 
the EtOH condition. 
Increased immune response is the increase of phagocytosis/endocytosis, pathways and 
function of the microglial cell, which is a process predicted to be down-regulated in our in vitro 
studies, as shown in Figure 45. While under the induced inflammatory response, the 
phagocytosis/endocytosis pathways and functions would be in a state of supported activation, such 
as that under the LPS condition and in other disease models that show induced microglia pro-
inflammatory activation, like that of encephalitis previously shown reference to, in Figure 36 and 37 
as experimental autoimmune encephalitis. 
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Figure 45. in vitro BV2 post 24 hours of EtOH Protein Group Results Associated with 
Cellular Endocytosis Pathways, image color prediction legend found in Appendix K (Qiagen, 
IPA). 
Immune Response: Receptor/Ligand CXCs 
As previously mentioned in the introduction, expression of C-X-C (two carbonyl-terminal 
cysteine residues between which is any amino acid, CXC) motif genes can reveal the inflammatory 
response of microglia. Although not considered significantly expressed among the LPS and EtOH-
treated microglia, CXC motifs were identified within the predicted molecule set of miRNAs, as well 
as within the protein datasets. Each condition showed that miRNA downstream targets contained 
numerous CXC receptor and ligands: 3 CXC types were found in the IPA networks of the EtOH 
condition (CXCL5, CXCL12, and CXCL13), whereas 5 CXC types (CXCL8, CXCL10, CXCL13, 
CXCR1, and CXCR4) were found in the networks of LPS miRNAs downstream proteins. Within 
the proteomes, there was only one CXC gene to be expressed within each, CXCR1 for LPS and 
CXCL8 (also known as IL8, a monocyte-derived neutrophil chemotactic factor) for EtOH.  
 These findings indicate that EtOH could increase IL8 cytokine expression of microglia and 
that upon an inflammatory response, the CXCR1 receptors may increase, invoking an inflammatory 
response like that induced by LPS. With IL8 released into the CNS environment by microglia after 
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EtOH exposure, then the inflammatory response elicited by other potential factors could produce a 
highly exaggerated inflammatory response. With CXCL8 expression, the facilitation of inflammatory 
processes, such as endocytosis and phagocytosis, could be a possibility and were compared across 
the data sets for predicted activation. Upon further investigation of endocytosis, it is predicted that 
there is evidence of decreased endocytosis in vitro in BV2 microglia upon EtOH exposure.  
Although phagocytosis/endocytosis may be occurring less frequently, as mentioned; 
neurons, astrocytes and microglia contain SNs, and with the influence of EtOH, they are proposed 
to be altering the localized expression of miRNA-mRNA coordination within each cell types by 
sharing SNs. Microglia can be activated upon the receipt of the SNs of surrounding cells, with the 
inclusion of transcripts, which could support the induction of the fully reactive immune response 
regardless of the miRNA-mRNA and protein interaction within the cell that may have maintained 
previous cellular homeostasis in microglia.  
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Chapter 5 
Conclusions 
This research provides knowledge of miRNAs and proteins potentially involved in the 
regulation of EtOH-induced microglial activation. The global miRNA and proteomic analyses 
performed using microarray, mass spectrometry and bioinformatics has identified several 
differentially expressed gene groups and gene families following EtOH exposure in microglia BV2 
cells. Additionally, this study has provided a comprehensive list of the proteins, miRNA-mRNA 
regulators and biological pathways that could be responsible for the specific phenotypic changes of 
microglia during EtOH exposure. This research provides a foundation for future studies aimed at 
characterizing the complex EtOH-induced phenotypic changes of microglia and how neuronal 
interaction affects this process. We have identified several miRNA targets that could play a role in 
regulating activation phenotype of microglia and we will pursue these miRNAs in future targeted 
studies using in vivo EtOH exposure models.  
MicroRNA Regulatory Mechanisms for Microglial Homeostasis in Chronic EtOH 
Conditions 
This research has provided the characterization of the BV2 microglial miRNA expression 
profiles after exposure to LPS and EtOH over the course of 24 hours through microarray-based 
transcriptomic approaches. We identified 3,195 miRNA genes, which revealed 61 transcripts and 
128 transcripts differentially expressed (with 2-fold change as compared to the control) within LPS 
and EtOH groups, respectively. Transcript, mmu-301b-5p, was the only transcript that had 
decreased expression similarly among both conditions over time. At 12 hours, LPS-treated microglia 
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had 26 transcripts differentially expressed, and 73 transcripts were differentially expressed in EtOH-
treated microglia. Of those transcripts, miR-155-5p was the only one identified in both data sets 
(among the 7) as having up-regulation in LPS-treated microglia and downregulation within the 
EtOH-treated microglia. After 24 hours of EtOH exposure, miR-155-5p was no longer shown to 
have a significant change, whereas in the LPS-treated microglia it was greatly increased. The results 
indicate alcohol-exposed microglia will induce an alternative phenotype that is distinct from a pro-
inflammatory activation, which will continue to be altered with increased alcohol exposure over time 
as a result of the specific proteome profile changes.  
The quantity of miRNA–mRNA interactions was predicted using Decision Tree (DT) and 
Ingenuity Pathway Analysis (IPA) methods of bioinformatics for the 24-hour exposed microglia. 
Analysis through IPA revealed 956 mRNA identified to have 1,051 miRNA-mRNA connections 
that were highly predicted and experimentally observed, with miRNA that were differentially 
expressed in microglia after 24 hours under the LPS condition, and 6,139 mRNA targets were 
recognized with 7,951 miRNA-mRNA connections in microglia after 24 hours under the influence 
of the EtOH condition. The DT analysis, resulted in 3 (miR-155, miR-146a and miR-146b) known 
highly influential transcripts that down-regulate the top 20 predicted interacting mRNA expressed in 
microglia when influenced by LPS and 4 known influential transcripts (miR-34a, miR-212, miR-210, 
miR-181a, and miR132) down-regulated that would no longer have inhibition of their predicted top 
20 mRNA. The DT analysis for the EtOH condition, resulted in 5 (miR-125a, miR-181d, miR-223, 
miR-33, and miR-7a) known highly influential transcripts that down-regulate the top 20 predicted 
interacting mRNA expressed in microglia and one known influential transcript (miR-126a) that was 
down-regulated, and is predicted to no longer having inhibition of their predicted top mRNA. The 
IPA analysis was also able to contribute transcript location and gene target function information for 
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both conditions, which were primarily within the cytoplasm, and as enzyme & transcription 
regulators, respectively, for both conditions. 
In order to better associate the miRNA-mRNA regulatory mechanisms with the changes of 
the microglial proteome profile, microglia cells cultured in parallel were used to produce a proteomic 
profile with mass spectrometry. The proteomic analysis resulted in 2,277 identified protein groups, 
with 170 differentially expressed and identified within IPA, for the LPS and/or EtOH treatment 
groups for 24 hours. The microglia influenced by LPS or EtOH had 26 proteins that were expressed 
within both conditions, with 20 of them being increased in expression in both conditions. Two 
proteins, alcohol dehydrogenase 5 (ADH5) and glucosidase II alpha subunit (GANAB), were down-
regulated similarly within microglia under the influence of LPS or EtOH. Proteins that became more 
abundant within the EtOH-treated microglia and decreased within microglia activated by LPS were 
actin-related protein 2 /3 complex subunit 5 like (ARPC5L), fermitin family homolog 3 (FERMT3, a 
gene for integrin-mediated platelet adhesion), and methionyl-tRNA synthetase (MARS, an enzyme 
that charges tRNAs with cognate amino acids). One transcript, poly (A) binding protein cytoplasmic 
1 (PABPC1), had increased expression in microglia influenced with LPS, that was decreased within 
the EtOH condition after 24 hours. The top biological functions associated with the differentially 
expressed proteins identified include cellular assembly, organization and morphology, cell cycle, lipid 
metabolism, protein folding, and posttranslational modifications. 
The predicted upstream miRNA influence through IPA method of bioinformatics, was used 
to assess miRNA regulatory mechanisms associated with EtOH and LPS-induced microglial 
proteome profile changes. This approach revealed miRNAs expressed in different species (of which 
we can use to identify the gene/chromosome origins) inclined to be affected. Molecules predicted to 
be targets of miRNAs from the proteome expressed by microglia upon 24 hours of LPS were: 
DHFR, CERS2, TBL1X, BAX, TLR2, LARP4, MTHFD2, POLR2K, PPIB, SRXN1, ISG15, OAS1, 
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ADD1, BET1, PPIB, ARF6, CKS2, UBE2L6, VRK1. Target molecules of miRNAs from the 
proteome expressed by microglia upon 24 hours of EtOH were: ATL3, CERS2, TMEM109, PPIF, 
UBE2S, SRSF2, MIF, FTL, RAP1B, RAC1, SLC39A7. Both lists of targeted proteins contained 
CERS2, ceramide synthase. 
The predicted upstream regulators within the EtOH condition consist of 6 miRNAs that are 
comparable to the miRNAs identified through the microarray results: miR-124-3p, miR-183-5p, 
miR-451a (mir-451), miR-133a-3p miR-193a-3p, miR-149-5p, and mir-194. The upstream regulators 
predicted within the LPS condition consist of 7 miRNAs that are comparable to the miRNAs 
identified through the microarray results: miR-192-5p, miR-133a-3p, miR-125b-2-3p, miR-24-3p, 
miR-1-3p, mir-15, mir-1, and mir-21. Both lists of upstream regulatory miRNAs contain miR-133a-
3p, a regulator of CERS2. 
Possible Target Phenotypes and microRNA Regulatory Mechanisms for Microglial 
Activation 
The comparison of the miRNA expressed in microglia post-LPS and EtOH exposure 
indicate that EtOH miRNA influence alone doesn’t support a pro-inflammatory phenotype (or that 
of autoimmune encephalitis), but that miRNA expressed under the influence of LPS leads to this 
phenotype. This supports previous studies and the prediction that microglia influenced with alcohol 
alone may not induce an inflammatory response depending on dose and time of EtOH exposure, 
but with the influence of inflammatory triggers such as that from the surrounding cells influenced by 
EtOH, could induce microglia miRNA expression changes that induce a pro-inflammatory posture. 
The differential activation of microglia in an inflammatory state, in comparison to the 
activation induced by EtOH, although capable of supporting inflammation, was evident in the 
miRNA family miR-6825 expression. This miRNA was increased within the LPS condition and 
could possibly inhibit ABHD12 and PTK2B. Inhibition of ABHD12 is predicted to support the 
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activation of the inflammatory response. Within the EtOH condition, miR-6825 expression is 
decreased supporting the down regulation of the inflammatory response through ABHD12, with 
PTK2B protein expression being similar to that induced in LPS, but with ABHD12 being highly 
expressed. Inflammatory activation of LPS, increases the expression of miR-6825, allowing for it to 
inhibit proteins that are predicted as being anti-inflammatory, like that predicted upon ABHD12. 
Transcript miR-6825 indicates more effective inhibition upon ABHD12 (Abhydrolase 
domain containing 12); a member of acylglycerol lipase, a lysophospholipase, which is involved in 
hyperactive behavior, microgliosis, polyneuropathy, muscle weakness, and ataxia, than on PTK2B. 
PTK2B is known to be located/involved in: apical processes of axons for cell-cell contacts/focal 
adhesions, cell cortex, cell membrane leading and lagging edges, dendrites and dendritic spines, golgi 
apparatus, cytoplasm, cytosol, intercellular junctions, lamellipodia, membrane 
processes/functions/rafts, nucleus, perinuclear region, postsynaptic density, and synaptosomes. 
PTK2B has been shown to regulate the immune response through Jnk, MAPK1, P38 MAPK, SRC, 
MAPK8, L-tyrosine, EGFR, Akt, ERK1/2, PXN, ERK, Mapk, MAPK14, and STAT3. 
ABHD12 and PTK2B, are only two of the 3,078 targeted mRNAs of the miR-6825-5p-
regulated genes that are able to contribute to synaptic connections, immune activation, microgliosis 
and muscle weakness. The down regulation of miR-6825-5p within the EtOH-induced microglia 
response shows an alternative activation to that of the inflammatory response, that is brought on by 
defense against an endotoxin. 
Microglia exposed to EtOH had miRNA expressed that are predicted to increase apoptosis, 
and decrease cell proliferation. TLR2 activation increases the measure of transcript miR-155 when 
activated by LPS. This transcript inhibits apoptosis, and supports cell proliferation, among other 
transcripts that increased expression after LPS and TLR2 influence.  
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Ethanol activation of microglia did not indicate increased TLR2 activation and transcript 
miR-155 was less active, not showing a significant fold-change, within the miRNA data after 12 
hours, after which time it decreased. Transcript, miR-155-5p, revealed opposing expression between 
the LPS and EtOH conditions in which it is up-regulated in LPS and down-regulated in the EtOH-
treated cells, after 12 hours of exposure. Although, miRNA transcript expression can indicate 
inhibition ability, their influence is can be governed by numerous molecules that regulate their 
expression and degradation. An example of this is the influence TLR2 has upon numerous 
transcripts (miR-155, miR-125b, miR-132, mir132 and miR-212) as well as it being regulated by 
miRNA transcripts, miR-105 and mir-21. Molecular influence upon miRNA expression such as this 
demonstrates the complexity of global-scale regulatory networks that could collectively define 
microglial activation phenotype. The TLR influence on miRNA expression under LPS is apparent 
and minimal with the EtOH condition based on IPA predictions. An example of differential 
repercussions is the EtOH influence of miR-155 and miR-149 targeting RAP1B (RAS-like small 
GTP-binding protein) and, with the LPS influence, miR-155 and mir-1 target BET1 (a golgi-
associated vesicle membrane trafficking protein).  
Inflammatory activation by the decreased expression of miR-342 could correspond to 
increased translation of proteins (NFKB, LGALS9B, and MIF) supportive of the immune response. 
This miRNA was predicted to be up-regulated within the EtOH condition, which would inhibit 
those proteins and down-regulating an inflammatory response. Overexpression of miR-342 and 
miR-125b, which are both increased after LPS exposure, could increase the inflammatory response 
of microglia through increased levels of NFKB as an example. 
Overexpression of miR-342 and miR-125b, which are both decreased after the LPS induced 
expression of the inflammatory response of microglia, are possible methods to regulate the microglia 
inflammatory response, inhibiting NFKB and TNF-α respectively. 
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Microglia transit through multiple phases of activation following detection of injury or in the 
presence of foreign substances as catalogued by Raivich et al [37, 38]. The resting phase is 
characterized by microglial immune surveillance utilizing long branched processes. The 
alert/priming phase is the earliest stage of microglial activation and is marked by an increase in 
immunoreactivity and cell surface integrins relating to adhesion. 
There wasn’t extensive overlap in comparison to the miRNAs and mRNAs found in the 
Most et al, synaptic neuron study, such as the singular enrichment of microRNA, miR-411, which is 
a maternal miRNA that is essential for the earliest stages of mouse embryonic development [57]. 
miR-411 did not show significant fold change throughout the analysis within this study. A miRNA 
that was found to be within both studies was miR-374, which was also found within an exposure to 
alcohol vapor study done on rats [51], as well as that from a study of human alcoholics up-regulated 
microRNAs [63, 101]. As specified within the Most et al, (2014) study, miRNA-374 and its mRNA 
targets, are specific to glutamate neurons, Grm7 (glutamate receptor, metabotropic 7) and Gria2 
(glutamate receptor, ionotropic, AMPA 2) [63]. The up regulation of miR-374 under the ethanol 
condition in this study is supporting those previous results that alcohol regulates synaptic 
microRNAs, that in turn affecting the expression of mRNAs in glutamate synapses, and the 
glutamate dysregulation in alcoholics is possibly due to the regulation of miRNAs [63, 102]. In a 
study of the miRNA transcriptome changes during long term potentiation (LTP), the persistent 
synapse pattern of release that strengthens long-term neuronal signaling for information storage and 
memory formation (which requires protein synthesis), Gu et al (2015), identified the transcripts miR-
26a, let-7a and miR-125 as regulators of the development of synaptic transmission and specifically 
the maintenance of dendrite spine morphology enlargement, which were identified in this study as 
being up-regulated in microglia upon exposure to a chronic dose of EtOH [56]. Transcript miR-26a 
was also identified, in the current research, as an inhibitor for BID protein that is known to activate 
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the inflammatory response, as well as having influence that induces apoptosis. Transcripts let-7a and 
miR-125 also show activity to inhibit proteins that activate the inflammatory response as well as 
showing supportive regulation of proteins that induce apoptosis under the influence of EtOH.  
C-X-C motif receptors are directly correlated to microglial overstimulation, and down 
regulation of CX3CR1 has been shown to decrease the activation state of microglia associated with 
age-related impairments [34, 49, 50, 103]. Although not considered significantly differentially 
expressed within the predicted molecule sets of proteins among both LPS and EtOH-treated 
microglia, CXC motif-containing proteins were identified. In each condition, miRNA downstream 
targets contained numerous CXC receptor and ligands: 3 CXC types were found in the IPA 
networks of the EtOH condition (CXCL5, CXCL12, and CXCL13), whereas 5 CXC types (CXCL8, 
CXCL10, CXCL13, CXCR1, and CXCR4) were found in the networks of LPS – specifically, in the 
predicted targeted downstream proteins. Within the proteomic data, there was only one CXC gene 
to be expressed within LPS, CXCR1, and CXCL8 (also known as IL8, a monocyte-derived 
neutrophil chemotactic factor) for EtOH. As previously describe neurons, astrocytes and microglia 
contain SNs, and with the influence of EtOH they are proposed to be altering the localized 
expression of miRNA-mRNA coordination within each cell type by sharing SNs. This may be the 
cause of such confusion of the difference between microglial immune activation and the EtOH 
activation, within the CNS the surrounding cellular influence would encourage the microgliosis 
activity, regardless of the decreased endocytosis of an EtOH microglia. This is another avenue of 
future research – to understand neuroimmune cell signaling within the CNS during chronic EtOH 
exposure and determine if miRNAs are released and take up by surrounding cells to influence 
overall function.  
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Future Directions 
It was found that differentially expressed proteins associated with RICTOR inhibition were 
upregulated after EtOH influence in BV2 microglia. Endocytosis in this study was predicted to be 
decreased in activation for BV2 microglia cells after ethanol treatment. There could be indication 
that the longer BV2 microglia are exposed to EtOH, the greater protein modification following 
exo/endocytosis, receptor/ligand interactions will occur and the more immune activated microglia 
will become producing response factors that contribute to the surrounding CNS cell dysfunction. 
The morphology imaged, in Appendix A, of BV2 cells under each condition, but not 
mentioned in detail was also supportive of the previous research on morphological and expression 
profiling studies, and the results by Liu et al (2006) in which their findings were also to have altered 
expression of the development of biological processes in the CNS relating to synapse formation 
through myelination and cell adhesion. The consensus of that study as well as others being that 
alcohol, is responsible for the structural and functional alterations like remodeling synaptic 
connections, is dependent upon changes in gene expression. As in this study many of the 
morphological changes predicted through gene regulation also relate to cellular plasticity within the 
brain, of which pair long term potentiation with alcohol dependence within behavior.  
The miRNA expression profile reflected the EtOH-induced proteome profile changes and 
the related activation phenotype, as an associated regulatory mechanism. This study has identified a 
comprehensive list of proteins and pathways responsible for expression regulation of microglia 
during EtOH exposure that can be further researched for therapeutic modifications. To overcome 
the issue of cognitive impairment, and brain damages as a result of chronic alcohol intake, it is 
important to continue to understand the mechanisms and targets of EtOH influence within the 
central nervous system. Chronic alcohol abuse can cause permanent damage to individuals, 
contributing to their socio-economic disruption; and although there are means to treat alcoholism 
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and disorders associated with alcohol abuse, there are no effective therapies for the long term 
cellular brain damage. 
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Appendix A: Microscopic BV2 Cell Images Under Each Condition Examined  
 
Figure A1. Microscopic BV2 Cells examined on Zeiss microscope. Images taken with Iphone 7 iOS 10.3.3 through ocular. 
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Figure A2. Microscopic BV2 Cell Images After 12 hours of Exposure Under Each Condition examined on Zeiss microscope. 
Images taken with Iphone 7 iOS 10.3.3 through ocular. 
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Figure A3. Microscopic BV2 Cell Images After 24 hours of Exposure Under Each Condition examined on Zeiss microscope. 
Images taken with Iphone 7 iOS 10.3.3 through ocular. 
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Appendix B: Microarray Hybridization, Data Quality Assessment, and Analysis 
 
 
 
Figure B1. Microarray Hybridization, Data Quality Assessment, and Analysis: Genomic DNA Contamination, RNA Integrity (RIN) 
and Quantification Reference Guide 
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Figure B2. Microarray Hybridization, Data Quality Assessment, and Analysis: Genomic DNA Contamination, RNA Integrity (RIN) 
and Quantification Reference Guide
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Figure B3. Microarray Hybridization, Data Quality Assessment, and Analysis: Genomic 
DNA Contamination, RNA Integrity (RIN) and Quantification Reference Guide
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Appendix C: RNA Integrity (RIN) and Quantification Post Microarray for Each Sample  
 
 
Figure C1. RNA Integrity (RIN) and Quantification within the Control Sample at Time 0 
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Figure C2a. RNA Integrity (RIN) and Quantification Post Microarray for Each Sample Continued  
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Figure C2a. RNA Integrity (RIN) and Quantification Post Microarray for Each Sample Continued 
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Appendix D: Summary of LPS and EtOH microRNA Quantification 
 
Table D1. Summary of LPS and EtOH microRNA Quantification Result 
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Appendix E: 24 hour Lipopolysaccharide Exposures Regulated microRNAs Downstream Target Interaction Predictions by 
Decision Tree Analysis 
Table E1. 24 hour Lipopolysaccharide Exposures Up-Regulated microRNAs Downstream Target Interaction Predictions by 
Decision Tree Analysis 
  
24 hour Lipopolysacc aride Exposures Up Regulated miRNAs Downstream Target Interaction Predictions by 
Decision Tree Analysis 
 
24 hour Lipopolysaccharide Exposures Up 
Regulated miRNAs Downstream Target 
Interaction Predictions by Decision Tree Analysis 
miRNA 
Transcript 
Protein 
Symbol 
Interaction 
Probability Z-
Score 
mmu-miR-146a MAP4K4 -0.4578 
mmu-miR-146a ANXA4 0.1500 
mmu-miR-146a PRMT5 -1.0746 
mmu-miR-146a TXNDC5 -0.7743 
mmu-miR-146a SYNCRIP -0.7270 
mmu-miR-146a AGPS 0.1977 
mmu-miR-146a UBTF 0.6147 
mmu-miR-146a LIG3 -0.4654 
mmu-miR-146a FLNA -0.9111 
mmu-miR-146a PCMT1 -0.8670 
mmu-miR-146a WDFY4 0.1063 
mmu-miR-146a HNRNPD -1.5059 
mmu-miR-146a EIF4G2 -0.9395 
mmu-miR-146a HK2 -0.2632 
mmu-miR-146a STX7 -0.7179 
mmu-miR-146a HNRNPA2B1 -1.3085 
mmu-miR-146a PTPRC -0.5639 
mmu-miR-146a SOD2 1.2062 
mmu-miR-146a LAMP2 -1.0428 
mmu-miR-146a AP1G1 1.4707 
mmu-miR-146a KRAS -1.5406 
mmu-miR-146a ADSS -1.0547 
mmu-miR-146a ATP6V1A -1.2004 
mmu-miR-146a HMGA2 -0.4054 
mmu-miR-146a FAF1 -0.6109 
mmu-miR-146a DDX6 -0.6923 
mmu-miR-146a ADK 1.9483 
mmu-miR-146a BCL2L13 0.6184 
mmu-miR-146a NPLOC4 0.2574 
mmu-miR-146a UBE2N -0.6069 
mmu-miR-146a UBE2G1 0.1583 
mmu-miR-146a MAPK1 -0.8124 
mmu-miR-146a RPL22 -0.1794 
mmu-miR-146a RAD50 -0.2260 
mmu-miR-146a SLC9A3R1 0.0865 
mmu-miR-146a DTYMK -0.5773 
24 hour Lipopolysaccharide Exposures Up 
Regulated miRNAs Downstream Target 
Interaction Predictions by Decision Tree Analysis 
miRNA 
Transcript 
miRNA 
Transcript 
miRNA 
Transcript 
mmu-miR-146a FABP5 0.1201 
mmu-miR-146a ZC3H15 -0.8335 
mmu-miR-146a SRSF6 -0.1227 
mmu-miR-146a RPA1 -0.6842 
mmu-miR-146a OGDH -0.2082 
mmu-miR-146a CSNK2A1 -0.1118 
mmu-miR-146a ARHGDIB -0.1782 
mmu-miR-146a DDX3X -0.0979 
mmu-miR-146a NAA50 -0.2448 
mmu-miR-146a CCDC93 3.5801 
mmu-miR-146a TNPO1 1.1038 
mmu-miR-146a CGGBP1 1.5901 
mmu-miR-146a CPNE3 -0.5997 
mmu-miR-146a NOB1 3.1553 
mmu-miR-146a COMMD2 -0.1219 
mmu-miR-146a DOCK8 0.8791 
mmu-miR-146a OGT -1.1757 
mmu-miR-146a LYRM4 -0.4077 
mmu-miR-146a ZNFX1 -0.8112 
mmu-miR-146a RNPEP -0.4973 
mmu-miR-146a NLN -0.4295 
mmu-miR-146a PARP1 1.1959 
mmu-miR-146a THUMPD1 1.0255 
mmu-miR-146a ASF1A -0.0650 
mmu-miR-146a GMFB 0.0690 
mmu-miR-146a MRI1 1.3113 
mmu-miR-146a FAM32A -0.5701 
mmu-miR-146a OLA1 0.7448 
mmu-miR-146a OXCT1 -0.8171 
mmu-miR-146a RNMT 1.7395 
mmu-miR-146a DNAJC10 0.7302 
mmu-miR-146a SACM1L 1.7539 
mmu-miR-146a DSTN -0.4372 
mmu-miR-146a GIPC1 1.5788 
mmu-miR-146a LIPA 2.1723 
mmu-miR-146a USO1 0.3526 
mmu-miR-146b HNRNPD -1.0000 
mmu-miR-146b HNRNPA2B1 -0.1686 
mmu-miR-146b SUB1 0.5647 
24 hour Lipopolysaccharide Exposures Up 
Regulated miRNAs Downstream Target 
Interaction Predictions by Decision Tree Analysis 
miRNA 
Transcript 
miRNA 
Transcript 
miRNA 
Transcript 
mmu-miR-146b PSMD3 -1.1213 
mmu-miR-146b KRAS -0.3694 
mmu-miR-146b G3BP1 1.6305 
mmu-miR-146b PRPF38A -0.9790 
mmu-miR-146b ARCN1 0.6549 
mmu-miR-146b CGGBP1 1.6877 
mmu-miR-146b TMED10 0.1036 
mmu-miR-146b EEF1E1 0.1328 
mmu-miR-155 SH3GLB1 0.4584 
mmu-miR-155 SMARCA4 -0.1118 
mmu-miR-155 NAP1L1 -0.1682 
mmu-miR-155 PAPOLA -0.6187 
mmu-miR-155 AP3D1 1.1777 
mmu-miR-155 HSD17B12 -1.1240 
mmu-miR-155 HNRNPA2B1 0.4248 
mmu-miR-155 AKAP10 -1.0512 
mmu-miR-155 MARCKS -1.0714 
mmu-miR-155 MCM4 0.2274 
mmu-miR-155 PA2G4 -0.2442 
mmu-miR-155 HSD17B4 0.9926 
mmu-miR-155 SLC16A1 -1.0103 
mmu-miR-155 PPP1CB 0.9260 
mmu-miR-155 ACTA1 -1.3960 
mmu-miR-155 DDX17 2.0207 
mmu-miR-155 CAPRIN1 -0.8975 
mmu-miR-155 GDI2 -1.3316 
mmu-miR-155 DEK -0.6448 
mmu-miR-155 CCDC93 -1.1182 
mmu-miR-155 PSMF1 -0.7615 
mmu-miR-155 RAP2C -0.2604 
mmu-miR-155 SLC38A2 -0.2679 
mmu-miR-155 AQR 1.0932 
mmu-miR-155 PITRM1 0.1768 
mmu-miR-155 DDX41 -0.5048 
mmu-miR-155 LRRC59 -0.3514 
mmu-miR-155 ME2 0.0364 
mmu-miR-155 GMFB 0.6391 
mmu-miR-155 PPA1 0.5641 
mmu-miR-155 AKAP8 -0.1741 
24 hour Lipopolysaccharide Exposures Up 
Regulated miRNAs Downstream Target 
Interaction Predictions by Decision Tree Analysis 
miRNA 
Transcript 
miRNA 
Transcript 
miRNA 
Transcript 
mmu-miR-155 DKC1 1.6319 
mmu-miR-155 PTS 0.7091 
mmu-miR-186 CUL4B -1.3418 
mmu-miR-186 SUZ12 0.0815 
mmu-miR-186 7-Sep -0.4037 
mmu-miR-186 ADD1 1.2046 
mmu-miR-186 IFI204 0.0825 
mmu-miR-186 TPR -1.1992 
mmu-miR-186 SPP1 nan 
mmu-miR-186 BCL2L13 -1.5938 
mmu-miR-186 CDC42 -1.6450 
mmu-miR-186 PPP1CB -0.3997 
mmu-miR-186 NUP35 0.8618 
mmu-miR-186 SAR1A 0.3239 
mmu-miR-186 RNF2 0.4318 
mmu-miR-186 GNAI3 -0.7367 
mmu-miR-186 HYOU1 0.6460 
mmu-miR-186 SUCLA2 0.4013 
mmu-miR-21a ZNF207 0.5882 
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Table E2a. 24 hour Lipopolysaccharide Exposures Down-Regulated microRNAs Downstream Target Interaction Predictions 
by Decision Tree Analysis 
 
24 hour Lipopolysaccharide Exposures D wn Regulated miRNAs Downstream Target Interacti n Predictions by 
Decision Tree Analysis 
 
24 hour Lipopolysaccharide Exposures Down 
Regulated miRNAs Downstream Target 
Interaction Predictions by Decision Tree Analysis 
miRNA 
Transcript 
Protein 
Symbol 
Interaction 
Probability Z-
Score 
mmu-miR-34a 11-Sep -1.0354 
mmu-miR-132 BZW1 -0.2485 
mmu-miR-132 FUBP1 -0.1458 
mmu-miR-132 ANXA4 -1.1504 
mmu-miR-132 LMNB2 1.1471 
mmu-miR-132 SYNCRIP -0.1770 
mmu-miR-132 EML4 0.0435 
mmu-miR-132 HK2 -1.0084 
mmu-miR-132 CALU 0.3334 
mmu-miR-132 WDR1 -1.2541 
mmu-miR-132 PTPRC -0.2171 
mmu-miR-132 SOD2 -0.1176 
mmu-miR-132 MTHFD2 0.3276 
mmu-miR-132 CCT8 1.9068 
mmu-miR-132 ACADM -0.0223 
mmu-miR-132 PSMA2 -0.9423 
mmu-miR-132 ATP6V1A -1.2621 
mmu-miR-132 HMGA2 -0.1807 
mmu-miR-132 PAFAH1B1 -0.8198 
mmu-miR-132 MAPK1 0.4925 
mmu-miR-132 USP9X -0.8191 
mmu-miR-132 BID -0.0713 
mmu-miR-132 ATP1B3 -1.0636 
mmu-miR-132 FABP5 -0.0717 
mmu-miR-132 LARP7 -0.5973 
mmu-miR-132 TSR1 -0.4703 
mmu-miR-132 SIN3A -0.0937 
mmu-miR-132 P4HA1 -0.4444 
mmu-miR-132 LCP2 -0.2306 
mmu-miR-132 PPM1G 0.2839 
mmu-miR-132 LCP1 -0.8227 
mmu-miR-132 DDX5 -0.9687 
mmu-miR-132 TSN -0.3062 
mmu-miR-132 PIGS -0.1314 
mmu-miR-132 ZC3H14 -0.5976 
mmu-miR-132 OGT 0.8883 
24 hour Lipopolysaccharide Exposures Down 
Regulated miRNAs Downstream Target 
Interaction Predictions by Decision Tree Analysis 
miRNA 
Transcript 
Protein 
Symbol 
Interaction 
Probability Z-
Score 
mmu-miR-132 NOL6 -0.3500 
mmu-miR-132 CSDE1 1.0553 
mmu-miR-132 DNAJC9 1.0366 
mmu-miR-132 SAR1A -0.0760 
mmu-miR-132 EIF2S2 -1.1227 
mmu-miR-132 CSTF3 2.4304 
mmu-miR-132 DPY30 -0.8155 
mmu-miR-132 RNASEH2C 1.1199 
mmu-miR-132 NDUFC2 2.2226 
mmu-miR-132 GMFB -1.0287 
mmu-miR-132 HNRNPM 0.3762 
mmu-miR-132 OXCT1 0.0776 
mmu-miR-132 ACP1 -1.1700 
mmu-miR-132 PRKAR1A -1.0013 
mmu-miR-132 AP3S1 -0.8245 
mmu-miR-132 TXNRD1 0.1661 
mmu-miR-132 DNAJA2 -0.9337 
mmu-miR-132 DSTN 0.4241 
mmu-miR-132 TFG -0.2618 
mmu-miR-181a BZW1 -0.9510 
mmu-miR-181a PRRC2C -0.0265 
mmu-miR-181a VCPIP1 0.5101 
mmu-miR-181a TFAM 1.3243 
mmu-miR-181a ARFGEF2 -0.3569 
mmu-miR-181a LASP1 -0.8820 
mmu-miR-181a AGPS 1.8576 
mmu-miR-181a IGF2BP2 -0.6804 
mmu-miR-181a RBM25 -0.0941 
mmu-miR-181a CARM1 -0.2313 
mmu-miR-181a TMEM109 3.3036 
mmu-miR-181a ACSL1 -0.1884 
mmu-miR-181a XPO7 -0.5377 
mmu-miR-181a LARP4 1.0867 
mmu-miR-181a BTAF1 -0.3825 
mmu-miR-181a LYPLAL1 0.3856 
mmu-miR-181a SEC24C 0.2423 
mmu-miR-181a CPSF6 -0.0997 
mmu-miR-181a DPYSL2 0.4822 
24 hour Lipopolysaccharide Exposures Down 
Regulated miRNAs Downstream Target 
Interaction Predictions by Decision Tree Analysis 
miRNA 
Transcript 
Protein 
Symbol 
Interaction 
Probability Z-
Score 
mmu-miR-181a AP1G1 0.2735 
mmu-miR-181a RDX 0.2429 
mmu-miR-181a PLAA 1.5227 
mmu-miR-181a BRCC3 -0.5092 
mmu-miR-181a CAPZA1 -0.4075 
mmu-miR-181a SRP9 -0.5282 
mmu-miR-181a ATP6V1A -0.6275 
mmu-miR-181a BCL2L13 -0.1339 
mmu-miR-181a COPS2 -0.3774 
mmu-miR-181a YWHAG -1.4486 
mmu-miR-181a YWHAE 0.2348 
mmu-miR-181a VAMP3 0.5431 
mmu-miR-181a RPL22 0.4717 
mmu-miR-181a PDIA6 1.8801 
mmu-miR-181a LBR -1.1136 
mmu-miR-181a ERMP1 1.0143 
mmu-miR-181a RBBP7 -0.5644 
mmu-miR-181a SOAT1 -1.1682 
mmu-miR-181a DDX3X -0.3232 
mmu-miR-181a TSN -0.6602 
mmu-miR-181a GALK2 0.3346 
mmu-miR-181a SPCS3 -1.0175 
mmu-miR-181a LUC7L2 -0.7892 
mmu-miR-181a SLC25A12 -1.0125 
mmu-miR-181a NUDT9 -0.8206 
mmu-miR-181a AQR 1.3489 
mmu-miR-181a SMC2 0.9805 
mmu-miR-181a PDLIM5 -1.3513 
mmu-miR-181a PAK2 0.9685 
mmu-miR-181a AFG3L2 0.7182 
mmu-miR-181a UBQLN1 -0.6273 
mmu-miR-181a COPS8 -0.1234 
mmu-miR-181a SMARCA5 0.4860 
mmu-miR-181a RRAGC -0.9789 
mmu-miR-181a RTN4 -0.0614 
mmu-miR-181a ATP5L -1.0275 
mmu-miR-181a LAP3 -0.1556 
mmu-miR-181a RNMT 1.1227 
24 hour Lipopolysaccharide Exposures Down 
Regulated miRNAs Downstream Target 
Interaction Predictions by Decision Tree Analysis 
miRNA 
Transcript 
Protein 
Symbol 
Interaction 
Probability Z-
Score 
mmu-miR-181a ACP1 -0.9383 
mmu-miR-181a EHD4 -0.6661 
mmu-miR-181a HYOU1 1.4835 
mmu-miR-181a CD2AP 2.1125 
mmu-miR-181a PTGES3 -0.6126 
mmu-miR-181a SUCLG2 -0.2014 
mmu-miR-210 NDUFA4 -0.0216 
mmu-miR-210 UBTF 0.9728 
mmu-miR-210 ISCU -1.3630 
mmu-miR-210 WIZ -1.4655 
mmu-miR-210 EIF4G2 -0.7283 
mmu-miR-210 PRKACB 0.5658 
mmu-miR-210 TPM3 0.1849 
mmu-miR-210 SIN3A 0.7418 
mmu-miR-210 SPCS3 -1.3404 
mmu-miR-210 MYO5A -0.1236 
mmu-miR-212 BCLAF1 -0.2706 
mmu-miR-212 MAP4K4 -0.9229 
mmu-miR-212 HMGB1 1.1805 
mmu-miR-212 LMNB2 0.8838 
mmu-miR-212 OSBPL8 -0.6167 
mmu-miR-212 NUP98 1.2617 
mmu-miR-212 MRPS12 -0.3302 
mmu-miR-212 CLPB 0.6709 
mmu-miR-212 LARP4 0.9095 
mmu-miR-212 NOLC1 0.7768 
mmu-miR-212 IPO9 -0.9675 
mmu-miR-212 EML4 -0.8699 
mmu-miR-212 REEP5 0.0683 
mmu-miR-212 STX7 -0.5285 
mmu-miR-212 WDR1 0.3833 
mmu-miR-212 PRKACB -0.5351 
mmu-miR-212 RRM1 -0.1746 
mmu-miR-212 SOD2 -0.5898 
mmu-miR-212 SUB1 -0.4538 
mmu-miR-212 AP1G1 -0.7106 
mmu-miR-212 SNRPB 0.7235 
mmu-miR-212 CCT8 1.9753 
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Table E2b. 24 hour Lipopolysaccharide Exposures Down-Regulated microRNAs Downstream Target Interaction Predictions 
by Decision Tree Analysis 
 
24 hour Lipopolysaccharide Exposures Down 
Regulated miRNAs Downstream Target 
Interaction Predictions by Decision Tree Analysis 
miRNA 
Transcript 
Protein 
Symbol 
Interaction 
Probability Z-
Score 
mmu-miR-212 HMGA2 -1.4496 
mmu-miR-212 ACTR2 0.9939 
mmu-miR-212 CALM1 -0.9735 
mmu-miR-212 MAPK1 -1.2817 
mmu-miR-212 USP9X 0.8740 
mmu-miR-212 MCM2 0.9528 
mmu-miR-212 PSMD1 1.1347 
mmu-miR-212 TTLL12 -0.8451 
mmu-miR-212 SIRT1 0.5763 
mmu-miR-212 OGDH 0.0888 
mmu-miR-212 CAPRIN1 -1.1628 
mmu-miR-212 DDX19B 0.8313 
mmu-miR-212 HSPH1 -0.0354 
mmu-miR-212 SORD 0.2129 
mmu-miR-212 ABCF1 -0.9505 
mmu-miR-212 PIGS -0.8994 
mmu-miR-212 LNPEP -0.0745 
mmu-miR-212 MYH9 0.7383 
mmu-miR-212 CSDE1 1.1412 
mmu-miR-212 EIF3H -0.7527 
mmu-miR-212 NLN 0.1447 
mmu-miR-212 WDR77 0.5583 
mmu-miR-212 ACTR3 1.8723 
mmu-miR-212 RRAGC 1.3472 
mmu-miR-212 DPP3 -0.8250 
mmu-miR-212 MAT2B -0.7963 
mmu-miR-212 PSMD12 0.3027 
mmu-miR-212 UPF1 -0.7884 
mmu-miR-212 SH3BGRL -0.2158 
mmu-miR-212 DNAJA2 -1.3737 
mmu-miR-212 DSTN 0.4148 
mmu-miR-212 TIMM9 1.0450 
mmu-miR-212 UBA2 0.6737 
mmu-miR-212 SUCLA2 1.9044 
mmu-miR-26a FAIM -1.2812 
mmu-miR-26a MDN1 -0.5077 
mmu-miR-26a ACSL3 -1.5519 
mmu-miR-26a NAA15 -1.1807 
24 hour Lipopolysaccharide Exposures Down 
Regulated miRNAs Downstream Target 
Interaction Predictions by Decision Tree Analysis 
miRNA 
Transcript 
Protein 
Symbol 
Interaction 
Probability Z-
Score 
mmu-miR-26a CPSF6 0.0166 
mmu-miR-26a KPNA6 0.5837 
mmu-miR-26a MTX2 1.0852 
mmu-miR-26a COX5A -0.1871 
mmu-miR-26a HMGA1 2.3210 
mmu-miR-26a FKBP1A nan 
mmu-miR-26a PRKCD 0.5049 
mmu-miR-26a KPNA2 1.0245 
mmu-miR-26a EIF5 -0.3326 
mmu-miR-26a UBE2G1 1.1159 
mmu-miR-26a USP9X 0.4639 
mmu-miR-26a EIF2S1 -0.9444 
mmu-miR-26a SLC38A2 0.9444 
mmu-miR-26a RBM39 -0.3041 
mmu-miR-26a TWF1 -0.9441 
mmu-miR-26a GRPEL1 1.4257 
mmu-miR-26a GMFB 0.4795 
mmu-miR-26a SERBP1 1.3354 
mmu-miR-26a LMAN1 -0.8018 
mmu-miR-26a TRAPPC6B -1.2711 
mmu-miR-342 CAPZB 1.2036 
mmu-miR-342 NIP7 0.8091 
mmu-miR-342 PTPRC -0.1839 
mmu-miR-342 DDX3X -0.1446 
mmu-miR-342 ATXN2L -1.1992 
mmu-miR-342 TM9SF3 -1.2167 
mmu-miR-342 STK4 0.5262 
mmu-miR-34a PPP4R2 1.3183 
mmu-miR-34a NUP210 -1.4769 
mmu-miR-34a TALDO1 -0.9578 
mmu-miR-34a LDHA -1.5235 
mmu-miR-34a DGKZ 0.5271 
mmu-miR-34a STRN3 0.4223 
mmu-miR-34a NINJ1 0.7795 
mmu-miR-34a GLS -0.7532 
mmu-miR-34a DNM1L 0.4861 
mmu-miR-34a ABR 1.1000 
mmu-miR-34a RAP1GDS1 -0.8575 
24 hour Lipopolysaccharide Exposures Down 
Regulated miRNAs Downstream Target 
Interaction Predictions by Decision Tree Analysis 
miRNA 
Transcript 
Protein 
Symbol 
Interaction 
Probability Z-
Score 
mmu-miR-34a LYPLAL1 -1.5458 
mmu-miR-34a NPEPPS 1.2654 
mmu-miR-34a IDE -0.6797 
mmu-miR-34a IKZF1 -0.7576 
mmu-miR-34a ATP6V0A1 -1.1898 
mmu-miR-34a AP1B1 0.8638 
mmu-miR-34a CALU 0.6881 
mmu-miR-34a SNX12 -1.4711 
mmu-miR-34a COPS4 -0.3501 
mmu-miR-34a RPP30 0.5088 
mmu-miR-34a DHFR 0.0979 
mmu-miR-34a ALDOA 0.1324 
mmu-miR-34a MARCKS -1.4436 
mmu-miR-34a MAP2K1 -0.8526 
mmu-miR-34a PITPNB 0.9405 
mmu-miR-34a GFER -0.1539 
mmu-miR-34a RAB8B -0.8227 
mmu-miR-34a LSM6 1.5312 
mmu-miR-34a SUMO1 -1.4505 
mmu-miR-34a BID -0.0374 
mmu-miR-34a DDX17 0.7752 
mmu-miR-34a MCM5 -1.5159 
mmu-miR-34a DNAJC11 -1.0837 
mmu-miR-34a VAT1 0.1519 
mmu-miR-34a VCL -1.3288 
mmu-miR-34a LIMD2 -0.9880 
mmu-miR-34a METAP1 -0.4732 
mmu-miR-34a HEATR3 0.1672 
mmu-miR-34a SLC44A2 0.5515 
mmu-miR-34a DOCK8 0.2866 
mmu-miR-34a PPWD1 -0.9393 
mmu-miR-34a PDXK -0.2516 
mmu-miR-34a THUMPD1 1.3347 
mmu-miR-34a ADI1 1.4485 
mmu-miR-34a SAR1A -0.3823 
mmu-miR-34a NONO 1.6530 
mmu-miR-34a RRAGC -1.1942 
mmu-miR-34a DPP3 -1.6297 
24 hour Lipopolysaccharide Exposures Down 
Regulated miRNAs Downstream Target 
Interaction Predictions by Decision Tree Analysis 
miRNA 
Transcript 
Protein 
Symbol 
Interaction 
Probability Z-
Score 
mmu-miR-34a ADRBK1 -0.3630 
mmu-miR-34a OGFR -0.3724 
mmu-miR-34a GMFB -0.6064 
mmu-miR-34a TMED5 1.0456 
mmu-miR-34a LMAN1 -0.7757 
mmu-miR-34a ATP6V1F -1.0487 
mmu-miR-34a CORO7 0.2337 
mmu-miR-34a ATP13A1 -1.3527 
mmu-miR-34a LIMA1 -1.0600 
mmu-miR-34a ACSL4 0.5406 
mmu-miR-34a PIN1 -1.0000 
mmu-miR-34a CORO1B 0.9734 
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Appendix F: 24 hour Ethanol Exposures Regulated microRNAs Downstream Target Interaction Predictions by Decision Tree 
Analysis 
Table F1a. 24 hour Ethanol Exposures Up-Regulated microRNAs Downstream Target Interaction Predictions by Decision 
Tree Analysis 
 
24 hour Ethanol Exp s res Up Regulated miRNAs Downstream Target Interaction Pre ictions by Decision Tree 
Analysis 
 
24 hour Ethanol Exposures Up Regulated 
miRNAs Downstream Target Interaction 
Predictions by Decision Tree Analysis 
miRNA 
Transcript 
Protein 
Symbol 
Interaction 
Probability 
Z-Score 
mmu-let-7e BZW1 1.4105 
mmu-let-7e IGF2BP2 -1.4676 
mmu-let-7e EIF4G2 -0.0251 
mmu-let-7e HMGA1 -0.5709 
mmu-let-7e RDX -0.5441 
mmu-let-7e HMGA2 -0.1045 
mmu-let-7e IKBKAP 0.0227 
mmu-let-7e PRPF38B 0.1835 
mmu-let-7e LIMD2 -1.3985 
mmu-let-7e EEA1 -1.0546 
mmu-let-7e MYO1F 0.1896 
mmu-let-7e HDLBP 1.1162 
mmu-let-7e BZW2 -0.0589 
mmu-let-7e IGF2BP3 0.2837 
mmu-let-7e TMED5 0.6342 
mmu-let-7e TOR1AIP2 -0.7371 
mmu-let-7e DNAJA2 0.5938 
mmu-let-7e NME4 -0.7877 
mmu-let-7f BZW1 1.3867 
mmu-let-7f SYNCRIP 0.0670 
mmu-let-7f IGF2BP2 -1.3575 
mmu-let-7f GLS 1.4227 
mmu-let-7f CLPB 1.5170 
mmu-let-7f PRKACB 1.0144 
mmu-let-7f HMGA1 -0.4351 
mmu-let-7f RDX -0.1996 
mmu-let-7f PLAA 1.0974 
mmu-let-7f HMGA2 0.3144 
mmu-let-7f RAB8B -0.2694 
mmu-let-7f IKBKAP 0.1614 
mmu-let-7f PRPF38B 0.4632 
mmu-let-7f EEA1 -0.8878 
mmu-let-7f HDLBP 1.1885 
mmu-let-7f IGF2BP3 0.4306 
mmu-let-7f TMED5 0.6842 
mmu-let-7f TOR1AIP2 -0.8501 
24 hour Ethanol Exposures Up Regulated 
miRNAs Downstream Target Interaction 
Predictions by Decision Tree Analysis 
miRNA 
Transcript 
Protein 
Symbol 
Interaction 
Probability 
Z-Score 
mmu-let-7f NME4 -0.6784 
mmu-miR-125a PDXDC1 0.0040 
mmu-miR-125a ARFIP1 2.0863 
mmu-miR-125a FLNA -0.1549 
mmu-miR-125a RPS6KA1 -1.3247 
mmu-miR-125a NUMA1 -0.8474 
mmu-miR-125a GLG1 0.1532 
mmu-miR-125a CPSF6 -1.2586 
mmu-miR-125a BET1 -1.2793 
mmu-miR-125a CALU 1.9118 
mmu-miR-125a EIF6 1.2666 
mmu-miR-125a ENO1 -1.0677 
mmu-miR-125a HSPA5 -0.0178 
mmu-miR-125a VPS4B 0.6271 
mmu-miR-125a SLC16A1 1.2031 
mmu-miR-125a NPLOC4 -0.6711 
mmu-miR-125a RAB8B -0.4968 
mmu-miR-125a PPP1CB 1.6718 
mmu-miR-125a ITGA4 -1.4954 
mmu-miR-125a PTPN18 -0.7264 
mmu-miR-125a PCBP2 -0.3224 
mmu-miR-125a SUPT6H 0.3126 
mmu-miR-125a NAA25 1.2374 
mmu-miR-125a PPWD1 -0.4835 
mmu-miR-125a PPM1F -0.7820 
mmu-miR-125a POLDIP2 3.5412 
mmu-miR-125a GMFB -0.6737 
mmu-miR-125a PSMG3 -0.8872 
mmu-miR-125a SEC13 0.6982 
mmu-miR-125a TRAPPC6B 1.1176 
mmu-miR-125a PSMD12 -0.9841 
mmu-miR-125a SAE1 -0.6830 
mmu-miR-125a TIMM8A1 -1.1589 
mmu-miR-181d MAGOHB 2.0736 
mmu-miR-181d RBPJ -0.3110 
mmu-miR-181d TFAM 0.6381 
mmu-miR-181d 8-Sep -0.8298 
mmu-miR-181d CARM1 -0.2169 
24 hour Ethanol Exposures Up Regulated 
miRNAs Downstream Target Interaction 
Predictions by Decision Tree Analysis 
miRNA 
Transcript 
Protein 
Symbol 
Interaction 
Probability 
Z-Score 
mmu-miR-181d ACSL1 -1.1072 
mmu-miR-181d GLS 0.2485 
mmu-miR-181d LARP4 1.0530 
mmu-miR-181d ITGAM -0.4526 
mmu-miR-181d SEC24C 0.1624 
mmu-miR-181d API5 -0.7565 
mmu-miR-181d IDH1 1.3016 
mmu-miR-181d PCNA 0.2637 
mmu-miR-181d PRKCD 0.8670 
mmu-miR-181d OAT 1.0815 
mmu-miR-181d SSB -0.0277 
mmu-miR-181d COPS2 0.4929 
mmu-miR-181d EIF5B 2.1549 
mmu-miR-181d RBBP7 0.7788 
mmu-miR-181d CTCF 1.3859 
mmu-miR-181d RAD21 0.6524 
mmu-miR-181d DDX3X 1.2292 
mmu-miR-181d DOCK2 -0.2719 
mmu-miR-181d TCERG1 1.0967 
mmu-miR-181d LYRM4 2.0375 
mmu-miR-181d ARRB2 1.3919 
mmu-miR-181d DERL1 0.0689 
mmu-miR-181d ME2 1.1669 
mmu-miR-181d PWP1 -1.4406 
mmu-miR-181d RNMT 1.0616 
mmu-miR-181d EHD4 -0.9561 
mmu-miR-181d CD2AP 2.0201 
mmu-miR-181d ACSL4 -0.6440 
mmu-miR-186 CUL4B -1.3418 
mmu-miR-186 SUZ12 0.0815 
mmu-miR-186 7-Sep -0.4037 
mmu-miR-186 ADD1 1.2046 
mmu-miR-186 IFI204 0.0825 
mmu-miR-186 TPR -1.1992 
mmu-miR-186 SPP1 nan 
mmu-miR-186 BCL2L13 -1.5938 
mmu-miR-186 CDC42 -1.6450 
mmu-miR-186 PPP1CB -0.3997 
24 hour Ethanol Exposures Up Regulated 
miRNAs Downstream Target Interaction 
Predictions by Decision Tree Analysis 
miRNA 
Transcript 
Protein 
Symbol 
Interaction 
Probability 
Z-Score 
mmu-miR-186 NUP35 0.8618 
mmu-miR-186 SAR1A 0.3239 
mmu-miR-186 RNF2 0.4318 
mmu-miR-186 GNAI3 -0.7367 
mmu-miR-186 HYOU1 0.6460 
mmu-miR-186 SUCLA2 0.4013 
mmu-miR-21a ZNF207 0.5882 
mmu-miR-223 CDV3 1.1045 
mmu-miR-223 EEFSEC -1.0852 
mmu-miR-223 PPP4R2 -0.5533 
mmu-miR-223 NUP210 -0.9942 
mmu-miR-223 KCTD12 1.4174 
mmu-miR-223 ASPH 1.0702 
mmu-miR-223 8-Sep -1.2746 
mmu-miR-223 MACF1 -0.5930 
mmu-miR-223 GEMIN5 1.0655 
mmu-miR-223 WDFY4 0.6846 
mmu-miR-223 USP14 -0.4405 
mmu-miR-223 IPO9 -0.4247 
mmu-miR-223 CTSA 1.0856 
mmu-miR-223 ATP2B1 2.0583 
mmu-miR-223 VIM -0.7448 
mmu-miR-223 FCER1G -0.6931 
mmu-miR-223 KRAS -0.4045 
mmu-miR-223 POLA2 1.4183 
mmu-miR-223 DDX6 -0.3447 
mmu-miR-223 RAB10 0.2138 
mmu-miR-223 CYCS 0.6705 
mmu-miR-223 YWHAZ 1.4207 
mmu-miR-223 UBE2I 0.2280 
mmu-miR-223 YWHAH -1.3386 
mmu-miR-223 SBDS 1.1932 
mmu-miR-223 PSMD8 0.3095 
mmu-miR-223 DDX17 0.2478 
mmu-miR-223 GIT1 1.0775 
mmu-miR-223 VPS41 -1.0448 
mmu-miR-223 VDAC1 -0.4425 
mmu-miR-223 CYBB 1.0969 
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Table F1b. 24 hour Ethanol Exposures Up-Regulated microRNAs Downstream Target Interaction Predictions by Decision 
Tree Analysis 
  
24 hour Ethanol Exposures Up Regulated 
miRNAs Downstream Target Interaction 
Predictions by Decision Tree Analysis 
miRNA 
Transcript 
Protein 
Symbol 
Interaction 
Probability 
Z-Score 
mmu-miR-223 BCAP29 1.2931 
mmu-miR-223 CBX5 0.4970 
mmu-miR-223 ABCF1 -0.7590 
mmu-miR-223 DEK -0.0239 
mmu-miR-223 EEA1 -0.4545 
mmu-miR-223 DOCK8 1.2107 
mmu-miR-223 MMGT1 -1.1449 
mmu-miR-223 RRAGC 0.9347 
mmu-miR-223 IGF2BP3 -1.0228 
mmu-miR-223 DUT 0.1678 
mmu-miR-223 MTAP -1.2883 
mmu-miR-223 TXNDC12 0.3880 
mmu-miR-223 CYB5B 0.3789 
mmu-miR-223 TMED5 -0.4245 
mmu-miR-223 OLA1 -0.3672 
mmu-miR-223 CS -0.9982 
mmu-miR-223 TRAPPC6B -0.4774 
mmu-miR-223 NOL7 0.6127 
mmu-miR-223 DNAJC10 -0.2613 
mmu-miR-223 TM9SF3 -1.0106 
mmu-miR-223 PSMA6 1.0540 
mmu-miR-223 USO1 -0.1501 
mmu-miR-223 LETM1 -0.3349 
mmu-miR-26b FAIM -1.2692 
mmu-miR-26b MDN1 -0.3881 
mmu-miR-26b ACSL3 -0.9573 
mmu-miR-26b CPSF6 -0.0436 
mmu-miR-26b KPNA6 0.4753 
mmu-miR-26b MTX2 0.8852 
mmu-miR-26b HMGA1 2.0096 
mmu-miR-26b PRKCD 0.4040 
mmu-miR-26b KPNA2 0.9308 
mmu-miR-26b EIF5 -0.3866 
mmu-miR-26b UBE2G1 0.9857 
mmu-miR-26b USP9X 0.3606 
mmu-miR-26b DDX17 -0.7729 
mmu-miR-26b EIF2S1 -1.1613 
mmu-miR-26b RAP2C 1.4121 
24 hour Ethanol Exposures Up Regulated 
miRNAs Downstream Target Interaction 
Predictions by Decision Tree Analysis 
miRNA 
Transcript 
Protein 
Symbol 
Interaction 
Probability 
Z-Score 
mmu-miR-26b SLC38A2 0.8198 
mmu-miR-26b GSPT1 -1.0000 
mmu-miR-26b TWF1 -0.9178 
mmu-miR-26b GRPEL1 1.2445 
mmu-miR-26b GMFB 0.3760 
mmu-miR-26b TRAPPC6B -1.1575 
mmu-miR-26b NUP50 -0.3442 
mmu-miR-33 FUBP1 -0.9486 
mmu-miR-33 RBPJ -0.0463 
mmu-miR-33 UBE2K -0.5645 
mmu-miR-33 VCPIP1 -0.5795 
mmu-miR-33 PPP4R2 -1.0000 
mmu-miR-33 MORF4L2 -0.1082 
mmu-miR-33 CLCC1 1.7710 
mmu-miR-33 MPP1 -1.0267 
mmu-miR-33 DYNC1I2 1.0598 
mmu-miR-33 LIG3 -0.2733 
mmu-miR-33 RBM25 -0.8010 
mmu-miR-33 CAV2 -0.5285 
mmu-miR-33 CTNND1 -1.4227 
mmu-miR-33 NUDCD2 -0.4142 
mmu-miR-33 CUL5 0.4567 
mmu-miR-33 USP7 -1.1602 
mmu-miR-33 NCF1 -0.9627 
mmu-miR-33 HECTD1 1.4122 
mmu-miR-33 REEP5 0.7969 
mmu-miR-33 ARHGEF2 0.4138 
mmu-miR-33 GTPBP1 1.2219 
mmu-miR-33 STX7 -0.2685 
mmu-miR-33 HNRNPA2B1 -0.1260 
mmu-miR-33 EEF1A1 0.4572 
mmu-miR-33 TPM3 -0.7093 
mmu-miR-33 FKBP4 -0.9953 
mmu-miR-33 BRCC3 1.3688 
mmu-miR-33 RAD23B -0.0108 
mmu-miR-33 MAPK1 -0.5323 
mmu-miR-33 PPP1CC -0.0776 
mmu-miR-33 GNG2 2.2167 
24 hour Ethanol Exposures Up Regulated 
miRNAs Downstream Target Interaction 
Predictions by Decision Tree Analysis 
miRNA 
Transcript 
Protein 
Symbol 
Interaction 
Probability 
Z-Score 
mmu-miR-33 YWHAH -0.3874 
mmu-miR-33 TOP2A -0.8365 
mmu-miR-33 LARP7 1.0591 
mmu-miR-33 NPM1 1.3725 
mmu-miR-33 LCP1 -0.5183 
mmu-miR-33 KIF15 -0.4420 
mmu-miR-33 OXSR1 -0.2721 
mmu-miR-33 TM9SF4 -0.8165 
mmu-miR-33 NOL11 -0.4274 
mmu-miR-33 CPNE3 -0.7332 
mmu-miR-33 MINA 2.8989 
mmu-miR-33 NEK9 -0.1871 
mmu-miR-33 LZIC 0.8094 
mmu-miR-33 CSDE1 -1.1826 
mmu-miR-33 TWF1 -1.0870 
mmu-miR-33 FAR1 0.9819 
mmu-miR-33 HADHB -0.3401 
mmu-miR-33 RRAGC 0.4378 
mmu-miR-33 UQCRFS1 1.0000 
mmu-miR-33 SNX2 1.0772 
mmu-miR-33 SERBP1 -1.2970 
mmu-miR-33 OLA1 -0.8208 
mmu-miR-33 FUNDC2 -0.3861 
mmu-miR-33 CYB5R1 -0.6324 
mmu-miR-33 GNAI3 -1.0691 
mmu-miR-33 CSE1L 1.3648 
mmu-miR-33 WDR12 1.6213 
mmu-miR-33 SLC25A13 -0.5057 
mmu-miR-33 CLIC4 -0.5599 
mmu-miR-33 DNAJA2 -0.6914 
mmu-miR-33 IK 0.0142 
mmu-miR-33 USO1 0.7140 
mmu-miR-340 HMGB1 0.0449 
mmu-miR-340 CYFIP1 -1.2926 
mmu-miR-340 CAV2 -0.5381 
mmu-miR-340 2-Sep -0.6360 
mmu-miR-340 CDC42 0.6557 
mmu-miR-340 HP1BP3 -0.4760 
24 hour Ethanol Exposures Up Regulated 
miRNAs Downstream Target Interaction 
Predictions by Decision Tree Analysis 
miRNA 
Transcript 
Protein 
Symbol 
Interaction 
Probability 
Z-Score 
mmu-miR-340 MAT2A 0.6487 
mmu-miR-340 NOC3L 0.7157 
mmu-miR-340 IGF2BP3 0.6631 
mmu-miR-340 SERBP1 -0.0551 
mmu-miR-7a ARL8B 0.1906 
mmu-miR-7a MARK2 -0.8886 
mmu-miR-7a NUP210 0.2306 
mmu-miR-7a VDAC3 0.6093 
mmu-miR-7a ARFGEF2 -0.4138 
mmu-miR-7a RBMX 3.1643 
mmu-miR-7a IGF2BP2 -0.5023 
mmu-miR-7a 8-Sep -0.6545 
mmu-miR-7a RBM25 1.1718 
mmu-miR-7a TMEM109 -0.1002 
mmu-miR-7a CTNND1 -1.0147 
mmu-miR-7a RBM26 0.7626 
mmu-miR-7a PISD -0.9742 
mmu-miR-7a CLPB -0.1459 
mmu-miR-7a PTK2B 0.5040 
mmu-miR-7a GTF3C4 2.5975 
mmu-miR-7a NUMA1 0.4234 
mmu-miR-7a FMR1 -0.1148 
mmu-miR-7a LYPLAL1 -0.9168 
mmu-miR-7a FXYD5 -0.8896 
mmu-miR-7a STXBP2 1.8068 
mmu-miR-7a SPR 0.0655 
mmu-miR-7a ITGB2 2.5244 
mmu-miR-7a DPYSL2 1.5513 
mmu-miR-7a METAP2 -0.8120 
mmu-miR-7a SNX3 -1.0168 
mmu-miR-7a AKAP10 -0.0473 
mmu-miR-7a TPP1 -0.5449 
mmu-miR-7a CTSB -1.1748 
mmu-miR-7a SLC3A2 -1.1109 
mmu-miR-7a CALR -1.0022 
mmu-miR-7a U2AF2 -1.0676 
mmu-miR-7a RAB18 -1.0741 
mmu-miR-7a CANX -0.4473 
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Table F1c. 24 hour Ethanol Exposures Up-Regulated microRNAs Downstream Target Interaction Predictions by Decision 
Tree Analysis 
 
24 hour Ethanol Exposures Up Regulated 
miRNAs Downstream Target Interaction 
Predictions by Decision Tree Analysis 
miRNA 
Transcript 
Protein 
Symbol 
Interaction 
Probability 
Z-Score 
mmu-miR-7a ACADM 1.2027 
mmu-miR-7a SLC16A3 -0.9927 
mmu-miR-7a CDC42 -0.8452 
mmu-miR-7a RAB8B 0.6070 
mmu-miR-7a PSME3 -1.3211 
mmu-miR-7a ARF4 -1.1229 
mmu-miR-7a ARF6 0.7213 
mmu-miR-7a YWHAZ -0.3127 
mmu-miR-7a PEBP1 1.6551 
mmu-miR-7a ELAVL1 -1.3824 
mmu-miR-7a RAD50 -0.3337 
mmu-miR-7a SLC9A3R1 -0.4568 
mmu-miR-7a G3BP2 -1.0286 
mmu-miR-7a BOP1 2.4106 
mmu-miR-7a HP1BP3 -0.3812 
mmu-miR-7a HSPA4 1.2510 
mmu-miR-7a ALDH9A1 0.2198 
mmu-miR-7a LBR 0.1813 
mmu-miR-7a SNX27 -0.7007 
mmu-miR-7a ERMP1 -0.4561 
mmu-miR-7a ARCN1 2.3467 
mmu-miR-7a HELLS 0.6864 
mmu-miR-7a CAPRIN1 -0.8967 
mmu-miR-7a CTCF 1.5509 
mmu-miR-7a LCP1 -1.3313 
mmu-miR-7a RAD21 -0.5162 
mmu-miR-7a DDX5 0.3848 
mmu-miR-7a CD180 2.4600 
mmu-miR-7a TPM4 -0.1527 
mmu-miR-7a SRI -0.1624 
mmu-miR-7a CAND1 -0.3373 
mmu-miR-7a SND1 0.5293 
mmu-miR-7a ATG2B -1.4044 
mmu-miR-7a TNPO1 0.9746 
mmu-miR-7a PTBP1 1.3510 
mmu-miR-7a PSMF1 0.9946 
mmu-miR-7a GANAB 0.0212 
mmu-miR-7a PSMD5 -0.9306 
24 hour Ethanol Exposures Up Regulated 
miRNAs Downstream Target Interaction 
Predictions by Decision Tree Analysis 
miRNA 
Transcript 
Protein 
Symbol 
Interaction 
Probability 
Z-Score 
mmu-miR-7a CPNE3 -0.3695 
mmu-miR-7a IARS -0.8633 
mmu-miR-7a PDCL3 -0.5946 
mmu-miR-7a SNX18 0.4922 
mmu-miR-7a UTP15 -0.0619 
mmu-miR-7a PRPF31 0.0784 
mmu-miR-7a SLC38A2 -0.7639 
mmu-miR-7a RAB14 -0.8128 
mmu-miR-7a DR1 -0.3444 
mmu-miR-7a PARP1 -1.4096 
mmu-miR-7a EIF2S2 -0.2202 
mmu-miR-7a IGF2BP3 -0.7741 
mmu-miR-7a RGS10 -0.4278 
mmu-miR-7a OLA1 -0.7258 
mmu-miR-7a CS 0.5806 
mmu-miR-7a RFC5 0.3041 
mmu-miR-7a MRPS25 0.2259 
mmu-miR-7a IDH3A -0.5095 
mmu-miR-7a MRPL17 0.3302 
mmu-miR-7a NAPA -1.2627 
mmu-miR-7a AKAP8 0.6994 
mmu-miR-7a DNAJC10 1.3961 
mmu-miR-7a TM9SF3 -1.0788 
mmu-miR-7a IQGAP1 1.8559 
mmu-miR-7a ACSL4 -1.2624 
mmu-miR-7a PLEC -1.1787 
mmu-miR-7a PLOD3 3.9209 
mmu-miR-7a MYO1C -0.3274 
mmu-miR-7a CORO1C 1.3655 
mmu-miR-98 BZW1 1.3693 
mmu-miR-98 SYNCRIP -0.0828 
mmu-miR-98 IGF2BP2 -1.2830 
mmu-miR-98 QARS -1.0518 
mmu-miR-98 HMGA1 -0.4265 
mmu-miR-98 RDX -0.1606 
mmu-miR-98 HMGA2 -0.0081 
mmu-miR-98 RAB8B -0.6347 
mmu-miR-98 IKBKAP 0.2022 
24 hour Ethanol Exposures Up Regulated 
miRNAs Downstream Target Interaction 
Predictions by Decision Tree Analysis 
miRNA 
Transcript 
Protein 
Symbol 
Interaction 
Probability 
Z-Score 
mmu-miR-98 PRPF38B 0.4344 
mmu-miR-98 EEA1 -0.8442 
mmu-miR-98 NCEH1 nan 
mmu-miR-98 HDLBP 1.1794 
mmu-miR-98 IGF2BP3 0.4450 
mmu-miR-98 TMED5 0.6310 
mmu-miR-98 NME4 -0.6321 
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Table F2. 24 hour Ethanol Exposures Down-Regulated microRNAs Downstream Target Interaction Predictions by Decision 
Tree Analysis 
 
 
24 hour Ethanol Exposures Down Regulated miRNAs Downstream Target Interaction Predictions by Decision 
Tree Analysis 
 
24 hour Ethanol Exposures Down Regulated 
miRNAs Downstream Target Interaction 
Predictions by Decision Tree Analysis 
miRNA 
Transcript 
Protein 
Symbol 
Interaction 
Probability 
Z-Score 
mmu-miR-126a CADM1 1.3806 
mmu-miR-126a TTC39B -0.4250 
mmu-miR-126a FBXO33 -0.9556 
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Appendix G: Protein Assay Results, Including; Standard Curve (Stdcurve) and Calculated Concentrations of Each 24 hour 
Sample 
 
 
 
Figure G1. Protein Assay Results, Including; Standard Curve (Stdcurve) and Calculated Concentrations of Each 24 hour Sample 
 
 116 
 
Appendix H: miRNA-mRNA Transcript Types Expressed Under Each Condition After 24 
hours  
 
 
Figure H1. miRNA-mRNA Transcript Type for 24 hour Lipopolysaccharide Treatment 
 
 
Figure H2. miRNA-mRNA Transcript Type for 24 hour Ethanol Treatment 
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Appendix I: Proteins Identified in IPA from LC-MS/MS for Each Condition After 24 hours 
 
Table I1a. Lipopolysaccharide Proteins Identified in IPA from LC-MS/MS  
 
Lipopolysaccharide Proteins Identified in IPA post L-MS/MS 
 
Lipopolysaccharide Proteins Identified in IPA post L-MS/MS 
Expression 
Fold 
Change 
Symbol Entrez Gene Name Location Type(s) 
189.395 ACOD1 Aconitate Decarboxylase 1 Cytoplasm enzyme 
42.855 B2M Beta-2-Microglobulin Plasma 
Membrane 
transmembrane 
receptor 
42.683 POLR2K RNA Polymerase II Subunit K Nucleus enzyme 
30.111 ISG15 ISG15 Ubiquitin-Like Modifier Extracellular 
Space 
other 
28.107 DBI Diazepam Binding Inhibitor, Acyl-Coa Binding 
Protein 
Cytoplasm other 
26.59 TMCO1 Transmembrane And Coiled-Coil Domains 1 Cytoplasm ion channel 
17.667 ENY2 ENY2, Transcription And Export Complex 2 
Subunit 
Nucleus transcription 
regulator 
15.238 Mcts2 Malignant T Cell Amplified Sequence 2 Other other 
13.575 AP1S1 Adaptor Related Protein Complex 1 Sigma 1 
Subunit 
Cytoplasm transporter 
13.368 GTF2A2 General Transcription Factor IIA Subunit 2 Nucleus transcription 
regulator 
12.834 POMP Proteasome Maturation Protein Nucleus other 
12.481 DLST Dihydrolipoamide S-Succinyltransferase Cytoplasm enzyme 
11.764 MRPL49 Mitochondrial Ribosomal Protein L49 Cytoplasm enzyme 
11.448 ARF6 ADP Ribosylation Factor 6 Plasma 
Membrane 
transporter 
11.179 LRRC25 Leucine Rich Repeat Containing 25 Other other 
10.451 MRPS33 Mitochondrial Ribosomal Protein S33 Cytoplasm other 
10.293 PFDN4 Prefoldin Subunit 4 Cytoplasm other 
10.279 BAX BCL2 Associated X, Apoptosis Regulator Cytoplasm transporter 
10.119 COX7A2 Cytochrome C Oxidase Subunit 7A2 Cytoplasm enzyme 
10.083 UFC1 Ubiquitin-Fold Modifier Conjugating Enzyme 1 Cytoplasm enzyme 
9.991 EMC8 ER Membrane Protein Complex Subunit 8 Cytoplasm other 
9.99 RAB18 RAB18, Member RAS Oncogene Family Cytoplasm enzyme 
9.808 STX7 Syntaxin 7 Plasma 
Membrane 
transporter 
9.472 MRPL48 Mitochondrial Ribosomal Protein L48 Cytoplasm other 
9.374 CERS2 Ceramide Synthase 2 Nucleus transcription 
regulator 
9.003 MRPL40 Mitochondrial Ribosomal Protein L40 Cytoplasm other 
8.637 SPCS3 Signal Peptidase Complex Subunit 3 Cytoplasm peptidase 
7.723 POLR1D RNA Polymerase I Subunit D Nucleus enzyme 
7.576 TMEM109 Transmembrane Protein 109 Cytoplasm other 
6.651 ARFGAP2 ADP Ribosylation Factor Gtpase Activating 
Protein 2 
Nucleus other 
6.648 FAR1 Fatty Acyl-Coa Reductase 1 Cytoplasm enzyme 
Lipopolysaccharide Proteins Identified in IPA post L-MS/MS 
Expression 
Fold 
Change 
Symbol Entrez Gene Name Location Type(s) 
6.236 BID BH3 Interacting Domain Death Agonist Cytoplasm other 
6.052 MRPL57 Mitochondrial Ribosomal Protein L57 Cytoplasm other 
5.894 MTHFD2 Methylenetetrahydrofolate Dehydrogenase 
(NADP+ Dependent) 2, 
Methenyltetrahydrofolate Cyclohydrolase 
Cytoplasm enzyme 
5.637 NIP7 NIP7, Nucleolar Pre-Rrna Processing Protein Nucleus other 
5.276 APOO Apolipoprotein O Extracellular 
Space 
other 
5.253 PTPMT1 Protein Tyrosine Phosphatase, Mitochondrial 1 Cytoplasm phosphatase 
4.818 LGALS9B Galectin 9B Cytoplasm other 
4.723 NDUFAF3 NADH:Ubiquinone Oxidoreductase Complex 
Assembly Factor 3 
Nucleus other 
4.721 SOAT1 Sterol O-Acyltransferase 1 Cytoplasm enzyme 
4.369 RNF213 Ring Finger Protein 213 Cytoplasm enzyme 
4.211 CSTF2 Cleavage Stimulation Factor Subunit 2 Nucleus other 
3.698 PPIB Peptidylprolyl Isomerase B Cytoplasm enzyme 
3.665 TLR2 Toll Like Receptor 2 Plasma 
Membrane 
transmembrane 
receptor 
3.644 ZC3H14 Zinc Finger CCCH-Type Containing 14 Nucleus other 
3.611 CDC37 Cell Division Cycle 37 Cytoplasm kinase 
3.581 EHD1 EH Domain Containing 1 Cytoplasm other 
3.506 VRK1 Vaccinia Related Kinase 1 Nucleus kinase 
3.419 Tpm4 Tropomyosin 4 Cytoplasm other 
3.313 NAA25 N(Alpha)-Acetyltransferase 25, Natb Auxiliary 
Subunit 
Cytoplasm other 
3.279 OAS1 2'-5'-Oligoadenylate Synthetase 1 Cytoplasm enzyme 
3.268 PTK2B Protein Tyrosine Kinase 2 Beta Cytoplasm kinase 
3.258 FTH1 Ferritin Heavy Chain 1 Cytoplasm enzyme 
3.119 BET1 Bet1 Golgi Vesicular Membrane Trafficking 
Protein 
Cytoplasm transporter 
3.044 BLOC1S1 Biogenesis Of Lysosomal Organelles Complex 1 
Subunit 1 
Cytoplasm other 
3.038 LRRC59 Leucine Rich Repeat Containing 59 Cytoplasm other 
2.925 Gm5814 Morf4 Family Associated Protein 1 Pseudogene Other other 
2.863 NFKB2 Nuclear Factor Kappa B Subunit 2 Nucleus transcription 
regulator 
2.858 TMEM11 Transmembrane Protein 11 Plasma 
Membrane 
G-protein 
coupled 
receptor 
2.842 DHFR Dihydrofolate Reductase Nucleus enzyme 
2.761 CYB5B Cytochrome B5 Type B Cytoplasm enzyme 
2.706 PTGES3 Prostaglandin E Synthase 3 Cytoplasm enzyme 
2.677 GSTP1 Glutathione S-Transferase Pi 1 Cytoplasm enzyme 
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Table I1b. Lipopolysaccharide 24 hour Treatment Expressed Proteins Identified in IPA Post LC-MS/MS  
 
  
Lipopolysaccharide Proteins Identified in IPA post L-MS/MS 
Expression 
Fold 
Change 
Symbol Entrez Gene Name Location Type(s) 
2.671 SRXN1 Sulfiredoxin 1 Cytoplasm enzyme 
2.666 NHP2 NHP2 Ribonucleoprotein Nucleus other 
2.634 UBE2L6 Ubiquitin Conjugating Enzyme E2 L6 Cytoplasm enzyme 
2.486 CKS2 CDC28 Protein Kinase Regulatory Subunit 2 Other kinase 
2.447 APOBR Apolipoprotein B Receptor Plasma 
Membrane 
transmembrane 
receptor 
2.353 SSR4 Signal Sequence Receptor Subunit 4 Cytoplasm other 
2.231 RPSA Ribosomal Protein SA Cytoplasm translation 
regulator 
2.211 FABP4 Fatty Acid Binding Protein 4 Cytoplasm transporter 
2.097 EIF2S2 Eukaryotic Translation Initiation Factor 2 
Subunit Beta 
Cytoplasm translation 
regulator 
2.092 Gm10036 Ribosomal Protein L11 Pseudogene Other other 
2.038 EEF1B2 Eukaryotic Translation Elongation Factor 1 Beta 
2 
Cytoplasm translation 
regulator 
2.017 PDIA6 Protein Disulfide Isomerase Family A Member 6 Cytoplasm enzyme 
1.989 LARP4 La Ribonucleoprotein Domain Family Member 
4 
Cytoplasm other 
1.988 RPS19 Ribosomal Protein S19 Cytoplasm other 
1.968 CYBA Cytochrome B-245 Alpha Chain Cytoplasm enzyme 
-2.281 GLOD4 Glyoxalase Domain Containing 4 Cytoplasm enzyme 
-2.284 TBL1X Transducin Beta Like 1X-Linked Nucleus transcription 
regulator 
-2.45 SDHD Succinate Dehydrogenase Complex Subunit D Cytoplasm enzyme 
-2.467 ADD1 Adducin 1 Cytoplasm other 
-2.528 APOE Apolipoprotein E Extracellular 
Space 
transporter 
-2.546 CAMK1 Calcium/Calmodulin Dependent Protein Kinase 
I 
Cytoplasm kinase 
-2.623 NUP54 Nucleoporin 54 Nucleus transporter 
-2.648 LIMS1 LIM Zinc Finger Domain Containing 1 Plasma 
Membrane 
other 
-2.802 EIF4H Eukaryotic Translation Initiation Factor 4H Cytoplasm translation 
regulator 
-3.239 RAB21 RAB21, Member RAS Oncogene Family Cytoplasm enzyme 
-3.245 C1QC Complement C1q C Chain Extracellular 
Space 
peptidase 
-3.294 ETFDH Electron Transfer Flavoprotein Dehydrogenase Cytoplasm enzyme 
-3.46         
-3.582 MRPL19 Mitochondrial Ribosomal Protein L19 Cytoplasm other 
-3.628 GOLGA5 Golgin A5 Cytoplasm kinase 
-4.246 AP4S1 Adaptor Related Protein Complex 4 Sigma 1 
Subunit 
Cytoplasm other 
-4.418 ECH1 Enoyl-Coa Hydratase 1 Cytoplasm enzyme 
Lipopolysaccharide Proteins Identified in IPA post L-MS/MS 
Expression 
Fold 
Change 
Symbol Entrez Gene Name Location Type(s) 
-5.116 OARD1 O-Acyl-ADP-Ribose Deacylase 1 Other enzyme 
-5.143 TSNAX Translin Associated Factor X Nucleus transporter 
-5.16 LGMN Legumain Cytoplasm peptidase 
-6.185 TMA7 Translation Machinery Associated 7 Homolog Other other 
-6.27 ABHD12 Abhydrolase Domain Containing 12 Plasma 
Membrane 
enzyme 
-6.863 Gm16494 Predicted Gene 16494 Other other 
-11.663 DPY30 Dpy-30, Histone Methyltransferase Complex 
Regulatory Subunit 
Nucleus enzyme 
 
 119 
 
Table I2a. Ethanol 24 hour Treatment Expressed Proteins Identified in IPA Post LC-MS/MS  
 
Ethanol Proteins Identified in IPA post L-MS/MS 
 
Ethanol Proteins Identified in IPA post L-MS/MS 
Expression 
Fold 
Change 
Symbol Entrez Gene Name Location Type(s) 
12.841 HPCAL1 Hippocalcin Like 1 Cytoplasm other 
12.39 MCEE Methylmalonyl-Coa Epimerase Cytoplasm enzyme 
9.899 CERS2 Ceramide Synthase 2 Nucleus transcriptio
n regulator 
5.93 MRPL49 Mitochondrial Ribosomal Protein 
L49 
Cytoplasm enzyme 
5.358 PTPMT1 Protein Tyrosine Phosphatase, 
Mitochondrial 1 
Cytoplasm phosphatase 
4.925 DSN1 DSN1 Homolog, MIS12 
Kinetochore Complex 
Component 
Nucleus other 
4.642 CCDC12 Coiled-Coil Domain Containing 
12 
Other other 
4.354 TMEM109 Transmembrane Protein 109 Cytoplasm other 
3.853 RAC1 Rac Family Small Gtpase 1 Plasma 
Membrane 
enzyme 
3.003 VPS29 VPS29, Retromer Complex 
Component 
Cytoplasm transporter 
2.878 RBM8A RNA Binding Motif Protein 8A Nucleus other 
2.845 PTK2B Protein Tyrosine Kinase 2 Beta Cytoplasm kinase 
2.761 SKP1 S-Phase Kinase Associated 
Protein 1 
Nucleus transcriptio
n regulator 
2.608 EIF1AD Eukaryotic Translation Initiation 
Factor 1A Domain Containing 
Nucleus other 
2.55 MRPL21 Mitochondrial Ribosomal Protein 
L21 
Cytoplasm other 
2.526 SRI Sorcin Cytoplasm transporter 
2.514 COPS8 COP9 Signalosome Subunit 8 Nucleus other 
2.457 Rpl23a Ribosomal Protein L23A Nucleus other 
2.413 MRPL13 Mitochondrial Ribosomal Protein 
L13 
Cytoplasm other 
2.379 RPS11 Ribosomal Protein S11 Cytoplasm other 
2.344 RAP1B RAP1B, Member Of RAS 
Oncogene Family 
Cytoplasm enzyme 
2.311 DUSP12 Dual Specificity Phosphatase 12 Nucleus phosphatase 
2.303 UBE2G1 Ubiquitin Conjugating Enzyme 
E2 G1 
Cytoplasm enzyme 
2.201 DNPH1 2'-Deoxynucleoside 5'-Phosphate 
N-Hydrolase 1 
Nucleus enzyme 
2.133 PSMB5 Proteasome Subunit Beta 5 Cytoplasm peptidase 
2.097 GNB1 G Protein Subunit Beta 1 Plasma 
Membrane 
enzyme 
2.001 OASL 2'-5'-Oligoadenylate Synthetase 
Like 
Cytoplasm enzyme 
Ethanol Proteins Identified in IPA post L-MS/MS 
Expression 
Fold 
Change 
Symbol Entrez Gene Name Location Type(s) 
1.839 NDUFB2 NADH:Ubiquinone 
Oxidoreductase Subunit B2 
Cytoplasm enzyme 
1.83 TMEM199 Transmembrane Protein 199 Cytoplasm other 
-2.091 PHPT1 Phosphohistidine Phosphatase 1 Cytoplasm phosphatase 
-2.188 FTL Ferritin Light Chain Cytoplasm enzyme 
-2.2 RNF181 Ring Finger Protein 181 Cytoplasm enzyme 
-2.218 ARHGDIB Rho GDP Dissociation Inhibitor 
Beta 
Cytoplasm enzyme 
-2.333 PPIA Peptidylprolyl Isomerase A Cytoplasm enzyme 
-2.337 UBE2S Ubiquitin Conjugating Enzyme 
E2 S 
Other other 
-2.341 ATL3 Atlastin Gtpase 3 Cytoplasm other 
-2.468 CMC2 C-X9-C Motif Containing 2 Cytoplasm other 
-2.572 AAMP Angio Associated Migratory Cell 
Protein 
Plasma 
Membrane 
other 
-2.879 SNAP23 Synaptosome Associated Protein 
23 
Plasma 
Membrane 
transporter 
-2.993 Gar1 GAR1 Ribonucleoprotein Nucleus other 
-3.178 SLC39A7 Solute Carrier Family 39 Member 
7 
Plasma 
Membrane 
transporter 
-3.385 PNKP Polynucleotide Kinase 3'-
Phosphatase 
Nucleus kinase 
-3.532 TMEM11 Transmembrane Protein 11 Plasma 
Membrane 
G-protein 
coupled 
receptor 
-3.773 MAP1S Microtubule Associated Protein 
1S 
Cytoplasm enzyme 
-5.413 PPIF Peptidylprolyl Isomerase F Cytoplasm enzyme 
-5.675 Gm20498 Predicted Gene 20498 Other other 
-6.106 TMPO Thymopoietin Nucleus other 
-6.211 CISD2 CDGSH Iron Sulfur Domain 2 Cytoplasm other 
-6.296 ARF1 ADP Ribosylation Factor 1 Cytoplasm enzyme 
-8.269 POLE3 DNA Polymerase Epsilon 3, 
Accessory Subunit 
Nucleus enzyme 
-8.287 MYDGF Myeloid Derived Growth Factor Extracellular 
Space 
cytokine 
-8.941 MIF Macrophage Migration Inhibitory 
Factor 
Extracellular 
Space 
cytokine 
-9.73 MVD Mevalonate Diphosphate 
Decarboxylase 
Cytoplasm enzyme 
-10.914 MRPL30 Mitochondrial Ribosomal Protein 
L30 
Cytoplasm other 
-12.361 ADD1 Adducin 1 Cytoplasm other 
-13.78 MPC1 Mitochondrial Pyruvate Carrier 1 Cytoplasm other 
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Table I2b. Ethanol Proteins Identified in IPA from LC-MS/MS  
 
 
Ethanol Proteins Identified in IPA post L-MS/MS 
Expression 
Fold 
Change 
Symbol Entrez Gene Name Location Type(s) 
-14.46 Rbx1 Ring-Box 1 Cytoplasm enzyme 
-15.154 SNRPF Small Nuclear Ribonucleoprotein 
Polypeptide F 
Nucleus other 
-20.457 FAM136A Family With Sequence Similarity 
136 Member A 
Cytoplasm other 
-23.488 GNG12 G Protein Subunit Gamma 12 Plasma 
Membrane 
enzyme 
-24.124 TRAPPC6B Trafficking Protein Particle 
Complex 6B 
Cytoplasm other 
-24.684 SRSF2 Serine And Arginine Rich 
Splicing Factor 2 
Nucleus transcriptio
n regulator 
-96.555 BANF1 Barrier To Autointegration 
Factor 1 
Nucleus other 
-114.812 NME1 NME/NM23 Nucleoside 
Diphosphate Kinase 1 
Cytoplasm kinase 
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Appendix J: Location of Differentially Expressed Proteins Within the Proteome of Each 
Condition after 24 hours of exposure 
 
 
Figure J1. Proteomic Location After 24 hour Lipopolysaccharide Treatment 
 
 
 
 
Figure J2. Proteomic Location After 24 hour Ethanol Treatment 
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Appendix K: Prediction Legend 
 
Figure K. Color prediction legend for images produced in Qiagen, IPA.  
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